data_2jsx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jsx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.418 -2.052 0 CA-C-O 120.978 0.418 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.55 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HB3' HG11 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HG2' ' CG2' ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.66 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 28.7 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.423 HG22 HD23 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.551 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.413 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.461 HG23 HD22 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 HD22 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HG2' HG11 ' A' ' 7' ' ' VAL . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' THR . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t . . . . . 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG21 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 HD12 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.707 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 11' ' ' VAL . 98.1 t . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.388 0.613 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.425 HG13 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.469 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HG3' HG13 ' A' ' 7' ' ' VAL . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.667 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.667 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.451 HG13 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 66' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 121.396 0.617 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.551 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 22' ' ' ILE . 17.4 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 HD23 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.551 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD12 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.613 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.423 HG22 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t . . . . . 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.422 -1.872 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.66 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 26' ' ' LEU . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.643 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.643 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG22 HD23 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.629 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 53' ' ' SER . 7.6 pt20 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.433 0.635 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 27.2 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.537 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.403 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.598 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? . . . . . 0 C--O 1.242 0.661 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.488 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG2' HG12 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 24.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.417 HG21 HD22 ' A' ' 44' ' ' LEU . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 22' ' ' ILE . 20.6 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.061 0.458 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.43 HD12 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.43 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' A' ' 53' ' ' SER . 17.5 mt-30 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 22' ' ' ILE . 15.5 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HE22 ' A' ' 6' ' ' GLN . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' H ' HG11 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.92 0.39 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.405 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.482 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 ' CB ' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.456 HD11 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.426 ' CB ' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -88.23 107.89 19.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -85.65 163.18 18.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -77.73 90.01 4.01 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 122.315 1.055 . . . . 0.0 108.276 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -85.93 164.97 17.13 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.161 -177.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -127.66 142.33 51.37 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.969 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' HD23 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.473 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.412 HG23 HD23 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.55 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.417 ' HB3' HG11 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.567 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD23 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.567 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.412 ' HG2' ' CG2' ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.473 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.422 HD21 ' O ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.5 -20.99 25.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.422 ' O ' HD21 ' A' ' 74' ' ' LEU . 83.8 t80 -121.7 104.93 9.96 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -130.76 147.21 52.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -113.01 -178.02 3.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -79.52 177.11 9.1 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.45 157.11 34.55 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.64 -42.51 92.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 69.82 -51.67 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.369 1.467 . . . . 0.0 112.458 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.6 132.69 5.59 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.82 122.9 34.79 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.83 -21.99 60.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.296 -173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -141.21 109.84 6.37 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.99 160.88 42.21 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.661 2.24 . . . . 0.0 113.323 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -96.35 -168.97 1.83 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.695 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.8 m -75.58 125.09 28.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.279 0.562 . . . . 0.0 111.376 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -108.36 143.58 37.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -126.57 44.17 2.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.433 0.635 . . . . 0.0 110.313 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -90.13 92.76 9.1 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -110.89 130.72 55.5 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.203 0.525 . . . . 0.0 111.613 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -83.67 -23.69 31.64 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.343 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.5 t60 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.405 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -113.43 148.18 36.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.4 m 74.7 -47.21 0.62 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.514 1.125 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -76.15 102.6 5.82 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -63.68 169.06 4.27 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.811 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -123.8 143.49 50.28 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.432 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.66 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 28.7 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' HB3' HG11 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.443 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.574 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.461 ' O ' HG21 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.52 -17.97 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -108.58 23.4 14.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.969 0.89 . . . . 0.0 108.962 -174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -137.9 111.09 7.86 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -91.56 96.69 10.61 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.583 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -75.55 -49.39 18.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.31 -164.62 0.24 Allowed 'General case' 0 C--O 1.241 0.628 0 O-C-N 124.478 1.111 . . . . 0.0 110.593 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -74.13 -24.02 59.37 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.32 113.71 11.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.869 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.51 144.27 16.0 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.18 -73.3 0.13 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.145 0.974 . . . . 0.0 109.772 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.74 102.44 3.29 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -110.76 109.19 57.81 Favored Pre-proline 0 C--N 1.28 -2.436 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.79 -170.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.457 ' HA ' ' NE2' ' A' ' 91' ' ' HIS . 88.1 Cg_endo -78.69 36.98 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.822 3.014 . . . . 0.0 113.025 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -108.94 21.83 16.7 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.888 0.851 . . . . 0.0 108.787 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -126.1 170.88 11.33 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.383 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -90.76 94.45 9.68 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.457 ' NE2' ' HA ' ' A' ' 87' ' ' PRO . 73.7 m-70 -84.93 -56.34 3.61 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -176.3 152.66 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.651 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -102.61 1.87 35.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.5 92.83 0.07 Allowed 'General case' 0 C--O 1.248 1.017 0 C-N-CA 126.056 1.742 . . . . 0.0 110.272 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.4 t60 . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -179.14 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -106.99 95.27 5.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -24.59 59.4 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.714 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 63.7 87.41 0.11 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.6 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.32 156.18 23.01 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.112 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -88.76 120.04 29.8 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.423 HG22 HD23 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.426 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.551 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.92 87.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -84.95 -26.68 27.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.244 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -89.65 98.62 11.87 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -123.26 124.6 43.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.807 0.337 . . . . 0.0 111.738 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 66.18 90.21 0.09 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 125.641 1.577 . . . . 0.0 111.564 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.46 -22.1 0.08 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.212 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.93 -37.61 87.72 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.226 0.536 . . . . 0.0 111.078 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.78 177.56 5.66 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.11 66.68 0.45 Allowed Glycine 0 CA--C 1.478 -2.276 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.78 -151.32 0.38 Allowed 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -66.58 159.1 28.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -140.96 117.1 7.49 Favored Pre-proline 0 C--N 1.28 -2.421 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.63 171.82 11.41 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.418 2.079 . . . . 0.0 112.845 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -83.51 7.15 17.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.448 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -139.25 121.99 16.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -83.22 -25.03 32.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.695 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 73.88 115.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -92.51 -27.26 17.52 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -111.01 105.85 14.75 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.516 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.84 -17.41 47.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.952 0.882 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.13 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.489 -1.402 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.431 ' C ' ' HG1' ' A' ' 3' ' ' THR . 24.1 m-70 -76.22 127.82 33.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 2' ' ' HIS . 18.3 m -148.47 50.95 1.01 Allowed 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 174.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -133.15 49.32 2.32 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.718 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.588 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -65.81 153.49 41.74 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.829 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -94.75 141.57 28.47 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.131 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.413 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.461 HG23 HD22 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 HD22 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.588 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.422 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.508 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' THR . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -74.6 -2.41 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -134.24 102.59 5.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -128.77 135.9 49.8 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.04 145.15 46.11 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.976 0.417 . . . . 0.0 111.434 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -86.05 -47.52 9.48 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -103.6 103.87 13.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -73.25 -41.48 63.65 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 62.87 -178.8 0.14 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.766 1.626 . . . . 0.0 113.112 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.1 -126.28 2.28 Favored Glycine 0 N--CA 1.408 -3.194 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 -18.51 14.93 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 67.66 94.61 0.07 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.832 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.8 t -107.47 125.99 31.04 Favored Pre-proline 0 N--CA 1.417 -2.102 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.979 -173.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -93.37 -171.79 0.3 Allowed 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 122.381 2.054 . . . . 0.0 111.273 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -113.55 160.76 18.18 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -150.27 142.06 23.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -81.25 131.04 35.27 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.93 -38.47 32.35 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.942 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -127.98 126.91 42.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -82.13 145.63 30.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -87.33 174.43 8.56 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.982 1.313 . . . . 0.0 110.456 178.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -93.18 119.05 31.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.177 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m 51.09 80.13 0.08 Allowed 'General case' 0 C--O 1.253 1.271 0 C-N-CA 125.011 1.324 . . . . 0.0 114.478 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.58 116.7 24.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -116.61 171.54 7.8 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.406 -173.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -124.3 134.8 53.1 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.64 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.707 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG21 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 HD12 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.458 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.707 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' CG2' HG21 ' A' ' 11' ' ' VAL . 98.1 t -88.75 -58.82 3.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.471 ' HH ' ' NE2' ' A' ' 78' ' ' GLN . 89.9 t80 -139.61 146.22 39.5 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.485 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.88 -172.68 3.16 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.471 ' NE2' ' HH ' ' A' ' 76' ' ' TYR . 18.0 mm-40 -117.03 143.31 45.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -94.27 46.55 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.637 0.732 . . . . 0.0 109.611 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.628 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 5.4 mm-40 -83.97 -0.54 51.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.526 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.69 -49.65 37.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.83 161.63 0.22 Allowed 'General case' 0 C--O 1.245 0.83 0 C-N-CA 125.264 1.426 . . . . 0.0 111.284 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.74 -167.17 16.15 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.392 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -120.34 156.1 32.01 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.52 88.16 6.24 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.349 0.595 . . . . 0.0 110.022 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -85.87 114.42 56.87 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.591 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -98.77 -164.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.747 2.298 . . . . 0.0 112.149 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -110.42 89.42 3.03 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -90.44 -8.94 49.24 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.967 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -153.49 112.42 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -87.08 83.76 7.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.366 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -82.21 -33.08 29.51 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.707 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -105.34 102.7 12.16 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.657 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 74.7 110.9 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.555 1.542 . . . . 0.0 110.944 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.48 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -133.8 176.26 8.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.844 0.354 . . . . 0.0 110.53 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -87.59 -16.72 33.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.185 0.993 . . . . 0.0 108.456 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.18 104.68 9.63 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.242 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -71.14 148.55 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.695 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.2 130.66 35.11 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.18 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.425 HG13 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.441 ' HB3' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.559 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.683 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' CG2' HD11 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.469 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.667 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.553 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.667 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.553 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.509 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.451 HG13 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 66' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 39.8 t -105.84 73.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 56.8 t80 160.76 78.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.705 2.002 . . . . 0.0 107.652 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -128.25 65.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.288 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -103.09 87.88 3.01 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -94.75 96.69 9.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.809 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.39 130.46 36.47 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.84 -46.71 74.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.9 -158.11 0.33 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.975 0.797 . . . . 0.0 109.355 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.51 0.51 Allowed Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.26 131.94 52.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.41 -4.09 35.45 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.649 0.738 . . . . 0.0 109.606 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -126.12 95.46 39.11 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.806 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.53 -172.84 1.65 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.839 2.36 . . . . 0.0 110.434 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -92.79 136.9 32.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.215 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.6 t -86.91 112.31 21.65 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -125.0 48.26 2.03 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -65.83 -29.97 70.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.715 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -123.69 120.47 32.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -71.65 97.48 1.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.961 0.886 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -94.79 144.38 25.69 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.428 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.3 m80 . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.64 -174.914 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -83.14 122.77 28.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.2 m -118.6 114.48 22.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.27 98.72 3.86 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.583 0.706 . . . . 0.0 110.46 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.41 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -68.64 162.1 26.71 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.926 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -109.89 141.81 42.08 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.696 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.551 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.413 HG23 HD23 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.401 HE21 ' HA ' ' A' ' 22' ' ' ILE . 17.4 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.411 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 27' ' ' ASN . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.437 HG22 HG21 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.538 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 HD23 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 ' CG2' HD11 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.551 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.475 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.485 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD12 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -91.24 86.66 2.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -143.62 139.04 29.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.107 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -162.1 172.29 16.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.979 0.799 . . . . 0.0 109.072 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -100.78 166.5 10.83 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.571 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 12.6 pt20 -137.94 129.84 28.54 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.595 0.236 . . . . 0.0 111.413 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -133.08 -51.41 0.89 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.78 0.8 . . . . 0.0 110.172 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -89.89 -17.01 28.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.337 0.589 . . . . 0.0 111.369 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.571 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 24.8 mt-30 -129.41 137.51 50.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.32 -82.33 1.48 Allowed Glycine 0 C--N 1.304 -1.223 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.328 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.74 74.74 2.38 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 122.024 0.916 . . . . 0.0 109.567 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.53 124.45 30.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.812 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -123.88 89.11 51.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.09 -38.15 2.99 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.415 2.077 . . . . 0.0 111.123 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -79.46 88.81 5.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -77.36 -178.77 5.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.185 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -63.09 137.77 58.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.471 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -82.23 -58.55 2.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -81.85 86.3 6.51 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.025 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.0 100.31 12.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -130.58 19.11 5.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.81 0.814 . . . . 0.0 109.495 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' N ' ' SD ' ' A' ' 1' ' ' MET . 49.8 m80 -71.19 98.93 1.79 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.511 0.596 . . . . 0.0 109.903 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.555 ' HB ' ' OE1' ' A' ' 51' ' ' GLU . 15.4 p -73.65 97.84 2.75 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -100.84 77.75 1.89 Allowed 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.326 1.06 . . . . 0.0 112.369 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.667 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -54.48 157.36 2.9 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.41 -2.177 . . . . 0.0 115.312 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -103.94 127.0 51.47 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.958 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.613 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' HB3' HD12 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.423 HG22 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.566 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.613 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.667 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.555 ' OE1' ' HB ' ' A' ' 3' ' ' THR . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -88.42 -39.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 65.04 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.152 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -161.32 98.53 1.15 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.56 91.87 8.89 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.836 0.826 . . . . 0.0 110.556 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.88 147.3 37.15 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.117 -1.402 . . . . 0.0 109.241 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 67.28 96.88 0.06 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.473 1.109 . . . . 0.0 110.566 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.42 -47.53 41.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -161.42 147.88 14.37 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.685 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 139.28 18.29 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.88 136.11 40.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.576 0.688 . . . . 0.0 110.112 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -137.76 149.11 46.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -129.9 123.17 20.81 Favored Pre-proline 0 N--CA 1.402 -2.832 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.27 147.28 41.82 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 120.706 0.938 . . . . 0.0 110.785 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.44 96.76 6.15 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.171 -170.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 12.0 m -101.1 121.45 41.84 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.61 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -94.88 -32.05 13.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.057 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.13 -29.1 38.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 89' ' ' SER . 54.5 m-70 -111.56 96.82 6.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.796 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -94.84 164.57 12.87 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -74.92 157.16 35.49 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.2 m80 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.045 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.02 118.25 21.29 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.2 m -70.72 114.89 9.25 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.059 0.457 . . . . 0.0 110.017 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -97.65 77.19 2.55 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.427 1.108 . . . . 0.0 112.048 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.8 175.26 5.56 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.114 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.64 121.42 45.27 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.743 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.549 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.481 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.66 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.66 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.427 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.409 ' HB ' ' CG2' ' A' ' 69' ' ' VAL . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.91 88.04 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -150.88 -72.28 0.17 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -157.17 151.89 25.58 Favored 'General case' 0 CA--C 1.487 -1.442 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.615 ' HA ' HE21 ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.31 -42.22 37.68 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.044 -177.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -125.9 -16.06 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.013 0.435 . . . . 0.0 112.099 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.94 76.29 7.9 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.59 -39.74 27.01 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -83.84 -41.92 16.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.92 -161.54 27.52 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.52 -12.26 13.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.2 133.8 56.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.924 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 t -138.17 105.96 7.96 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-O 121.862 0.839 . . . . 0.0 111.148 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.04 176.51 5.14 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.341 2.027 . . . . 0.0 111.049 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -80.71 -82.4 0.12 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.55 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 m -128.78 24.62 5.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.685 0.755 . . . . 0.0 109.366 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -129.27 98.7 4.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.276 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.11 131.92 38.58 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.533 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.85 106.64 18.6 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.68 171.22 7.45 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.792 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -102.48 175.48 5.49 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.798 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.543 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 C--O 1.244 0.793 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -81.34 93.97 6.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.434 0.635 . . . . 0.0 111.193 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 p -86.32 146.44 26.49 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.362 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.94 121.95 34.0 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -130.0 146.08 51.67 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.204 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -91.27 142.96 27.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.451 HG13 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.545 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.462 HG23 HD23 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 26' ' ' LEU . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.57 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.643 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.643 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.41 ' O ' HG22 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.51 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.519 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -151.04 131.76 14.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -82.02 123.41 28.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -70.85 -175.2 1.05 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.652 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.11 171.91 11.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -80.76 69.84 7.39 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.94 -41.05 91.8 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -113.09 89.02 2.97 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.32 160.0 27.79 Favored Glycine 0 N--CA 1.424 -2.126 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.081 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.89 23.26 9.99 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.592 1.157 . . . . 0.0 111.904 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -72.77 -28.96 62.93 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -118.59 91.67 42.33 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.48 169.19 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.502 2.135 . . . . 0.0 112.642 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.78 -29.66 56.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.954 0.407 . . . . 0.0 109.967 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -86.88 111.0 20.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -77.59 -20.62 53.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.022 0.439 . . . . 0.0 110.95 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -88.32 143.67 26.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -79.15 156.68 28.14 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -71.83 -32.09 67.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.048 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -86.0 134.62 33.85 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.263 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--N 1.296 -1.733 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.466 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -90.23 -63.2 1.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.1 p 59.16 151.12 0.02 OUTLIER 'General case' 0 C--O 1.246 0.903 0 C-N-CA 125.355 1.462 . . . . 0.0 114.772 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.6 m120 74.34 132.49 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.049 0.94 . . . . 0.0 111.237 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.5 p-90 -69.29 143.23 53.91 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 177.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -117.85 147.44 43.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.558 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG22 HD23 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.428 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.629 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD23 HG22 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.419 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.457 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.558 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.89 -29.59 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -133.1 94.45 3.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -157.42 138.3 13.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.458 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 23.8 pt20 -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.55 79.46 1.97 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.4 0.619 . . . . 0.0 112.237 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.458 ' HG3' ' HG3' ' A' ' 78' ' ' GLN . 35.8 mt-10 -102.81 -55.96 2.33 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.553 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.69 -12.58 60.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.226 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -150.8 94.79 2.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.392 0.615 . . . . 0.0 109.798 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.72 -60.8 0.01 OUTLIER Glycine 0 C--N 1.303 -1.302 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.66 19.0 6.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.019 0.438 . . . . 0.0 110.463 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -52.79 117.58 3.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.622 1.169 . . . . 0.0 111.486 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.3 m -105.44 99.04 18.75 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -87.68 -25.69 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.901 1.734 . . . . 0.0 112.329 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -97.71 102.42 14.18 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -101.77 100.87 11.27 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.434 0.635 . . . . 0.0 110.67 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.45 156.68 20.72 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.526 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -97.53 83.88 3.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -137.61 32.17 2.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.295 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -159.2 148.01 18.22 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.464 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -94.26 -38.36 11.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.297 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.529 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.5 m-70 -86.63 100.84 12.73 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -29.8 62.05 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -99.35 83.7 2.87 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 140.12 57.59 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.71 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.434 ' NE2' ' HA ' ' A' ' 53' ' ' SER . 7.6 pt20 -89.9 134.06 34.42 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.113 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.582 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 27.2 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.537 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' O ' ' HB2' ' A' ' 2' ' ' HIS . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.434 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.437 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.418 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.478 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -91.78 87.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -145.68 124.49 12.65 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -100.06 141.97 32.17 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.636 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -141.94 156.73 45.48 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.405 ' H ' ' NE2' ' A' ' 79' ' ' GLN . 1.8 mp0 -69.86 93.22 0.74 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.069 0.547 . . . . 0.0 110.842 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -97.69 129.12 44.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -89.68 -36.82 15.01 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 67.33 -77.94 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.532 1.133 . . . . 0.0 112.312 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.83 -170.64 54.03 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.509 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 66.37 107.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.81 135.07 54.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.421 0.629 . . . . 0.0 111.394 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.6 m -128.23 91.51 44.09 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.15 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 113.01 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.8 19.41 9.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t 75.25 144.76 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.718 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -81.85 -35.8 28.97 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -109.72 140.64 43.36 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.616 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -69.56 108.46 3.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.473 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.44 96.28 6.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.081 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -130.67 116.84 18.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.2 m170 . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.268 0.08 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 74.01 145.31 0.08 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.526 1.53 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 m -78.08 -46.14 21.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -145.68 115.62 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -109.03 160.44 16.04 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.35 138.66 54.05 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 124.867 1.267 . . . . 0.0 107.883 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' HD22 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.403 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.598 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 HD22 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG12 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.433 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.48 87.11 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -130.84 -47.16 1.03 Allowed 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.9 m170 65.48 -168.37 0.21 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.215 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -98.56 164.34 12.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.08 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.53 0.08 3.38 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -102.66 127.14 49.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.38 -60.83 2.95 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.629 0.771 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -87.83 48.24 1.61 Allowed 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.18 61.73 3.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.9 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -158.15 143.72 16.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.35 110.78 1.76 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.7 m -119.97 114.65 33.69 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.77 -160.08 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.684 2.256 . . . . 0.0 111.655 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -64.31 -11.37 31.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.149 0.58 . . . . 0.0 112.246 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 t -81.33 19.09 1.0 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -79.21 -14.13 59.26 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 58.4 m80 66.18 79.57 0.24 Allowed 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.321 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -81.47 82.42 7.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.98 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.5 t60 167.37 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 127.234 2.214 . . . . 0.0 105.572 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -72.08 -45.68 59.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.832 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.1 t60 . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.617 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -85.61 101.69 12.93 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.18 -0.325 . . . . 0.0 110.263 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -89.78 -15.49 32.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.8 OUTLIER -79.16 103.48 9.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.674 0.75 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -91.98 177.28 6.22 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.215 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -133.57 159.21 41.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.503 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.572 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.403 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' HG13 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.472 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.488 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.433 HG12 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' CG2' HG12 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.9 87.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -178.69 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.381 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -166.58 147.62 6.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.37 138.04 54.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -125.08 -77.18 0.59 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 57.82 -176.53 0.07 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.945 0.898 . . . . 0.0 111.298 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -89.66 -61.33 1.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -151.79 155.35 38.04 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.752 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.83 156.39 24.82 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.51 77.3 9.85 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.863 0.84 . . . . 0.0 108.988 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.01 -45.33 90.96 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.403 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -139.91 91.07 10.51 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-O 121.726 0.774 . . . . 0.0 110.617 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.11 -175.12 1.36 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.224 1.949 . . . . 0.0 111.832 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 61.68 85.23 0.12 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.774 1.23 . . . . 0.0 110.742 -174.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -66.73 -50.56 62.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -91.77 132.14 36.62 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -73.49 -66.58 0.68 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.68 148.21 1.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -150.72 105.6 3.31 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -80.29 64.6 5.16 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.868 0.842 . . . . 0.0 112.642 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.676 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.35 -17.88 20.35 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -113.04 -33.9 5.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -99.6 105.66 17.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CZ2' ' HG2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -162.14 178.44 8.78 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 122.944 0.498 . . . . 0.0 111.022 -174.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -105.16 120.59 41.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' HB2' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.58 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.472 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.472 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 24.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' HG13 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.484 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.521 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.463 HG12 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.9 84.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -172.46 125.0 0.49 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -110.71 134.05 52.8 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -81.24 81.45 7.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 82.08 8.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.842 0.829 . . . . 0.0 109.365 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.71 119.78 36.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.993 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.61 -24.21 21.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.618 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -124.61 159.92 29.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.75 94.92 1.91 Allowed Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.91 67.82 4.71 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.565 1.174 . . . . 0.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.74 -60.17 1.62 Allowed 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -146.13 91.27 5.55 Favored Pre-proline 0 N--CA 1.417 -2.079 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.48 7.12 3.19 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.945 2.43 . . . . 0.0 113.257 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -118.28 141.92 48.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.9 t -140.05 -71.25 0.38 Allowed 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -147.37 128.39 14.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.69 -54.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -62.31 137.81 58.32 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -69.75 119.5 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.406 -173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -79.13 110.5 14.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 C--O 1.212 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -93.78 128.07 39.83 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -71.53 138.49 48.91 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 123.536 0.523 . . . . 0.0 111.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -60.71 131.85 52.01 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.652 0.739 . . . . 0.0 112.396 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -120.14 158.81 26.12 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.001 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -108.82 140.89 41.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.503 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.417 HG21 HD22 ' A' ' 44' ' ' LEU . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 22' ' ' ILE . 20.6 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.526 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 HD22 HG21 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.425 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.503 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.75 89.75 2.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -66.57 -33.32 75.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -63.33 143.63 57.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.928 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -125.97 -176.53 3.66 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -54.9 -48.79 72.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.896 0.878 . . . . 0.0 111.053 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.66 123.65 29.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.33 -62.22 1.59 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.892 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -149.68 148.48 29.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.663 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.92 53.8 4.27 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.73 102.51 14.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.852 0.358 . . . . 0.0 110.426 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.551 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 8.0 pt-20 -105.04 1.78 28.88 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -95.86 104.34 16.21 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.63 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 72.2 Cg_endo -99.05 154.72 0.63 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.863 2.375 . . . . 0.0 112.495 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 70.46 151.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.529 1.532 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.6 t -78.39 90.78 4.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.16 115.03 24.55 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -130.43 154.67 47.49 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.96 -17.22 38.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.923 0.392 . . . . 0.0 110.81 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 m80 65.22 -170.95 0.19 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.218 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -142.13 144.66 33.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 . . . . . 0 C--N 1.302 -1.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.307 177.137 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.622 0.248 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -138.97 92.75 2.63 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -92.5 -66.0 0.96 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -161.35 133.74 5.96 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -117.13 160.17 21.44 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -114.53 137.65 51.6 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.198 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.43 HD12 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.43 ' HA2' HD12 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.56 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.15 89.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -151.98 137.53 17.77 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -89.31 133.98 34.26 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.434 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -79.47 158.97 27.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.641 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.65 -31.48 41.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.626 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -76.73 85.78 3.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.64 -41.82 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -88.25 -38.18 15.44 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.0 156.86 26.24 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -88.58 114.99 25.77 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -124.95 -67.92 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.568 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 m -127.38 94.94 37.13 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.41 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -96.91 26.22 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.141 2.561 . . . . 0.0 110.585 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.81 163.51 12.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.991 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -91.32 108.74 20.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.64 -17.88 1.94 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.53 -16.16 58.84 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.046 0.927 . . . . 0.0 109.044 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -147.16 138.87 24.2 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.395 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -114.2 -25.02 8.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 71.86 106.79 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.356 1.462 . . . . 0.0 113.758 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.426 1.09 . . . . 0.0 112.471 175.392 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HA ' ' HB3' ' A' ' 5' ' ' TRP . 26.8 ptt? . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -125.33 -70.43 0.75 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.206 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m -68.42 -33.59 74.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.604 0.716 . . . . 0.0 110.159 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.446 ' HB3' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 177.27 169.89 0.58 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.403 1.481 . . . . 0.0 108.495 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.405 HE22 ' HA ' ' A' ' 53' ' ' SER . 17.5 mt-30 -85.43 119.74 26.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' HB3' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 22' ' ' ILE . 15.5 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.419 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HA ' HE22 ' A' ' 6' ' ' GLN . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.43 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.48 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.504 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.411 HG11 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.411 ' H ' HG11 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.57 -53.63 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -99.73 84.04 2.86 Favored 'General case' 0 C--N 1.269 -2.912 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.286 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -131.91 106.34 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.171 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -123.16 110.16 14.92 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.55 -67.33 0.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.448 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -165.41 138.64 4.49 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.46 -38.37 21.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.3 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -124.88 177.78 5.84 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.32 -69.0 0.23 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.85 -59.7 2.34 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.422 ' C ' ' HG1' ' A' ' 86' ' ' THR . 60.1 mm-40 -93.07 151.82 19.65 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 85' ' ' GLU . 61.6 m -148.7 83.81 6.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.73 -43.56 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.19 1.926 . . . . 0.0 111.426 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.475 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 33.6 ptt180 -153.23 143.44 22.34 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.507 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.8 m -113.05 88.1 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.475 ' CE1' ' HD2' ' A' ' 88' ' ' ARG . 52.0 m170 -98.37 84.93 3.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.45 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.11 76.42 1.24 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.254 1.026 . . . . 0.0 111.458 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -72.71 125.12 26.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -78.09 95.64 4.94 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.718 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.3 m80 69.47 -71.87 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.24 1.816 . . . . 0.0 110.582 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 C--O 1.219 -0.535 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -97.65 -37.59 9.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.104 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -64.4 -53.19 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -98.39 92.77 5.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.518 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -108.89 162.11 14.5 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.283 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -72.68 120.24 18.02 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.469 -173.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' SG ' HD12 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.415 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.405 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.482 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.469 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.524 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD12 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 HG12 HD21 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 42.4 t -84.34 85.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -160.63 -39.49 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.4 m170 75.76 159.33 0.21 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.702 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -121.98 -47.42 2.17 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.633 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -85.16 91.08 8.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 122.362 1.077 . . . . 0.0 111.271 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -130.46 -54.63 1.09 Allowed 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.88 -32.89 74.56 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.711 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.18 -0.25 57.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.635 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.56 125.62 2.61 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.41 -20.69 43.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.635 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -84.11 136.57 33.95 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -90.26 117.58 68.15 Favored Pre-proline 0 N--CA 1.408 -2.565 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -84.85 -164.74 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 122.36 2.04 . . . . 0.0 112.865 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -74.35 98.3 3.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.424 0.63 . . . . 0.0 111.432 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -72.77 128.39 35.37 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.314 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.1 m80 73.46 102.39 0.07 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -81.11 80.71 7.51 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -100.08 -16.24 17.93 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.398 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -126.14 97.28 5.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.434 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -77.23 100.73 5.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--N 1.285 -2.212 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 -174.638 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.392 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -135.6 18.01 3.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 m -90.84 157.14 17.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -83.76 85.93 7.22 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 167.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.69 113.19 1.22 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 123.61 20.87 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.659 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.426 HG12 ' CB ' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' SG ' HD22 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.456 HD11 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 ' CG2' HD11 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.426 ' CB ' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.55 HD22 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.27 -44.76 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.77 123.64 28.05 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -100.68 165.06 11.58 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -62.09 152.41 32.84 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.277 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -75.63 101.89 5.13 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.526 0.679 . . . . 0.0 109.366 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -95.77 169.27 10.12 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.258 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.88 -51.03 11.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 61.65 -174.04 0.14 Allowed 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.106 0.879 . . . . 0.0 112.012 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -165.68 35.42 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.71 -36.92 50.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.053 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -82.54 142.32 31.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.275 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -132.67 103.71 13.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-O 121.128 0.489 . . . . 0.0 110.201 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.23 168.49 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.423 2.082 . . . . 0.0 113.436 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -87.24 -67.5 0.82 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 m -113.47 -41.89 3.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 166.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' CG ' ' H ' ' A' ' 91' ' ' HIS . 12.6 t-80 177.3 -152.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 175.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' H ' ' CG ' ' A' ' 90' ' ' HIS . 58.7 t60 -67.7 100.68 0.94 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 74.99 174.46 0.25 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 125.109 1.364 . . . . 0.0 109.793 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -96.08 -66.81 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.91 13.88 0.07 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 . . . . . 0 N--CA 1.417 -2.099 0 N-CA-C 100.905 -3.739 . . . . 0.0 100.905 -174.162 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.418 -2.052 0 CA-C-O 120.978 0.418 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 69' ' ' VAL . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 14' ' ' ALA . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 63' ' ' VAL . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD21 HG23 ' A' ' 19' ' ' ILE . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD21 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 HD22 ' A' ' 26' ' ' LEU . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.475 ' HG2' HG21 ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 15' ' ' LYS . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 12' ' ' VAL . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 49' ' ' GLU . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.667 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.667 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.3 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 19' ' ' ILE . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 72' ' ' VAL . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.429 ' HB ' HG11 ' A' ' 69' ' ' VAL . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 69' ' ' VAL . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 46' ' ' VAL . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 19' ' ' ILE . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 34' ' ' VAL . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 26' ' ' LEU . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' HG11 ' A' ' 72' ' ' VAL . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 12' ' ' VAL . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 49' ' ' GLU . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' HG12 ' A' ' 7' ' ' VAL . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t . . . . . 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 49' ' ' GLU . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.438 HG23 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.596 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 93.0 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 19' ' ' ILE . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 26' ' ' LEU . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.719 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.669 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 48' ' ' VAL . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' HG23 ' A' ' 11' ' ' VAL . 98.1 t . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.388 0.613 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG12 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 74' ' ' LEU . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 69' ' ' VAL . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 19' ' ' ILE . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 16' ' ' SER . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 66' ' ' VAL . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 11' ' ' VAL . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.683 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' SER . 5.1 m-20 -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 12' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 10' ' ' LEU . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 121.396 0.617 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 49' ' ' GLU . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 69' ' ' VAL . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 HD21 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' HG12 ' A' ' 7' ' ' VAL . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 12' ' ' VAL . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG2' HG11 ' A' ' 69' ' ' VAL . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 95.1 t . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 49' ' ' GLU . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 19' ' ' ILE . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' HG12 ' A' ' 7' ' ' VAL . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HG2' HG11 ' A' ' 72' ' ' VAL . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' VAL . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 66' ' ' VAL . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t . . . . . 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.422 -1.872 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 44' ' ' LEU . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.661 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.661 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 19' ' ' ILE . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.486 HG11 HG23 ' A' ' 22' ' ' ILE . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.508 ' HA ' HG12 ' A' ' 19' ' ' ILE . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 46' ' ' VAL . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.633 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 26' ' ' LEU . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.578 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 69' ' ' VAL . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.596 HG23 HD21 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' HB1' ' A' ' 14' ' ' ALA . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.631 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 26' ' ' LEU . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG2' HG12 ' A' ' 7' ' ' VAL . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 12' ' ' VAL . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.433 0.635 . . . . 0.0 112.113 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 49' ' ' GLU . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' ILE . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 16' ' ' SER . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 97.1 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 26' ' ' LEU . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 7' ' ' VAL . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.405 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 53' ' ' SER . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 59.0 t . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 19' ' ' ILE . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 32' ' ' CYS . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? . . . . . 0 C--O 1.242 0.661 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 44' ' ' LEU . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.617 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 19' ' ' ILE . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.413 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.57 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' SER . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' A' ' 39' ' ' ALA . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' HG23 ' A' ' 34' ' ' VAL . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 27' ' ' ASN . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 69.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.529 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG13 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 68' ' ' GLY . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 69' ' ' VAL . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 42' ' ' GLY . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 44' ' ' LEU . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 26' ' ' LEU . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 12' ' ' VAL . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 48.4 t . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.061 0.458 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 49' ' ' GLU . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 69' ' ' VAL . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.553 HD11 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 7' ' ' VAL . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HG2' HG11 ' A' ' 72' ' ' VAL . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 12' ' ' VAL . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 15' ' ' LYS . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 58.8 t . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.487 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 19' ' ' ILE . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 16' ' ' SER . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 37' ' ' SER . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 66' ' ' VAL . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 11.6 mt-30 . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.92 0.39 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.44 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.58 HG23 HD21 ' A' ' 44' ' ' LEU . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.548 HD22 HG13 ' A' ' 63' ' ' VAL . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' VAL . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 19' ' ' ILE . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 34' ' ' VAL . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' GLN . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 ' HE2' ' A' ' 15' ' ' LYS . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 42.4 t . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD21 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 HD21 ' A' ' 44' ' ' LEU . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 46' ' ' VAL . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD21 HG23 ' A' ' 19' ' ' ILE . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD21 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -88.23 107.89 19.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -85.65 163.18 18.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -77.73 90.01 4.01 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 122.315 1.055 . . . . 0.0 108.276 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -85.93 164.97 17.13 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.161 -177.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -127.66 142.33 51.37 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.969 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 69' ' ' VAL . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 14' ' ' ALA . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 63' ' ' VAL . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD21 HG23 ' A' ' 19' ' ' ILE . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 5' ' ' TRP . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD21 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 HD22 ' A' ' 26' ' ' LEU . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.475 ' HG2' HG21 ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 15' ' ' LYS . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 12' ' ' VAL . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.5 -20.99 25.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.429 ' O ' HD22 ' A' ' 74' ' ' LEU . 83.8 t80 -121.7 104.93 9.96 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -130.76 147.21 52.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -113.01 -178.02 3.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -79.52 177.11 9.1 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.45 157.11 34.55 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.64 -42.51 92.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 69.82 -51.67 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.369 1.467 . . . . 0.0 112.458 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.6 132.69 5.59 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.82 122.9 34.79 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.83 -21.99 60.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.296 -173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -141.21 109.84 6.37 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.99 160.88 42.21 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.661 2.24 . . . . 0.0 113.323 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -96.35 -168.97 1.83 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.695 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.8 m -75.58 125.09 28.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.279 0.562 . . . . 0.0 111.376 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 53.6 m-70 -108.36 143.58 37.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -126.57 44.17 2.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.433 0.635 . . . . 0.0 110.313 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' HIS . 63.1 m-70 -90.13 92.76 9.1 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -110.89 130.72 55.5 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.203 0.525 . . . . 0.0 111.613 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -83.67 -23.69 31.64 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.343 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.5 t60 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.405 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -113.43 148.18 36.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.4 m 74.7 -47.21 0.62 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.514 1.125 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -76.15 102.6 5.82 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -63.68 169.06 4.27 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.811 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -123.8 143.49 50.28 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 49' ' ' GLU . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.667 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.667 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 78.3 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 19' ' ' ILE . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 72' ' ' VAL . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.429 ' HB ' HG11 ' A' ' 69' ' ' VAL . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.52 -17.97 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -108.58 23.4 14.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.969 0.89 . . . . 0.0 108.962 -174.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -137.9 111.09 7.86 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -91.56 96.69 10.61 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.583 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -75.55 -49.39 18.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.31 -164.62 0.24 Allowed 'General case' 0 C--O 1.241 0.628 0 O-C-N 124.478 1.111 . . . . 0.0 110.593 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -74.13 -24.02 59.37 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.32 113.71 11.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.869 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.51 144.27 16.0 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.18 -73.3 0.13 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.145 0.974 . . . . 0.0 109.772 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.74 102.44 3.29 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -110.76 109.19 57.81 Favored Pre-proline 0 C--N 1.28 -2.436 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.79 -170.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.495 ' HA ' ' NE2' ' A' ' 91' ' ' HIS . 88.1 Cg_endo -78.69 36.98 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.822 3.014 . . . . 0.0 113.025 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -108.94 21.83 16.7 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.888 0.851 . . . . 0.0 108.787 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -126.1 170.88 11.33 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.383 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -90.76 94.45 9.68 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.495 ' NE2' ' HA ' ' A' ' 87' ' ' PRO . 73.7 m-70 -84.93 -56.34 3.61 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -176.3 152.66 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.651 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -102.61 1.87 35.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.5 92.83 0.07 Allowed 'General case' 0 C--O 1.248 1.017 0 C-N-CA 126.056 1.742 . . . . 0.0 110.272 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.4 t60 . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -179.14 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -106.99 95.27 5.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -24.59 59.4 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.714 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 63.7 87.41 0.11 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.6 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.32 156.18 23.01 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.112 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -88.76 120.04 29.8 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 69' ' ' VAL . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 46' ' ' VAL . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 19' ' ' ILE . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 34' ' ' VAL . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 26' ' ' LEU . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' HG11 ' A' ' 72' ' ' VAL . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 12' ' ' VAL . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.92 87.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -84.95 -26.68 27.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.244 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -89.65 98.62 11.87 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -123.26 124.6 43.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.807 0.337 . . . . 0.0 111.738 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 66.18 90.21 0.09 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 125.641 1.577 . . . . 0.0 111.564 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.46 -22.1 0.08 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.212 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.93 -37.61 87.72 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.226 0.536 . . . . 0.0 111.078 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.78 177.56 5.66 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.11 66.68 0.45 Allowed Glycine 0 CA--C 1.478 -2.276 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.78 -151.32 0.38 Allowed 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -66.58 159.1 28.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -140.96 117.1 7.49 Favored Pre-proline 0 C--N 1.28 -2.421 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.63 171.82 11.41 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.418 2.079 . . . . 0.0 112.845 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -83.51 7.15 17.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.448 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -139.25 121.99 16.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.7 p-80 -83.22 -25.03 32.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.695 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 73.88 115.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -92.51 -27.26 17.52 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -111.01 105.85 14.75 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.516 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.84 -17.41 47.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.952 0.882 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.13 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.489 -1.402 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -76.22 127.82 33.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.3 m -148.47 50.95 1.01 Allowed 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -133.15 49.32 2.32 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.718 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.597 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -65.81 153.49 41.74 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.829 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -94.75 141.57 28.47 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.131 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 49' ' ' GLU . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 76' ' ' TYR . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -74.6 -2.41 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.467 ' H ' HD22 ' A' ' 74' ' ' LEU . 63.0 t80 -134.24 102.59 5.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -128.77 135.9 49.8 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.04 145.15 46.11 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.976 0.417 . . . . 0.0 111.434 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -86.05 -47.52 9.48 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -103.6 103.87 13.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -73.25 -41.48 63.65 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 62.87 -178.8 0.14 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.766 1.626 . . . . 0.0 113.112 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.1 -126.28 2.28 Favored Glycine 0 N--CA 1.408 -3.194 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.07 -18.51 14.93 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 67.66 94.61 0.07 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.832 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.8 t -107.47 125.99 31.04 Favored Pre-proline 0 N--CA 1.417 -2.102 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.979 -173.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -93.37 -171.79 0.3 Allowed 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 122.381 2.054 . . . . 0.0 111.273 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -113.55 160.76 18.18 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -150.27 142.06 23.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -81.25 131.04 35.27 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.93 -38.47 32.35 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.942 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -127.98 126.91 42.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -82.13 145.63 30.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -87.33 174.43 8.56 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.982 1.313 . . . . 0.0 110.456 178.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -93.18 119.05 31.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.177 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m 51.09 80.13 0.08 Allowed 'General case' 0 C--O 1.253 1.271 0 C-N-CA 125.011 1.324 . . . . 0.0 114.478 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.58 116.7 24.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -116.61 171.54 7.8 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.406 -173.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -124.3 134.8 53.1 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.64 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 49' ' ' GLU . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.438 HG23 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.596 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 93.0 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 19' ' ' ILE . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 26' ' ' LEU . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.719 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.669 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 48' ' ' VAL . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' HG23 ' A' ' 11' ' ' VAL . 98.1 t -88.75 -58.82 3.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -139.61 146.22 39.5 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.485 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.88 -172.68 3.16 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.44 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 18.0 mm-40 -117.03 143.31 45.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -94.27 46.55 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.637 0.732 . . . . 0.0 109.611 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.639 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 5.4 mm-40 -83.97 -0.54 51.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.526 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.69 -49.65 37.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.83 161.63 0.22 Allowed 'General case' 0 C--O 1.245 0.83 0 C-N-CA 125.264 1.426 . . . . 0.0 111.284 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.74 -167.17 16.15 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.392 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -120.34 156.1 32.01 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.52 88.16 6.24 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.349 0.595 . . . . 0.0 110.022 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -85.87 114.42 56.87 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.591 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -98.77 -164.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.747 2.298 . . . . 0.0 112.149 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -110.42 89.42 3.03 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -90.44 -8.94 49.24 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.967 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -153.49 112.42 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -87.08 83.76 7.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.366 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -82.21 -33.08 29.51 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.707 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -105.34 102.7 12.16 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.657 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 74.7 110.9 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.555 1.542 . . . . 0.0 110.944 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.48 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -133.8 176.26 8.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.844 0.354 . . . . 0.0 110.53 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -87.59 -16.72 33.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.185 0.993 . . . . 0.0 108.456 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -122.18 104.68 9.63 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.242 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -71.14 148.55 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.695 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.2 130.66 35.11 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.18 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG12 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 74' ' ' LEU . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 69' ' ' VAL . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 19' ' ' ILE . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 16' ' ' SER . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 66' ' ' VAL . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 11' ' ' VAL . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.683 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' SER . 5.1 m-20 -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 12' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 10' ' ' LEU . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 39.8 t -105.84 73.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 56.8 t80 160.76 78.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.705 2.002 . . . . 0.0 107.652 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -128.25 65.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.288 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -103.09 87.88 3.01 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -94.75 96.69 9.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.809 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.39 130.46 36.47 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.84 -46.71 74.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -172.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.9 -158.11 0.33 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.975 0.797 . . . . 0.0 109.355 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.51 0.51 Allowed Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.26 131.94 52.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.41 -4.09 35.45 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.649 0.738 . . . . 0.0 109.606 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -126.12 95.46 39.11 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.806 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.53 -172.84 1.65 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.839 2.36 . . . . 0.0 110.434 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -92.79 136.9 32.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.215 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.6 t -86.91 112.31 21.65 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -125.0 48.26 2.03 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -65.83 -29.97 70.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.715 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -123.69 120.47 32.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -71.65 97.48 1.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.961 0.886 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -94.79 144.38 25.69 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.428 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.3 m80 . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.64 -174.914 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -83.14 122.77 28.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.2 m -118.6 114.48 22.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.27 98.72 3.86 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.583 0.706 . . . . 0.0 110.46 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -68.64 162.1 26.71 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.926 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -109.89 141.81 42.08 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.696 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 49' ' ' GLU . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 69' ' ' VAL . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 HD21 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' HG12 ' A' ' 7' ' ' VAL . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 12' ' ' VAL . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG2' HG11 ' A' ' 69' ' ' VAL . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 95.1 t -91.24 86.66 2.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -143.62 139.04 29.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.107 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -162.1 172.29 16.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.979 0.799 . . . . 0.0 109.072 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -100.78 166.5 10.83 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 7.3 pt20 -137.94 129.84 28.54 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.595 0.236 . . . . 0.0 111.413 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -133.08 -51.41 0.89 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.78 0.8 . . . . 0.0 110.172 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -89.89 -17.01 28.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.337 0.589 . . . . 0.0 111.369 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 89.7 mt-30 -129.41 137.51 50.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.32 -82.33 1.48 Allowed Glycine 0 C--N 1.304 -1.223 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.328 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.74 74.74 2.38 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 122.024 0.916 . . . . 0.0 109.567 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.53 124.45 30.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.812 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -123.88 89.11 51.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.09 -38.15 2.99 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.415 2.077 . . . . 0.0 111.123 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -79.46 88.81 5.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -77.36 -178.77 5.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.185 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -63.09 137.77 58.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.471 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -82.23 -58.55 2.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -81.85 86.3 6.51 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.025 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.0 100.31 12.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -130.58 19.11 5.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.81 0.814 . . . . 0.0 109.495 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' N ' ' SD ' ' A' ' 1' ' ' MET . 49.8 m80 -71.19 98.93 1.79 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.511 0.596 . . . . 0.0 109.903 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' OE1' ' A' ' 51' ' ' GLU . 15.4 p -73.65 97.84 2.75 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -100.84 77.75 1.89 Allowed 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.326 1.06 . . . . 0.0 112.369 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -54.48 157.36 2.9 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.41 -2.177 . . . . 0.0 115.312 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.94 127.0 51.47 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.958 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 49' ' ' GLU . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 19' ' ' ILE . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.679 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 3' ' ' THR . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HG2' HG11 ' A' ' 72' ' ' VAL . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' VAL . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 66' ' ' VAL . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -88.42 -39.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 65.04 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.152 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -161.32 98.53 1.15 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.56 91.87 8.89 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.836 0.826 . . . . 0.0 110.556 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' CD ' ' H ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -76.88 147.3 37.15 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.117 -1.402 . . . . 0.0 109.241 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 67.28 96.88 0.06 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.473 1.109 . . . . 0.0 110.566 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.42 -47.53 41.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -161.42 147.88 14.37 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.685 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 139.28 18.29 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.88 136.11 40.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.576 0.688 . . . . 0.0 110.112 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -137.76 149.11 46.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -129.9 123.17 20.81 Favored Pre-proline 0 N--CA 1.402 -2.832 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.27 147.28 41.82 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 120.706 0.938 . . . . 0.0 110.785 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.44 96.76 6.15 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.171 -170.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 12.0 m -101.1 121.45 41.84 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.61 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -94.88 -32.05 13.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.057 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.13 -29.1 38.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 89' ' ' SER . 54.5 m-70 -111.56 96.82 6.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.796 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -94.84 164.57 12.87 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -74.92 157.16 35.49 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.2 m80 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.045 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.02 118.25 21.29 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.2 m -70.72 114.89 9.25 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.059 0.457 . . . . 0.0 110.017 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -97.65 77.19 2.55 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.427 1.108 . . . . 0.0 112.048 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.8 175.26 5.56 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.114 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.64 121.42 45.27 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.743 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 44' ' ' LEU . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.661 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.661 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 19' ' ' ILE . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.486 HG11 HG23 ' A' ' 22' ' ' ILE . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.91 88.04 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -150.88 -72.28 0.17 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -157.17 151.89 25.58 Favored 'General case' 0 CA--C 1.487 -1.442 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -77.31 -42.22 37.68 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.044 -177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -125.9 -16.06 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.013 0.435 . . . . 0.0 112.099 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.94 76.29 7.9 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.59 -39.74 27.01 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -83.84 -41.92 16.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.92 -161.54 27.52 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.52 -12.26 13.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.2 133.8 56.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.924 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 t -138.17 105.96 7.96 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-O 121.862 0.839 . . . . 0.0 111.148 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.04 176.51 5.14 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.341 2.027 . . . . 0.0 111.049 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -80.71 -82.4 0.12 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.55 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 m -128.78 24.62 5.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.685 0.755 . . . . 0.0 109.366 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -129.27 98.7 4.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.276 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.11 131.92 38.58 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.533 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.85 106.64 18.6 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.68 171.22 7.45 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.792 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -102.48 175.48 5.49 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.798 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.543 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 C--O 1.244 0.793 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -81.34 93.97 6.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.434 0.635 . . . . 0.0 111.193 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 p -86.32 146.44 26.49 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.362 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -91.94 121.95 34.0 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -130.0 146.08 51.67 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.204 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.27 142.96 27.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.508 ' HA ' HG12 ' A' ' 19' ' ' ILE . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 46' ' ' VAL . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.633 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 26' ' ' LEU . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.578 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -151.04 131.76 14.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -82.02 123.41 28.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -70.85 -175.2 1.05 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.652 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.11 171.91 11.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -80.76 69.84 7.39 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.94 -41.05 91.8 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -113.09 89.02 2.97 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.32 160.0 27.79 Favored Glycine 0 N--CA 1.424 -2.126 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.081 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.89 23.26 9.99 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.592 1.157 . . . . 0.0 111.904 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -72.77 -28.96 62.93 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -118.59 91.67 42.33 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.48 169.19 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.502 2.135 . . . . 0.0 112.642 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.78 -29.66 56.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.954 0.407 . . . . 0.0 109.967 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -86.88 111.0 20.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -77.59 -20.62 53.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.022 0.439 . . . . 0.0 110.95 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -88.32 143.67 26.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -79.15 156.68 28.14 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -71.83 -32.09 67.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.048 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -86.0 134.62 33.85 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.263 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--N 1.296 -1.733 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.466 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -90.23 -63.2 1.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.1 p 59.16 151.12 0.02 OUTLIER 'General case' 0 C--O 1.246 0.903 0 C-N-CA 125.355 1.462 . . . . 0.0 114.772 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.6 m120 74.34 132.49 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.049 0.94 . . . . 0.0 111.237 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.5 p-90 -69.29 143.23 53.91 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 177.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -117.85 147.44 43.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 69' ' ' VAL . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.596 HG23 HD21 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' HB1' ' A' ' 14' ' ' ALA . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.631 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 26' ' ' LEU . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG2' HG12 ' A' ' 7' ' ' VAL . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 12' ' ' VAL . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.89 -29.59 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -133.1 94.45 3.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -157.42 138.3 13.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.521 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 23.8 pt20 -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.55 79.46 1.97 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.4 0.619 . . . . 0.0 112.237 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 78' ' ' GLN . 35.8 mt-10 -102.81 -55.96 2.33 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.553 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.69 -12.58 60.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.226 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -150.8 94.79 2.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.392 0.615 . . . . 0.0 109.798 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.72 -60.8 0.01 OUTLIER Glycine 0 C--N 1.303 -1.302 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.66 19.0 6.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.019 0.438 . . . . 0.0 110.463 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 26.2 mm-40 -52.79 117.58 3.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.622 1.169 . . . . 0.0 111.486 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.3 m -105.44 99.04 18.75 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 60.0 Cg_endo -87.68 -25.69 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.901 1.734 . . . . 0.0 112.329 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -97.71 102.42 14.18 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -101.77 100.87 11.27 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.434 0.635 . . . . 0.0 110.67 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.45 156.68 20.72 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.526 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -97.53 83.88 3.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -137.61 32.17 2.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.295 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -159.2 148.01 18.22 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.464 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -94.26 -38.36 11.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.297 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.5 m-70 -86.63 100.84 12.73 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -29.8 62.05 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -99.35 83.7 2.87 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 140.12 57.59 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.71 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 53' ' ' SER . 7.6 pt20 -89.9 134.06 34.42 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.113 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 49' ' ' GLU . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' ILE . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 16' ' ' SER . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 97.1 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 26' ' ' LEU . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 7' ' ' VAL . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 2' ' ' HIS . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 53' ' ' SER . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 59.0 t -91.78 87.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -145.68 124.49 12.65 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -100.06 141.97 32.17 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.636 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -141.94 156.73 45.48 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -69.86 93.22 0.74 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.069 0.547 . . . . 0.0 110.842 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -97.69 129.12 44.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -89.68 -36.82 15.01 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 67.33 -77.94 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.532 1.133 . . . . 0.0 112.312 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.83 -170.64 54.03 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.509 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 66.37 107.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.81 135.07 54.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.421 0.629 . . . . 0.0 111.394 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.6 m -128.23 91.51 44.09 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.15 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 113.01 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.8 19.41 9.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t 75.25 144.76 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.718 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -81.85 -35.8 28.97 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -109.72 140.64 43.36 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.616 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -69.56 108.46 3.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.473 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.44 96.28 6.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.081 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -130.67 116.84 18.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.268 0.08 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 74.01 145.31 0.08 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.526 1.53 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 m -78.08 -46.14 21.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -145.68 115.62 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -109.03 160.44 16.04 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.35 138.66 54.05 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 124.867 1.267 . . . . 0.0 107.883 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 19' ' ' ILE . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 32' ' ' CYS . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.48 87.11 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -130.84 -47.16 1.03 Allowed 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.48 -168.37 0.21 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.215 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -98.56 164.34 12.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.08 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.53 0.08 3.38 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -102.66 127.14 49.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.38 -60.83 2.95 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.629 0.771 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -87.83 48.24 1.61 Allowed 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.18 61.73 3.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.9 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -158.15 143.72 16.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.35 110.78 1.76 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.7 m -119.97 114.65 33.69 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.77 -160.08 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.684 2.256 . . . . 0.0 111.655 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -64.31 -11.37 31.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.149 0.58 . . . . 0.0 112.246 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 t -81.33 19.09 1.0 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -79.21 -14.13 59.26 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 58.4 m80 66.18 79.57 0.24 Allowed 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.321 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -81.47 82.42 7.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.98 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.5 t60 167.37 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 127.234 2.214 . . . . 0.0 105.572 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -72.08 -45.68 59.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.832 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.1 t60 . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.617 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -85.61 101.69 12.93 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.18 -0.325 . . . . 0.0 110.263 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -89.78 -15.49 32.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -79.16 103.48 9.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.674 0.75 . . . . 0.0 110.432 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -91.98 177.28 6.22 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.215 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -133.57 159.21 41.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 44' ' ' LEU . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.617 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 19' ' ' ILE . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.413 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.57 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' SER . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.9 87.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -178.69 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.381 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -166.58 147.62 6.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.37 138.04 54.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -125.08 -77.18 0.59 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 57.82 -176.53 0.07 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.945 0.898 . . . . 0.0 111.298 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -89.66 -61.33 1.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -151.79 155.35 38.04 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.752 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.83 156.39 24.82 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.51 77.3 9.85 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.863 0.84 . . . . 0.0 108.988 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.01 -45.33 90.96 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.403 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -139.91 91.07 10.51 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-O 121.726 0.774 . . . . 0.0 110.617 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.11 -175.12 1.36 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.224 1.949 . . . . 0.0 111.832 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 61.68 85.23 0.12 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.774 1.23 . . . . 0.0 110.742 -174.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -66.73 -50.56 62.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -91.77 132.14 36.62 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -73.49 -66.58 0.68 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.68 148.21 1.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -150.72 105.6 3.31 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -80.29 64.6 5.16 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.868 0.842 . . . . 0.0 112.642 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.676 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.35 -17.88 20.35 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -113.04 -33.9 5.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -99.6 105.66 17.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HG2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -162.14 178.44 8.78 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 122.944 0.498 . . . . 0.0 111.022 -174.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -105.16 120.59 41.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' A' ' 39' ' ' ALA . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' HG23 ' A' ' 34' ' ' VAL . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 27' ' ' ASN . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 69.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.529 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG13 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 68' ' ' GLY . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.9 84.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -172.46 125.0 0.49 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -110.71 134.05 52.8 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -81.24 81.45 7.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 82.08 8.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.842 0.829 . . . . 0.0 109.365 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.71 119.78 36.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.993 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.61 -24.21 21.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.618 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -124.61 159.92 29.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.75 94.92 1.91 Allowed Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.91 67.82 4.71 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.565 1.174 . . . . 0.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.74 -60.17 1.62 Allowed 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -146.13 91.27 5.55 Favored Pre-proline 0 N--CA 1.417 -2.079 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.48 7.12 3.19 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.945 2.43 . . . . 0.0 113.257 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -118.28 141.92 48.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.9 t -140.05 -71.25 0.38 Allowed 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -147.37 128.39 14.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.69 -54.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -62.31 137.81 58.32 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -69.75 119.5 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.406 -173.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -79.13 110.5 14.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 C--O 1.212 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -93.78 128.07 39.83 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -71.53 138.49 48.91 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 123.536 0.523 . . . . 0.0 111.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -60.71 131.85 52.01 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.652 0.739 . . . . 0.0 112.396 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -120.14 158.81 26.12 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.001 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -108.82 140.89 41.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 69' ' ' VAL . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 42' ' ' GLY . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 44' ' ' LEU . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 26' ' ' LEU . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 12' ' ' VAL . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 48.4 t -92.75 89.75 2.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -66.57 -33.32 75.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -63.33 143.63 57.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.928 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -125.97 -176.53 3.66 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -54.9 -48.79 72.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.896 0.878 . . . . 0.0 111.053 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.66 123.65 29.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.33 -62.22 1.59 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.892 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -149.68 148.48 29.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.663 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.92 53.8 4.27 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.73 102.51 14.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.852 0.358 . . . . 0.0 110.426 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 8.0 pt-20 -105.04 1.78 28.88 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -95.86 104.34 16.21 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.63 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 72.2 Cg_endo -99.05 154.72 0.63 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.863 2.375 . . . . 0.0 112.495 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 70.46 151.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.529 1.532 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.6 t -78.39 90.78 4.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.16 115.03 24.55 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -130.43 154.67 47.49 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.96 -17.22 38.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.923 0.392 . . . . 0.0 110.81 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 m80 65.22 -170.95 0.19 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.218 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -142.13 144.66 33.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 . . . . . 0 C--N 1.302 -1.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.307 177.137 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.622 0.248 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -138.97 92.75 2.63 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -92.5 -66.0 0.96 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -161.35 133.74 5.96 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.444 ' HD1' ' H ' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -117.13 160.17 21.44 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -114.53 137.65 51.6 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.198 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 49' ' ' GLU . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 69' ' ' VAL . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.553 HD11 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 7' ' ' VAL . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HG2' HG11 ' A' ' 72' ' ' VAL . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 12' ' ' VAL . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 15' ' ' LYS . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 58.8 t -99.15 89.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -151.98 137.53 17.77 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -89.31 133.98 34.26 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.434 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -79.47 158.97 27.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.641 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -79.65 -31.48 41.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.626 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -76.73 85.78 3.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.64 -41.82 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -88.25 -38.18 15.44 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.0 156.86 26.24 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -88.58 114.99 25.77 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -124.95 -67.92 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.568 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 m -127.38 94.94 37.13 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.41 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -96.91 26.22 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.141 2.561 . . . . 0.0 110.585 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.81 163.51 12.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.991 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -91.32 108.74 20.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.64 -17.88 1.94 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.53 -16.16 58.84 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.046 0.927 . . . . 0.0 109.044 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -147.16 138.87 24.2 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.395 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -114.2 -25.02 8.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 71.86 106.79 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.356 1.462 . . . . 0.0 113.758 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.426 1.09 . . . . 0.0 112.471 175.392 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 5' ' ' TRP . 26.8 ptt? . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -125.33 -70.43 0.75 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.206 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m -68.42 -33.59 74.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.604 0.716 . . . . 0.0 110.159 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 177.27 169.89 0.58 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.403 1.481 . . . . 0.0 108.495 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -85.43 119.74 26.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.487 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 19' ' ' ILE . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 16' ' ' SER . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 37' ' ' SER . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 66' ' ' VAL . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.57 -53.63 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -99.73 84.04 2.86 Favored 'General case' 0 C--N 1.269 -2.912 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.286 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -131.91 106.34 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.171 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -123.16 110.16 14.92 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.55 -67.33 0.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.448 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' GLN . 9.2 tp10 -165.41 138.64 4.49 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.46 -38.37 21.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.3 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 28.0 pt20 -124.88 177.78 5.84 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.32 -69.0 0.23 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.85 -59.7 2.34 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -93.07 151.82 19.65 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 m -148.7 83.81 6.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.73 -43.56 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.19 1.926 . . . . 0.0 111.426 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -153.23 143.44 22.34 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.507 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.8 m -113.05 88.1 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -98.37 84.93 3.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.45 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.11 76.42 1.24 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.254 1.026 . . . . 0.0 111.458 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -72.71 125.12 26.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -78.09 95.64 4.94 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.718 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.3 m80 69.47 -71.87 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.24 1.816 . . . . 0.0 110.582 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 C--O 1.219 -0.535 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -97.65 -37.59 9.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.104 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -64.4 -53.19 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -98.39 92.77 5.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.518 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -108.89 162.11 14.5 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.283 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 11.6 mt-30 -72.68 120.24 18.02 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.469 -173.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.44 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.58 HG23 HD21 ' A' ' 44' ' ' LEU . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.548 HD22 HG13 ' A' ' 63' ' ' VAL . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' VAL . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 19' ' ' ILE . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 34' ' ' VAL . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' GLN . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 ' HE2' ' A' ' 15' ' ' LYS . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 42.4 t -84.34 85.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -160.63 -39.49 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.4 m170 75.76 159.33 0.21 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.702 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -121.98 -47.42 2.17 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.633 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -85.16 91.08 8.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 122.362 1.077 . . . . 0.0 111.271 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -130.46 -54.63 1.09 Allowed 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.88 -32.89 74.56 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.711 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.18 -0.25 57.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.635 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.56 125.62 2.61 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.41 -20.69 43.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.635 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -84.11 136.57 33.95 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -90.26 117.58 68.15 Favored Pre-proline 0 N--CA 1.408 -2.565 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -84.85 -164.74 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 122.36 2.04 . . . . 0.0 112.865 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -74.35 98.3 3.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.424 0.63 . . . . 0.0 111.432 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -72.77 128.39 35.37 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.314 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.1 m80 73.46 102.39 0.07 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -81.11 80.71 7.51 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -100.08 -16.24 17.93 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.398 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -126.14 97.28 5.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.434 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -77.23 100.73 5.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--N 1.285 -2.212 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 -174.638 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.392 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -135.6 18.01 3.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 m -90.84 157.14 17.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -83.76 85.93 7.22 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 167.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.69 113.19 1.22 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 123.61 20.87 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.659 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD21 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 HD21 ' A' ' 44' ' ' LEU . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 46' ' ' VAL . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD21 HG23 ' A' ' 19' ' ' ILE . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD21 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.27 -44.76 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.77 123.64 28.05 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -100.68 165.06 11.58 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -62.09 152.41 32.84 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.277 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -75.63 101.89 5.13 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.526 0.679 . . . . 0.0 109.366 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -95.77 169.27 10.12 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.258 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.88 -51.03 11.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 61.65 -174.04 0.14 Allowed 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.106 0.879 . . . . 0.0 112.012 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -165.68 35.42 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.71 -36.92 50.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.053 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -82.54 142.32 31.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.275 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -132.67 103.71 13.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-O 121.128 0.489 . . . . 0.0 110.201 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.23 168.49 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.423 2.082 . . . . 0.0 113.436 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -87.24 -67.5 0.82 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 m -113.47 -41.89 3.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 166.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 91' ' ' HIS . 12.6 t-80 177.3 -152.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 175.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 90' ' ' HIS . 58.7 t60 -67.7 100.68 0.94 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 74.99 174.46 0.25 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 125.109 1.364 . . . . 0.0 109.793 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -96.08 -66.81 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.91 13.88 0.07 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 . . . . . 0 N--CA 1.417 -2.099 0 N-CA-C 100.905 -3.739 . . . . 0.0 100.905 -174.162 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 . . . . . 0 N--CA 1.418 -2.052 0 CA-C-O 120.978 0.418 . . . . 0.0 110.969 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 69' ' ' VAL . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 14' ' ' ALA . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 63' ' ' VAL . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD21 HG23 ' A' ' 19' ' ' ILE . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD21 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 HD22 ' A' ' 26' ' ' LEU . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.475 ' HG2' HG21 ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 15' ' ' LYS . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 12' ' ' VAL . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t . . . . . 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 49' ' ' GLU . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.667 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.667 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 28.7 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 19' ' ' ILE . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 72' ' ' VAL . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.429 ' HB ' HG11 ' A' ' 69' ' ' VAL . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 69' ' ' VAL . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 46' ' ' VAL . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 19' ' ' ILE . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 34' ' ' VAL . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 26' ' ' LEU . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' HG11 ' A' ' 72' ' ' VAL . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 12' ' ' VAL . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t . . . . . 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 49' ' ' GLU . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' HG2' HG12 ' A' ' 7' ' ' VAL . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t . . . . . 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 . . . . . 0 N--CA 1.411 -2.421 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 49' ' ' GLU . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.438 HG23 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.596 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.3 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 19' ' ' ILE . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 26' ' ' LEU . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.719 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.669 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 48' ' ' VAL . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' HG23 ' A' ' 11' ' ' VAL . 98.1 t . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.431 -1.4 0 CA-C-O 121.388 0.613 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.543 HG12 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 74' ' ' LEU . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 69' ' ' VAL . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 19' ' ' ILE . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 16' ' ' SER . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 66' ' ' VAL . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 11' ' ' VAL . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.683 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 12' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 10' ' ' LEU . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 . . . . . 0 N--CA 1.423 -1.795 0 CA-C-O 121.396 0.617 . . . . 0.0 111.696 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 49' ' ' GLU . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 69' ' ' VAL . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 HD21 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 22' ' ' ILE . 17.4 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' HG12 ' A' ' 7' ' ' VAL . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 12' ' ' VAL . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG2' HG11 ' A' ' 69' ' ' VAL . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 95.1 t . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 . . . . . 0 N--CA 1.418 -2.069 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 49' ' ' GLU . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 19' ' ' ILE . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 22' ' ' ILE . 4.5 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG2' HG12 ' A' ' 7' ' ' VAL . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HG2' HG11 ' A' ' 72' ' ' VAL . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' VAL . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 66' ' ' VAL . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t . . . . . 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 N--CA 1.422 -1.872 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 44' ' ' LEU . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.661 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.661 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 19' ' ' ILE . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.486 HG11 HG23 ' A' ' 22' ' ' ILE . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.508 ' HA ' HG12 ' A' ' 19' ' ' ILE . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 46' ' ' VAL . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.633 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 26' ' ' LEU . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.578 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p . . . . . 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 69' ' ' VAL . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.596 HG23 HD21 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' HB1' ' A' ' 14' ' ' ALA . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.631 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 26' ' ' LEU . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG2' HG12 ' A' ' 7' ' ' VAL . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 12' ' ' VAL . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 53' ' ' SER . 7.6 pt20 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.433 0.635 . . . . 0.0 112.113 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 49' ' ' GLU . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' ILE . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 16' ' ' SER . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 27.2 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 26' ' ' LEU . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 7' ' ' VAL . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 53' ' ' SER . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 59.0 t . . . . . 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 . . . . . 0 N--CA 1.433 -1.282 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 19' ' ' ILE . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 32' ' ' CYS . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? . . . . . 0 C--O 1.242 0.661 0 CA-C-O 119.716 -0.183 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 44' ' ' LEU . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.617 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 19' ' ' ILE . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.413 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.57 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' SER . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.431 -1.384 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' A' ' 39' ' ' ALA . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' HG23 ' A' ' 34' ' ' VAL . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 27' ' ' ASN . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 24.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.529 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.54 HG13 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 68' ' ' GLY . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 . . . . . 0 N--CA 1.435 -1.196 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 69' ' ' VAL . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 42' ' ' GLY . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.479 HE21 ' HA ' ' A' ' 22' ' ' ILE . 20.6 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 44' ' ' LEU . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 26' ' ' LEU . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 12' ' ' VAL . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 48.4 t . . . . . 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.061 0.458 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 49' ' ' GLU . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 69' ' ' VAL . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.553 HD11 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 7' ' ' VAL . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HG2' HG11 ' A' ' 72' ' ' VAL . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 12' ' ' VAL . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 15' ' ' LYS . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 58.8 t . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' A' ' 53' ' ' SER . 17.5 mt-30 . . . . . 0 N--CA 1.424 -1.755 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.487 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 19' ' ' ILE . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 16' ' ' SER . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 22' ' ' ILE . 15.5 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 37' ' ' SER . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.414 ' HA ' HE22 ' A' ' 6' ' ' GLN . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 66' ' ' VAL . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 11.6 mt-30 . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.92 0.39 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.44 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.58 HG23 HD21 ' A' ' 44' ' ' LEU . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.548 HD22 HG13 ' A' ' 63' ' ' VAL . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' VAL . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 19' ' ' ILE . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 34' ' ' VAL . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' GLN . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 ' HE2' ' A' ' 15' ' ' LYS . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 42.4 t . . . . . 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 N--CA 1.414 -2.262 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD21 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 HD21 ' A' ' 44' ' ' LEU . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 46' ' ' VAL . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD21 HG23 ' A' ' 19' ' ' ILE . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD21 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t . . . . . 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 C--O 1.238 0.48 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -88.23 107.89 19.02 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.8 p -85.65 163.18 18.45 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.091 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -77.73 90.01 4.01 Favored 'General case' 0 C--O 1.245 0.835 0 CA-C-O 122.315 1.055 . . . . 0.0 108.276 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -85.93 164.97 17.13 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.406 -1.725 . . . . 0.0 111.161 -177.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -127.66 142.33 51.37 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.969 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG12 ' HB3' ' A' ' 49' ' ' GLU . 10.2 m -100.48 147.64 7.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' SG ' HD21 ' A' ' 56' ' ' LEU . 83.6 m -141.99 131.59 23.98 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 118.036 0.38 . . . . 0.0 111.354 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.6 t -85.0 143.95 28.6 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.055 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 96.6 mt -123.33 125.71 45.52 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.823 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 95.7 t -96.17 101.46 12.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 69' ' ' VAL . 72.0 t -95.69 115.39 34.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.974 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -92.96 116.59 29.19 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -135.99 172.33 13.17 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-N 116.637 -0.256 . . . . 0.0 110.349 -175.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.405 ' HD3' ' HA2' ' A' ' 68' ' ' GLY . 0.4 OUTLIER -56.53 114.61 2.1 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 123.561 0.538 . . . . 0.0 109.679 174.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 m -58.39 -26.68 63.5 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.207 1.003 . . . . 0.0 111.677 -177.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -77.54 -29.42 52.25 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.551 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -105.0 12.75 31.94 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.848 0.832 . . . . 0.0 110.373 -169.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.496 HG23 HD21 ' A' ' 44' ' ' LEU . 27.4 mm -55.49 -39.19 52.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 -176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.4 m -65.23 -42.67 93.19 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -65.63 -49.01 70.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.371 0.605 . . . . 0.0 109.914 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.447 HD13 ' HB1' ' A' ' 14' ' ' ALA . 65.0 mt -61.65 -49.86 82.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.521 -176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -59.7 -46.23 89.72 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 111.633 0.234 . . . . 0.0 111.633 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.8 m -57.77 -48.92 78.3 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.577 0.548 . . . . 0.0 110.235 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -62.82 -46.34 88.41 Favored 'General case' 0 N--CA 1.416 -2.136 0 C-N-CA 122.899 0.48 . . . . 0.0 111.804 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD22 HG13 ' A' ' 63' ' ' VAL . 60.3 mt -66.73 -32.98 74.64 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -75.02 -8.61 57.01 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.955 0.884 . . . . 0.0 110.044 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.74 7.01 47.51 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.251 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.65 154.76 56.3 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -75.89 111.33 3.26 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.248 1.965 . . . . 0.0 112.07 -176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 90.83 0.94 74.2 Favored Glycine 0 N--CA 1.437 -1.24 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.555 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.5 m -102.82 124.59 48.63 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 117.127 0.464 . . . . 0.0 110.806 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -125.41 134.33 52.17 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.1 t -85.43 108.86 17.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.86 -54.11 5.11 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.292 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 54.6 t -123.43 139.51 49.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 p -136.21 103.73 5.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 121.189 0.519 . . . . 0.0 111.656 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.0 t70 -107.97 93.87 4.77 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -59.25 -44.38 98.23 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 114.71 -1.132 . . . . 0.0 113.704 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 18.8 Cg_endo -52.51 -44.36 47.77 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.401 2.734 . . . . 0.0 113.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.4 m -88.32 -26.12 22.42 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.545 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.08 25.57 24.06 Favored Glycine 0 N--CA 1.434 -1.478 0 C-N-CA 120.474 -0.87 . . . . 0.0 110.994 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -100.13 125.69 46.28 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-O 121.45 0.643 . . . . 0.0 111.1 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD21 HG23 ' A' ' 19' ' ' ILE . 86.3 mt -121.53 123.86 43.02 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.019 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 46.5 mm -97.16 117.87 42.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 175.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.1 t -120.91 126.08 74.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 53.5 t -103.01 123.11 56.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.8 t -113.93 129.21 70.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.506 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.9 pt-20 -120.56 122.42 40.54 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.069 0.462 . . . . 0.0 109.81 176.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -140.77 147.62 39.38 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.717 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.45 ' HA ' ' HB3' ' A' ' 5' ' ' TRP . 29.3 mt-10 -50.38 -61.23 2.3 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 126.093 1.757 . . . . 0.0 113.578 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 16.7 t70 -111.19 155.34 23.06 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' O ' HG12 ' A' ' 57' ' ' ILE . 25.1 m -57.51 -34.93 69.61 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 122.991 0.517 . . . . 0.0 111.38 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -73.7 -37.52 65.16 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 122.434 0.294 . . . . 0.0 110.421 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 1.9 m -63.09 -35.2 79.46 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD21 ' SG ' ' A' ' 8' ' ' CYS . 38.7 tp -63.41 -47.59 81.35 Favored 'General case' 0 N--CA 1.435 -1.198 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.235 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 53' ' ' SER . 48.2 mm -59.28 -46.26 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 123.487 0.492 . . . . 0.0 110.255 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -54.66 -41.34 70.03 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.97 0.508 . . . . 0.0 110.967 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.4 m -73.59 -49.41 26.38 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.537 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.54 -37.6 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 122.818 0.447 . . . . 0.0 111.969 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.63 -36.9 84.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 12.8 t -67.29 -38.25 84.73 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG13 HD22 ' A' ' 26' ' ' LEU . 96.2 t -58.56 -39.65 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-O 121.61 0.719 . . . . 0.0 109.712 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.475 ' HG2' HG21 ' A' ' 72' ' ' VAL . 41.2 mtp180 -76.64 -8.65 57.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.88 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -93.67 4.76 53.45 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.088 0.774 . . . . 0.0 113.088 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.4 t -85.45 135.88 23.98 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.452 0 CA-C-O 121.42 0.628 . . . . 0.0 111.405 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.01 117.67 13.92 Favored 'General case' 0 N--CA 1.389 -3.511 0 CA-C-O 122.497 1.141 . . . . 0.0 110.276 170.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 15' ' ' LYS . . . 141.31 -30.65 2.21 Favored Glycine 0 C--N 1.262 -3.571 0 N-CA-C 108.984 -1.647 . . . . 0.0 108.984 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 12' ' ' VAL . 59.9 t -81.02 130.62 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-N 114.411 -0.894 . . . . 0.0 109.629 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.01 -53.01 3.51 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -143.82 134.64 25.22 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.976 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG21 ' HG2' ' A' ' 64' ' ' ARG . 93.5 t -108.25 112.0 38.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -93.83 107.83 19.67 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 76' ' ' TYR . 0.6 OUTLIER -79.76 122.68 26.9 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -68.5 -20.99 25.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 121.515 0.674 . . . . 0.0 111.341 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.429 ' O ' HD22 ' A' ' 74' ' ' LEU . 83.8 t80 -121.7 104.93 9.96 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -130.76 147.21 52.4 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.784 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -113.01 -178.02 3.28 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -79.52 177.11 9.1 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -75.45 157.11 34.55 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.64 -42.51 92.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 69.82 -51.67 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.369 1.467 . . . . 0.0 112.458 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 113.6 132.69 5.59 Favored Glycine 0 N--CA 1.421 -2.332 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -91.82 122.9 34.79 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -72.83 -21.99 60.87 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.296 -173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.7 m -141.21 109.84 6.37 Favored Pre-proline 0 C--N 1.302 -1.473 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.99 160.88 42.21 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.661 2.24 . . . . 0.0 113.323 -173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -96.35 -168.97 1.83 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.695 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.8 m -75.58 125.09 28.34 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-O 121.279 0.562 . . . . 0.0 111.376 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' HB3' ' CD2' ' A' ' 92' ' ' HIS . 53.6 m-70 -108.36 143.58 37.07 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.9 m80 -126.57 44.17 2.94 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.433 0.635 . . . . 0.0 110.313 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 90' ' ' HIS . 63.1 m-70 -90.13 92.76 9.1 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -110.89 130.72 55.5 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.203 0.525 . . . . 0.0 111.613 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -83.67 -23.69 31.64 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.343 178.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.5 t60 . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 176.405 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 CA--C 1.502 -0.882 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -113.43 148.18 36.39 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.4 m 74.7 -47.21 0.62 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.514 1.125 . . . . 0.0 112.233 178.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -76.15 102.6 5.82 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 4.2 p-90 -63.68 169.06 4.27 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.811 177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -123.8 143.49 50.28 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.577 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 49' ' ' GLU . 32.7 m -103.63 153.58 5.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.706 -176.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 56' ' ' LEU . 31.8 p -139.43 132.48 29.54 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 171.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -94.95 129.57 41.94 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -111.58 120.22 41.37 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.505 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 73.8 t -90.58 102.08 13.01 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 86.7 t -99.15 103.08 14.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.834 -1.076 . . . . 0.0 109.874 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.63 108.05 20.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -133.69 172.81 12.26 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 122.897 0.479 . . . . 0.0 111.501 -172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.53 125.61 20.34 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.377 0.423 . . . . 0.0 111.498 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.8 t -61.9 -37.67 85.5 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.751 0.82 . . . . 0.0 112.333 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -80.49 -10.7 59.74 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.895 -0.503 . . . . 0.0 111.09 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -106.06 3.48 28.2 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.717 0.77 . . . . 0.0 109.591 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.426 HG12 ' HA ' ' A' ' 16' ' ' SER . 25.2 mm -56.97 -41.17 76.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.139 -0.937 . . . . 0.0 113.246 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.2 t -64.2 -41.86 96.88 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.217 0.532 . . . . 0.0 110.277 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.65 -50.63 66.32 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.075 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 78.9 mt -63.87 -40.19 88.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.073 -177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.0 m -59.41 -35.21 73.56 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.054 0.388 . . . . 0.0 111.445 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.8 m -77.55 -37.01 51.67 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -65.9 -45.66 81.18 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.494 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.3 mt -65.97 -36.53 83.57 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-O 121.18 0.514 . . . . 0.0 110.722 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -67.62 -26.88 66.46 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.019 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.08 -13.65 60.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 52.6 m-85 -78.84 149.64 74.29 Favored Pre-proline 0 N--CA 1.414 -2.272 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -63.9 117.44 4.44 Favored 'Trans proline' 0 C--O 1.24 0.577 0 C-N-CA 123.078 2.519 . . . . 0.0 111.765 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 76.48 2.13 73.36 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.802 -0.636 . . . . 0.0 113.613 176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 31.4 m -104.14 111.71 24.41 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -124.08 140.39 53.02 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.367 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.6 t -79.8 111.11 16.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.12 -58.03 2.71 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.028 0.442 . . . . 0.0 111.31 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.3 t -112.23 117.65 55.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 12.2 m -111.23 118.06 34.9 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.667 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 15.4 t70 -120.74 89.68 3.18 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.25 -40.71 79.34 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.667 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 Cg_endo -51.91 -44.41 45.37 Favored 'Trans proline' 0 C--N 1.388 2.648 0 C-N-CA 123.627 2.885 . . . . 0.0 113.197 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.5 m -89.9 -25.29 21.04 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 121.174 0.511 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.85 24.74 29.21 Favored Glycine 0 N--CA 1.439 -1.124 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 28.7 mt-30 -107.12 127.58 53.62 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 121.582 0.706 . . . . 0.0 112.322 -177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.413 HD21 HG23 ' A' ' 19' ' ' ILE . 84.0 mt -117.46 123.07 45.47 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.057 176.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.2 mm -92.04 118.42 37.48 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.15 123.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -104.11 118.44 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 41.8 t -115.75 132.57 64.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.467 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -118.8 122.11 41.63 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.252 172.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.1 158.1 38.91 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.055 -178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.18 -74.14 0.12 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 124.201 0.938 . . . . 0.0 111.403 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 17.5 m-20 -95.68 158.64 15.36 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.982 -177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.467 ' O ' HG12 ' A' ' 57' ' ' ILE . 12.5 m -65.99 -41.2 91.39 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.906 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.71 -32.35 67.69 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.069 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 7.0 m -63.62 -38.96 93.11 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' SG ' ' A' ' 8' ' ' CYS . 56.7 tp -61.78 -48.06 82.36 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 53' ' ' SER . 48.9 mm -56.01 -48.68 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.093 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -55.34 -41.99 73.22 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.335 0.588 . . . . 0.0 111.037 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 63' ' ' VAL . 39.7 m -66.22 -47.97 72.11 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.032 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 56' ' ' LEU . 84.5 mt -57.61 -39.03 67.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 123.152 0.581 . . . . 0.0 111.138 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -61.68 -46.43 89.74 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.935 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 14.9 t -64.95 -35.3 80.74 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 59' ' ' THR . 87.8 t -62.25 -39.72 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 121.333 0.587 . . . . 0.0 110.034 176.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 51.3 mtm180 -74.01 -9.35 58.54 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.998 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -72.89 -5.86 41.26 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.568 178.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.2 t -84.82 100.06 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -89.04 66.21 7.73 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 122.389 1.09 . . . . 0.0 113.913 -170.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -134.68 6.3 4.49 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 172.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 72' ' ' VAL . 24.5 t -94.87 135.84 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.077 -176.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.4 mt -90.34 -56.75 3.09 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -126.77 117.33 22.44 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.0 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.429 ' HB ' HG11 ' A' ' 69' ' ' VAL . 5.8 p -108.74 109.68 29.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.886 0.851 . . . . 0.0 109.181 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.8 m -106.05 116.61 32.22 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.995 -176.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 tt -82.74 124.41 30.22 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 105.745 -1.946 . . . . 0.0 105.745 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.52 -17.97 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.318 0.58 . . . . 0.0 112.427 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -108.58 23.4 14.58 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.969 0.89 . . . . 0.0 108.962 -174.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -137.9 111.09 7.86 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -91.56 96.69 10.61 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.022 0.439 . . . . 0.0 110.583 -177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -75.55 -49.39 18.79 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 61.31 -164.62 0.24 Allowed 'General case' 0 C--O 1.241 0.628 0 O-C-N 124.478 1.111 . . . . 0.0 110.593 176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -74.13 -24.02 59.37 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.123 176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.32 113.71 11.84 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.869 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.51 144.27 16.0 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.18 -73.3 0.13 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.145 0.974 . . . . 0.0 109.772 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -148.74 102.44 3.29 Favored 'General case' 0 N--CA 1.423 -1.805 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.6 m -110.76 109.19 57.81 Favored Pre-proline 0 C--N 1.28 -2.436 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.79 -170.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.495 ' HA ' ' NE2' ' A' ' 91' ' ' HIS . 88.1 Cg_endo -78.69 36.98 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.822 3.014 . . . . 0.0 113.025 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -108.94 21.83 16.7 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.888 0.851 . . . . 0.0 108.787 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -126.1 170.88 11.33 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.383 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -90.76 94.45 9.68 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.495 ' NE2' ' HA ' ' A' ' 87' ' ' PRO . 73.7 m-70 -84.93 -56.34 3.61 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -176.3 152.66 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.651 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -102.61 1.87 35.31 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 172.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 44.6 t60 76.5 92.83 0.07 Allowed 'General case' 0 C--O 1.248 1.017 0 C-N-CA 126.056 1.742 . . . . 0.0 110.272 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.4 t60 . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 -179.14 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.468 0.463 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -106.99 95.27 5.6 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 173.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -24.59 59.4 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.714 -174.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 63.7 87.41 0.11 Allowed 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.6 -173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.32 156.18 23.01 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.112 -177.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -88.76 120.04 29.8 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.3 m -118.74 113.75 42.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.5 m -129.98 151.1 50.91 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.6 t -98.05 140.27 32.63 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 90.4 mt -115.93 123.57 48.39 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.3 t -95.54 101.64 12.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 174.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 69' ' ' VAL . 48.7 t -94.65 106.71 18.47 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.153 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -84.55 118.48 24.35 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.58 169.28 18.04 Favored 'General case' 0 C--N 1.292 -1.93 0 C-N-CA 121.113 -0.235 . . . . 0.0 111.228 -173.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -56.77 115.72 2.74 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.9 m -62.8 -27.88 69.62 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.198 0.599 . . . . 0.0 111.726 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -77.73 -23.78 49.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.641 0.734 . . . . 0.0 110.733 178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -103.55 5.83 36.95 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.303 -174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 44' ' ' LEU . 16.3 mt -56.97 -38.51 60.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.966 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 m -56.49 -37.82 70.91 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.389 0.676 . . . . 0.0 110.531 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -78.06 -56.41 4.5 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.337 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 67.8 mt -59.73 -45.79 94.17 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.918 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.25 -174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.5 t -64.72 -30.65 71.67 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.772 0.32 . . . . 0.0 110.397 -177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -76.24 -36.93 58.28 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -70.74 -45.35 65.01 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.052 -1.431 . . . . 0.0 112.453 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 61.9 mt -66.46 -39.14 88.66 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-O 120.905 0.383 . . . . 0.0 110.623 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -77.94 -2.28 36.11 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 121.349 0.595 . . . . 0.0 110.852 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.25 -17.33 29.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.464 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 46.8 m-85 -80.57 143.68 55.47 Favored Pre-proline 0 N--CA 1.418 -2.029 0 O-C-N 122.143 -0.348 . . . . 0.0 110.29 -178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.09 126.17 12.79 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.524 2.149 . . . . 0.0 110.967 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.44 0.74 75.84 Favored Glycine 0 C--N 1.31 -0.877 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.618 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 49.5 t -123.94 119.28 29.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -136.44 141.24 43.56 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.118 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 46' ' ' VAL . 25.5 t -89.6 118.44 34.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.53 -40.6 10.22 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.187 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.1 t -137.45 120.89 21.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.0 m -112.25 123.05 49.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -118.41 95.78 5.02 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.13 -44.83 99.9 Favored Pre-proline 0 C--N 1.306 -1.312 0 O-C-N 123.926 0.766 . . . . 0.0 111.765 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 38.6 Cg_endo -58.77 -40.44 72.64 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.147 2.565 . . . . 0.0 112.782 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.2 m -86.5 -19.7 29.15 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.38 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.439 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 76.57 25.36 65.53 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -109.36 134.74 51.44 Favored 'General case' 0 CA--C 1.498 -1.042 0 C-N-CA 123.313 0.645 . . . . 0.0 111.983 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.548 HD21 HG23 ' A' ' 19' ' ' ILE . 87.6 mt -129.68 112.74 13.96 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 172.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.4 mm -89.69 117.54 33.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 34' ' ' VAL . 83.1 t -118.55 127.65 75.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.03 113.52 40.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 64.5 t -102.98 127.91 56.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.432 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.65 122.39 40.39 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.421 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.61 141.75 20.41 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -81.57 -53.58 6.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.281 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 7.5 m-20 -76.5 146.14 38.67 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 57' ' ' ILE . 23.1 t -65.01 -40.38 94.82 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.128 -177.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.47 -28.79 63.13 Favored 'General case' 0 C--O 1.216 -0.675 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.135 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.559 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 55.5 m -65.51 -35.21 80.21 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 176.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 tp -66.68 -49.21 66.86 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 53' ' ' SER . 50.2 mm -54.8 -51.63 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.325 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -58.32 -35.93 72.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.113 0.565 . . . . 0.0 112.069 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.6 m -71.12 -47.09 60.02 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.136 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.7 mt -62.73 -39.27 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.157 0.503 . . . . 0.0 109.756 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -54.94 -51.61 65.59 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 124.312 1.045 . . . . 0.0 109.702 176.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.72 -42.74 84.44 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.564 0.746 . . . . 0.0 111.873 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.421 HG13 HD22 ' A' ' 26' ' ' LEU . 25.1 t -60.81 -45.28 98.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 C-N-CA 124.115 0.966 . . . . 0.0 110.811 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.471 ' HG2' HG11 ' A' ' 72' ' ' VAL . 82.3 mtp180 -73.13 -9.52 58.81 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.122 0.487 . . . . 0.0 111.683 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -86.85 -4.41 59.17 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.49 177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -86.82 120.31 36.09 Favored 'Isoleucine or valine' 0 C--O 1.245 0.864 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 175.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -82.37 105.86 13.77 Favored 'General case' 0 N--CA 1.392 -3.336 0 CA-C-O 122.781 1.277 . . . . 0.0 111.309 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . 158.93 -10.74 0.19 Allowed Glycine 0 N--CA 1.404 -3.452 0 CA-C-N 112.774 -2.012 . . . . 0.0 109.55 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.465 HG13 HG13 ' A' ' 12' ' ' VAL . 58.5 t -81.14 122.49 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.0 mt -81.81 -53.15 6.42 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.49 124.01 7.15 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.597 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.471 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.7 p -108.9 109.22 27.52 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-O 121.618 0.723 . . . . 0.0 109.683 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -90.53 121.54 32.56 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.419 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.5 tt -83.44 115.81 22.23 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.92 87.09 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.904 0 CA-C-O 121.973 0.892 . . . . 0.0 109.009 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -84.95 -26.68 27.04 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.244 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -89.65 98.62 11.87 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -123.26 124.6 43.36 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.807 0.337 . . . . 0.0 111.738 -175.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 66.18 90.21 0.09 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 125.641 1.577 . . . . 0.0 111.564 176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -158.46 -22.1 0.08 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.212 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -62.93 -37.61 87.72 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 121.226 0.536 . . . . 0.0 111.078 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -123.78 177.56 5.66 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -144.11 66.68 0.45 Allowed Glycine 0 CA--C 1.478 -2.276 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 61.78 -151.32 0.38 Allowed 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -66.58 159.1 28.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 174.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.2 m -140.96 117.1 7.49 Favored Pre-proline 0 C--N 1.28 -2.421 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.63 171.82 11.41 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.418 2.079 . . . . 0.0 112.845 -174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -83.51 7.15 17.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.448 -175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.4 t -139.25 121.99 16.45 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -83.22 -25.03 32.1 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.695 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 73.88 115.17 0.06 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -92.51 -27.26 17.52 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.9 m-70 -111.01 105.85 14.75 Favored 'General case' 0 C--O 1.253 1.264 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.516 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -81.84 -17.41 47.52 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.952 0.882 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 41.1 m80 . . . . . 0 C--N 1.296 -1.754 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.13 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 CA--C 1.489 -1.402 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 24.1 m-70 -76.22 127.82 33.68 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 18.3 m -148.47 50.95 1.01 Allowed 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -133.15 49.32 2.32 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 113.945 -1.48 . . . . 0.0 107.718 -175.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.597 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -65.81 153.49 41.74 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 113.378 -1.737 . . . . 0.0 113.829 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -94.75 141.57 28.47 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.131 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' A' ' 49' ' ' GLU . 32.1 m -124.68 141.85 43.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 123.642 0.589 . . . . 0.0 109.938 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 27.1 p -143.87 155.22 44.02 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 177.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.4 t -107.8 147.14 31.26 Favored 'General case' 0 N--CA 1.418 -2.054 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.2 mt -128.58 130.8 47.86 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.077 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 62.8 t -96.05 102.61 13.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 66.5 t -94.11 104.42 15.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.797 -178.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -87.31 111.58 21.2 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.99 172.06 13.58 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 121.143 -0.223 . . . . 0.0 111.19 -175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 5.2 mptp? -57.23 117.46 4.09 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.54 0.525 . . . . 0.0 110.542 176.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.49 ' HA ' HG12 ' A' ' 19' ' ' ILE . 47.3 t -55.9 -36.39 67.61 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.585 0.754 . . . . 0.0 110.047 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -68.67 -17.42 64.08 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.834 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -123.63 9.26 8.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.309 0.576 . . . . 0.0 110.309 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 44' ' ' LEU . 23.3 mm -52.75 -47.5 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -57.75 -43.58 85.49 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.383 0.611 . . . . 0.0 111.243 -177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.07 -39.79 54.64 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.23 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.508 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 88.2 mt -63.83 -38.31 81.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.435 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -65.22 -32.92 74.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 110.25 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.9 m -72.95 -32.55 65.32 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -72.65 -45.35 59.39 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 113.636 -1.62 . . . . 0.0 112.118 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 89.6 mt -65.3 -39.59 92.7 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-O 120.694 0.283 . . . . 0.0 110.831 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -72.48 -3.34 23.77 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.52 -22.53 23.55 Favored 'General case' 0 C--N 1.309 -1.187 0 O-C-N 122.322 -0.237 . . . . 0.0 111.391 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 56.4 m-85 -77.81 141.62 64.28 Favored Pre-proline 0 N--CA 1.414 -2.26 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 3.7 Cg_exo -71.76 111.74 3.21 Favored 'Trans proline' 0 C--O 1.238 0.523 0 C-N-CA 122.465 2.11 . . . . 0.0 111.433 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.5 -7.99 43.48 Favored Glycine 0 C--N 1.302 -1.341 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.875 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 41.7 t -108.29 122.44 46.96 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -143.57 135.06 26.15 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 121.201 0.524 . . . . 0.0 110.745 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.4 t -80.18 114.21 20.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.07 -53.79 4.68 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.008 0.432 . . . . 0.0 110.44 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.6 t -119.04 131.05 72.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.6 p -122.72 109.09 13.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.586 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.539 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.6 t70 -108.08 88.48 2.74 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -55.99 -41.56 91.62 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.231 -1.349 . . . . 0.0 114.29 -178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.4 Cg_endo -49.85 -44.44 36.65 Favored 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.632 2.888 . . . . 0.0 113.204 178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 44.4 p -88.3 -31.39 18.99 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.312 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.28 23.2 25.12 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -106.11 130.19 54.06 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.671 0.748 . . . . 0.0 111.779 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 19' ' ' ILE . 96.0 mt -115.35 127.59 55.51 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.75 -1.114 . . . . 0.0 109.157 177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.0 mm -94.84 118.19 40.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.91 131.44 64.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.02 117.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 61.6 t -99.81 125.2 53.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 57.7 mt-10 -118.31 122.1 42.05 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.445 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -152.56 140.46 20.11 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.19 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -63.57 -46.48 85.72 Favored 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.934 0.771 . . . . 0.0 110.677 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 12.7 m-20 -95.94 144.79 25.94 Favored 'General case' 0 CA--C 1.502 -0.895 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.879 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 57' ' ' ILE . 22.6 t -70.29 -27.65 64.57 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HB3' ' A' ' 52' ' ' ASP . 14.5 pt-20 -73.72 -40.91 63.24 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.607 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.428 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 40.1 m -62.8 -34.05 76.48 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 176.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 60' ' ' ILE . 25.2 tp -58.6 -49.81 76.1 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 176.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.516 HG12 ' O ' ' A' ' 53' ' ' SER . 40.0 mm -61.67 -47.64 92.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.53 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -55.26 -41.82 72.7 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.632 0.583 . . . . 0.0 111.616 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.7 m -67.14 -35.54 79.93 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.811 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 56' ' ' LEU . 63.8 mt -69.88 -32.82 53.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 41.4 mt-10 -62.12 -42.97 99.77 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 63.3 m -57.56 -47.67 81.44 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 123.765 0.826 . . . . 0.0 111.182 177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.93 -40.31 80.05 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.47 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.8 mtm105 -74.8 -9.72 58.82 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.873 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -88.03 -7.24 57.32 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.006 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 52.4 t -78.61 116.89 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-O 121.967 0.889 . . . . 0.0 110.837 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -82.41 104.69 12.89 Favored 'General case' 0 N--CA 1.394 -3.233 0 CA-C-O 122.595 1.188 . . . . 0.0 110.867 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 146.79 -12.34 1.49 Allowed Glycine 0 C--N 1.276 -2.79 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 -173.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 64.2 t -89.5 139.41 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.8 mt -101.28 -40.44 7.13 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.33 -0.396 . . . . 0.0 109.996 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.37 127.1 6.77 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.94 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.26 109.65 29.05 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.1 t -98.23 124.61 42.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD22 ' H ' ' A' ' 76' ' ' TYR . 1.2 tt -84.02 132.17 34.76 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -74.6 -2.41 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-O 122.355 1.074 . . . . 0.0 111.517 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.467 ' H ' HD22 ' A' ' 74' ' ' LEU . 63.0 t80 -134.24 102.59 5.42 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 13.0 t60 -128.77 135.9 49.8 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -119.04 145.15 46.11 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.976 0.417 . . . . 0.0 111.434 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -86.05 -47.52 9.48 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -103.6 103.87 13.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.746 -178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -73.25 -41.48 63.65 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 174.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 62.87 -178.8 0.14 Allowed 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.766 1.626 . . . . 0.0 113.112 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.1 -126.28 2.28 Favored Glycine 0 N--CA 1.408 -3.194 0 N-CA-C 108.256 -1.938 . . . . 0.0 108.256 174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -103.07 -18.51 14.93 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 176.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 67.66 94.61 0.07 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 114.049 -1.432 . . . . 0.0 108.832 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.8 t -107.47 125.99 31.04 Favored Pre-proline 0 N--CA 1.417 -2.102 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.979 -173.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -93.37 -171.79 0.3 Allowed 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 122.381 2.054 . . . . 0.0 111.273 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -113.55 160.76 18.18 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.5 m -150.27 142.06 23.73 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -81.25 131.04 35.27 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -79.93 -38.47 32.35 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.942 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -127.98 126.91 42.29 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -82.13 145.63 30.03 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -87.33 174.43 8.56 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 112.546 0.572 . . . . 0.0 112.546 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 44.1 m80 . . . . . 0 C--O 1.25 1.082 0 C-N-CA 124.982 1.313 . . . . 0.0 110.456 178.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 C--O 1.233 0.227 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -93.18 119.05 31.95 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.177 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.0 m 51.09 80.13 0.08 Allowed 'General case' 0 C--O 1.253 1.271 0 C-N-CA 125.011 1.324 . . . . 0.0 114.478 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -85.58 116.7 24.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 171.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -116.61 171.54 7.8 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.406 -173.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -124.3 134.8 53.1 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.449 -1.251 . . . . 0.0 108.64 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.457 HG12 ' HB3' ' A' ' 49' ' ' GLU . 19.1 m -107.55 151.83 9.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.232 -176.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.2 p -141.5 151.56 43.4 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.0 t -119.34 137.5 53.67 Favored 'General case' 0 C--O 1.256 1.416 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.4 mt -126.78 130.06 49.55 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.697 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.438 HG23 ' CG2' ' A' ' 75' ' ' VAL . 61.5 t -94.12 102.15 13.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 172.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 96.2 t -89.32 108.78 19.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -92.89 118.06 30.72 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 177.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -142.23 172.45 12.67 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 123.134 0.271 . . . . 0.0 111.456 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.3 mptp? -60.75 121.47 12.37 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.321 175.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.8 t -60.48 -42.44 96.27 Favored 'General case' 0 C--N 1.313 -1.015 0 O-C-N 123.747 0.655 . . . . 0.0 111.045 -177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.4 -16.93 63.61 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.243 0.544 . . . . 0.0 111.624 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -108.29 0.69 21.45 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.127 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.596 HD11 ' HA2' ' A' ' 42' ' ' GLY . 16.1 mt -56.85 -35.27 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.214 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 m -55.44 -46.16 76.75 Favored 'General case' 0 CA--C 1.55 0.981 0 O-C-N 123.618 0.574 . . . . 0.0 110.448 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -74.74 -47.58 30.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.91 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.499 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 87.1 mt -59.72 -43.08 90.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.36 -175.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.7 m -61.88 -36.37 81.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.697 0.284 . . . . 0.0 111.615 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 74.8 m -76.5 -34.2 58.62 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 121.779 0.8 . . . . 0.0 108.878 -177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -66.96 -41.81 86.24 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.83 175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 91.2 mt -65.78 -38.9 90.28 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-O 120.512 0.196 . . . . 0.0 110.933 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -75.69 -2.57 30.19 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.1 -26.01 23.86 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 53.8 m-85 -76.04 140.25 69.89 Favored Pre-proline 0 N--CA 1.419 -2.015 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 14.3 Cg_exo -66.84 111.24 2.12 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.995 2.463 . . . . 0.0 112.326 -177.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 97.92 4.7 57.71 Favored Glycine 0 CA--C 1.494 -1.275 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.479 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 37.6 t -117.76 113.71 22.23 Favored 'General case' 0 N--CA 1.428 -1.563 0 CA-C-O 121.02 0.438 . . . . 0.0 109.995 -178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.47 142.22 49.94 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.01 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -87.65 128.45 40.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.03 -64.37 1.05 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.485 0.659 . . . . 0.0 109.977 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.0 t -99.94 128.92 51.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 p -126.63 105.38 8.67 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 120.762 0.315 . . . . 0.0 110.913 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 28.3 m-20 -103.54 92.5 4.49 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.581 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -47.26 99.17 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 119.156 -0.449 . . . . 0.0 111.698 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 35.7 Cg_endo -55.87 -44.32 48.59 Favored 'Trans proline' 0 C--N 1.386 2.54 0 C-N-CA 123.643 2.895 . . . . 0.0 113.203 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.2 m -81.29 -22.77 38.36 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.596 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 83.11 24.96 50.57 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -175.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.3 mt-30 -112.61 128.33 56.34 Favored 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 123.021 0.528 . . . . 0.0 112.257 -173.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.439 HD21 HG23 ' A' ' 19' ' ' ILE . 75.7 mt -128.3 119.12 24.49 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.86 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -89.41 118.38 34.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG21 HD13 ' A' ' 26' ' ' LEU . 66.9 t -113.28 128.4 70.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.11 111.5 35.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.719 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 80.1 t -106.39 125.98 62.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 7' ' ' VAL . 10.6 pt-20 -136.54 130.02 31.8 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.181 0.515 . . . . 0.0 110.869 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -156.03 162.98 40.24 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 34.4 tt0 -72.98 -66.41 0.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 123.284 0.365 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.476 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 8.4 m-20 -72.96 141.24 47.79 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.669 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.1 m -65.97 -34.93 79.23 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 123.421 0.451 . . . . 0.0 110.337 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.42 -45.63 86.71 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.7 m -61.87 -37.37 84.29 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.192 178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD12 HG12 ' A' ' 48' ' ' VAL . 21.6 tp -62.92 -50.3 71.38 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 53' ' ' SER . 48.4 mm -55.14 -48.57 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.671 0.788 . . . . 0.0 110.973 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -64.66 -30.83 71.85 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 120.913 0.387 . . . . 0.0 111.998 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.411 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.3 m -74.15 -36.49 64.11 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.4 mt -66.46 -40.37 86.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -55.38 -45.71 76.55 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.059 0.944 . . . . 0.0 109.033 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 59' ' ' THR . 64.1 m -57.38 -43.42 83.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 123.733 0.813 . . . . 0.0 111.787 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.1 t -62.57 -37.61 79.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 123.517 0.727 . . . . 0.0 110.568 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -75.12 -9.36 58.47 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.272 0.558 . . . . 0.0 110.554 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.33 -4.42 57.11 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 122.968 0.507 . . . . 0.0 111.357 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.96 118.17 25.85 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.234 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -80.57 113.34 18.68 Favored 'General case' 0 N--CA 1.389 -3.517 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.594 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.513 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 137.35 -6.06 3.58 Favored Glycine 0 C--N 1.272 -2.987 0 CA-C-N 112.88 -1.964 . . . . 0.0 108.872 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 85.3 t -88.41 144.7 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.8 mt -98.8 -47.72 5.2 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -156.43 137.18 13.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.176 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.4 t -107.98 108.77 26.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.423 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 39.1 m -95.6 121.89 37.78 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.272 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.13 116.02 21.51 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 ' CG2' HG23 ' A' ' 11' ' ' VAL . 98.1 t -88.75 -58.82 3.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.755 0.788 . . . . 0.0 111.112 -176.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -139.61 146.22 39.5 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.485 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -162.88 -172.68 3.16 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.44 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 18.0 mm-40 -117.03 143.31 45.89 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 176.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -94.27 46.55 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 121.637 0.732 . . . . 0.0 109.611 -177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.639 ' HB2' ' OG ' ' A' ' 53' ' ' SER . 5.4 mm-40 -83.97 -0.54 51.94 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.526 -174.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.69 -49.65 37.62 Favored 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 69.83 161.63 0.22 Allowed 'General case' 0 C--O 1.245 0.83 0 C-N-CA 125.264 1.426 . . . . 0.0 111.284 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 103.74 -167.17 16.15 Favored Glycine 0 N--CA 1.42 -2.393 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.392 178.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -120.34 156.1 32.01 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -92.52 88.16 6.24 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.349 0.595 . . . . 0.0 110.022 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.4 p -85.87 114.42 56.87 Favored Pre-proline 0 N--CA 1.423 -1.778 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.591 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -98.77 -164.23 0.07 OUTLIER 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.747 2.298 . . . . 0.0 112.149 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -110.42 89.42 3.03 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.193 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.1 m -90.44 -8.94 49.24 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.967 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -153.49 112.42 3.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -87.08 83.76 7.41 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.366 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -82.21 -33.08 29.51 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.707 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -105.34 102.7 12.16 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.657 -177.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 74.7 110.9 0.07 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.555 1.542 . . . . 0.0 110.944 -177.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.48 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.2 tpp . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -133.8 176.26 8.72 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.844 0.354 . . . . 0.0 110.53 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.7 p -87.59 -16.72 33.73 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 122.185 0.993 . . . . 0.0 108.456 174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.18 104.68 9.63 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.701 -1.136 . . . . 0.0 108.242 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.466 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -71.14 148.55 47.29 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.695 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.2 130.66 35.11 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.18 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.543 HG12 ' HG3' ' A' ' 49' ' ' GLU . 24.1 m -120.97 156.69 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.564 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 56' ' ' LEU . 21.0 p -147.22 149.36 32.77 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.4 m -106.68 149.95 26.74 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 74' ' ' LEU . 95.3 mt -126.5 127.81 45.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 59.2 t -96.03 102.44 13.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG23 ' A' ' 69' ' ' VAL . 63.5 t -88.67 105.58 15.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.25 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -89.41 115.38 26.81 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 22' ' ' ILE . . . -143.26 172.9 12.12 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.439 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.33 126.0 28.22 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.304 176.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.457 ' HA ' HG12 ' A' ' 19' ' ' ILE . 23.1 p -57.52 -35.03 69.75 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.21 1.004 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.0 -12.49 59.94 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.382 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -123.95 17.56 9.32 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-O 121.529 0.68 . . . . 0.0 110.071 -172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' A' ' 16' ' ' SER . 24.2 mm -60.07 -41.75 87.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.525 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.477 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.8 m -58.24 -45.91 86.9 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 123.146 0.579 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.18 -50.15 72.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.857 0.837 . . . . 0.0 109.541 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.588 HG23 HG11 ' A' ' 66' ' ' VAL . 83.5 mt -66.44 -44.76 90.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.342 -1.299 . . . . 0.0 111.687 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.2 t -63.19 -32.19 73.52 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 122.659 0.384 . . . . 0.0 110.944 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.4 m -74.51 -38.87 62.71 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -64.34 -46.21 84.46 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.627 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 79.9 mt -64.3 -42.04 96.56 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.044 0.538 . . . . 0.0 112.036 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -74.72 -10.22 59.31 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.32 -13.62 49.04 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.607 0.242 . . . . 0.0 111.268 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 36.0 m-85 -79.5 143.26 59.12 Favored Pre-proline 0 N--CA 1.415 -2.192 0 CA-C-O 120.639 0.257 . . . . 0.0 110.352 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -82.01 99.07 0.98 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.758 2.305 . . . . 0.0 111.915 -178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.51 -3.42 21.75 Favored Glycine 0 C--N 1.308 -1.02 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.847 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.593 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 69.1 m -114.27 132.64 56.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -142.81 140.67 31.42 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -74.19 117.33 18.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 176.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.05 -39.48 12.17 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.022 -178.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.2 t -133.47 125.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 p -116.06 105.08 12.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 16.3 t70 -119.94 95.11 4.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.522 0.677 . . . . 0.0 110.213 -177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.561 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -63.63 -42.18 70.71 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.605 177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.672 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 9.2 Cg_endo -47.29 -44.22 24.79 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 123.683 2.922 . . . . 0.0 114.07 176.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.6 p -93.49 -17.86 22.93 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.795 177.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.01 25.64 59.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.798 -0.921 . . . . 0.0 110.798 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -118.84 130.57 55.83 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.22 0.533 . . . . 0.0 110.063 -176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.5 mt -118.97 130.32 55.63 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.402 ' CD1' HG22 ' A' ' 11' ' ' VAL . 48.7 mm -96.52 118.38 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' CG2' HD13 ' A' ' 26' ' ' LEU . 87.1 t -110.4 137.21 43.75 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.0 p -109.47 133.72 53.81 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 60.8 t -122.65 124.39 70.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.321 -177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' HG12 ' A' ' 7' ' ' VAL . 2.6 mp0 -106.21 134.08 49.91 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.758 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.17 171.86 17.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -113.21 -65.89 1.14 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.683 ' OD2' ' HG2' ' A' ' 54' ' ' GLU . 9.6 t70 -74.77 131.57 40.92 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.246 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.565 ' O ' HG12 ' A' ' 57' ' ' ILE . 30.2 m -65.8 -35.59 81.13 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.683 ' HG2' ' OD2' ' A' ' 52' ' ' ASP . 11.6 pt-20 -73.63 -33.6 64.61 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 59.7 m -60.27 -46.17 90.76 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.143 175.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 8' ' ' CYS . 66.7 tp -55.27 -49.85 71.0 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.126 0.57 . . . . 0.0 110.467 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 53' ' ' SER . 44.6 mm -57.44 -49.78 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.079 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -64.34 -31.58 72.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.814 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 62' ' ' SER . 37.8 m -67.2 -38.33 85.16 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.52 0.676 . . . . 0.0 109.354 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.1 mt -67.32 -35.43 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.267 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.86 -42.36 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.647 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.499 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 69.6 m -57.62 -43.03 84.49 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.418 0.687 . . . . 0.0 110.916 176.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 55.3 t -61.38 -37.25 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.226 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.8 -9.54 58.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.057 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -81.71 -3.87 54.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.415 178.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.588 HG11 HG23 ' A' ' 22' ' ' ILE . 59.0 t -73.59 109.61 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -45.99 -35.69 4.97 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -96.12 13.31 66.08 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.049 -173.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG23 HG13 ' A' ' 12' ' ' VAL . 8.3 p -81.79 141.92 14.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 C-N-CA 119.816 -0.753 . . . . 0.0 110.671 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.6 mt -94.16 -60.36 1.75 Allowed 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.23 131.94 17.9 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.765 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 110.49 32.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 122.074 0.94 . . . . 0.0 108.747 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.465 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 37.9 m -88.36 120.27 29.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.678 -177.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 10' ' ' LEU . 1.7 tt -82.85 118.49 23.47 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 76' ' ' TYR . 39.8 t -105.84 73.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 75' ' ' VAL . 56.8 t80 160.76 78.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.705 2.002 . . . . 0.0 107.652 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -128.25 65.66 1.38 Allowed 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.288 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -103.09 87.88 3.01 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 24.6 tm0? -94.75 96.69 9.54 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.809 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.39 130.46 36.47 Favored 'General case' 0 N--CA 1.425 -1.699 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -66.84 -46.71 74.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -172.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 60.9 -158.11 0.33 Allowed 'General case' 0 C--O 1.244 0.808 0 O-C-N 123.975 0.797 . . . . 0.0 109.355 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -120.93 62.51 0.51 Allowed Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -61.26 131.94 52.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 120.727 0.298 . . . . 0.0 111.051 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -98.41 -4.09 35.45 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.649 0.738 . . . . 0.0 109.606 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.5 p -126.12 95.46 39.11 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.806 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -79.53 -172.84 1.65 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.839 2.36 . . . . 0.0 110.434 177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.1 ptt180 -92.79 136.9 32.83 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.215 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.6 t -86.91 112.31 21.65 Favored 'General case' 0 N--CA 1.422 -1.848 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -125.0 48.26 2.03 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -65.83 -29.97 70.52 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.715 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -123.69 120.47 32.82 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -71.65 97.48 1.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.961 0.886 . . . . 0.0 110.4 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -94.79 144.38 25.69 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.428 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.3 m80 . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.583 -0.722 . . . . 0.0 109.64 -174.914 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.504 0.187 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -83.14 122.77 28.8 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.2 m -118.6 114.48 22.84 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.27 98.72 3.86 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-O 121.583 0.706 . . . . 0.0 110.46 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.429 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -68.64 162.1 26.71 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.926 179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -109.89 141.81 42.08 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.696 -174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.516 HG12 ' HB3' ' A' ' 49' ' ' GLU . 27.2 m -118.32 153.69 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.801 -177.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 20.2 p -141.65 145.62 35.18 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 16.9 t -103.41 128.12 50.61 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 94.1 mt -109.71 117.43 33.89 Favored 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 45.8 t -92.73 102.01 13.18 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 69' ' ' VAL . 79.5 t -98.5 127.56 50.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.65 -175.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 tp-100 -102.72 129.42 49.33 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 172.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -148.05 172.66 13.9 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 123.184 0.303 . . . . 0.0 111.29 -174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -59.19 123.85 18.03 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.446 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.2 m -59.98 -31.6 70.06 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.478 0.711 . . . . 0.0 111.908 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.38 -10.18 59.59 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.974 0.416 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ttt180 -116.5 11.49 14.85 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-O 121.69 0.757 . . . . 0.0 109.895 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.475 HG23 HD21 ' A' ' 44' ' ' LEU . 40.2 mm -61.78 -39.98 85.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.046 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.8 t -63.18 -37.68 88.2 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 123.103 0.252 . . . . 0.0 110.396 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -68.51 -55.83 10.41 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.702 0.763 . . . . 0.0 109.363 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.1 mt -62.88 -42.86 98.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.572 -1.194 . . . . 0.0 112.346 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 t -63.28 -30.54 71.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.203 0.456 . . . . 0.0 110.801 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -77.79 -39.55 43.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.453 HE21 ' HA ' ' A' ' 22' ' ' ILE . 17.4 mt-30 -65.34 -40.98 94.32 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.118 -1.401 . . . . 0.0 112.395 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 95.1 mt -64.78 -33.97 77.25 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 120.776 0.322 . . . . 0.0 111.62 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' CYS . 46.8 m-80 -79.32 -7.76 58.56 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.922 0.391 . . . . 0.0 111.495 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.95 -12.54 58.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.921 0.391 . . . . 0.0 111.049 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 71.4 m-85 -84.13 147.31 50.41 Favored Pre-proline 0 N--CA 1.418 -2.051 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.82 116.34 3.49 Favored 'Trans proline' 0 C--O 1.242 0.677 0 C-N-CA 122.84 2.36 . . . . 0.0 111.949 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 69.98 23.62 76.94 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.815 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 58.2 m -116.01 109.52 17.65 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 139.95 52.47 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 24.0 t -88.56 108.76 19.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.75 -59.32 2.72 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.937 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.46 132.2 49.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.749 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.6 m -136.89 121.57 18.52 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -131.53 96.55 4.0 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 123.406 0.441 . . . . 0.0 110.044 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.01 -42.83 92.62 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 42.9 Cg_endo -61.44 -14.39 34.68 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.064 2.509 . . . . 0.0 113.036 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.6 t -113.07 -18.28 12.21 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.785 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.31 24.65 76.71 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -172.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -98.23 129.87 44.96 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-O 121.16 0.505 . . . . 0.0 111.595 -171.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 HD21 HG23 ' A' ' 19' ' ' ILE . 81.0 mt -134.66 112.28 10.68 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.846 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 34.6 mt -97.79 118.89 45.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.698 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' CG2' HD13 ' A' ' 26' ' ' LEU . 55.4 t -109.15 133.04 55.57 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.82 111.59 34.09 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.562 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 77.0 t -103.48 118.9 51.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' HG12 ' A' ' 7' ' ' VAL . 6.5 pt-20 -114.25 122.32 46.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.89 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -144.41 158.79 43.57 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -81.8 -54.21 5.55 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 123.346 0.404 . . . . 0.0 111.247 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 24.5 m-20 -88.51 145.25 25.84 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.496 ' O ' HG12 ' A' ' 57' ' ' ILE . 5.8 p -63.69 -41.17 98.17 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.482 0.658 . . . . 0.0 111.222 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.49 -35.75 63.25 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.096 -178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 16.9 m -67.51 -33.81 75.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 HD11 ' SG ' ' A' ' 8' ' ' CYS . 51.6 tp -58.88 -49.57 77.28 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 53' ' ' SER . 51.0 mm -54.24 -49.06 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.494 0.718 . . . . 0.0 110.924 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -58.14 -41.5 83.83 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.409 0.623 . . . . 0.0 111.069 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 62' ' ' SER . 15.9 m -69.71 -38.53 76.98 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.282 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 56' ' ' LEU . 85.8 mt -63.88 -42.37 95.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -61.77 -37.82 85.74 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.172 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 59' ' ' THR . 68.1 m -57.89 -45.45 86.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.356 0.598 . . . . 0.0 110.01 177.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -61.42 -37.62 78.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.571 177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 48.1 mtm180 -75.88 -10.44 59.43 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.999 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -87.91 8.96 23.73 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.326 0.584 . . . . 0.0 112.114 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 79.8 t -89.07 133.36 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.673 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -82.72 116.55 22.13 Favored 'General case' 0 N--CA 1.392 -3.333 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.653 173.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.64 -13.36 1.36 Allowed Glycine 0 C--N 1.269 -3.14 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.561 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.512 HG13 HG13 ' A' ' 12' ' ' VAL . 61.0 t -83.48 143.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.734 -0.733 . . . . 0.0 109.43 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 82.9 mt -112.89 -41.84 3.69 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.41 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . -145.12 135.21 23.87 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.537 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' CG2' HG11 ' A' ' 69' ' ' VAL . 60.6 t -120.72 110.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.402 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 18.8 t -96.28 125.33 40.72 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.55 105.54 17.65 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.452 0.644 . . . . 0.0 109.476 -174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 95.1 t -91.24 86.66 2.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 177.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -143.62 139.04 29.43 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.451 -1.249 . . . . 0.0 108.107 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -162.1 172.29 16.09 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 123.979 0.799 . . . . 0.0 109.072 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -100.78 166.5 10.83 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.585 ' HB2' ' O ' ' A' ' 82' ' ' GLN . 12.6 pt20 -137.94 129.84 28.54 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.595 0.236 . . . . 0.0 111.413 -175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -133.08 -51.41 0.89 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.78 0.8 . . . . 0.0 110.172 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -89.89 -17.01 28.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.337 0.589 . . . . 0.0 111.369 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 79' ' ' GLN . 24.8 mt-30 -129.41 137.51 50.95 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.32 -82.33 1.48 Allowed Glycine 0 C--N 1.304 -1.223 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.328 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.74 74.74 2.38 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 122.024 0.916 . . . . 0.0 109.567 -175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -83.53 124.45 30.76 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 114.337 -1.302 . . . . 0.0 108.812 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.7 m -123.88 89.11 51.85 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -73.09 -38.15 2.99 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.415 2.077 . . . . 0.0 111.123 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -79.46 88.81 5.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 170.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -77.36 -178.77 5.33 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.185 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -63.09 137.77 58.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.471 -174.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -82.23 -58.55 2.9 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -81.85 86.3 6.51 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.025 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -92.0 100.31 12.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -130.58 19.11 5.2 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.81 0.814 . . . . 0.0 109.495 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 . . . . . 0 C--N 1.309 -1.162 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.539 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.475 ' N ' ' SD ' ' A' ' 1' ' ' MET . 49.8 m80 -71.19 98.93 1.79 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 118.511 0.596 . . . . 0.0 109.903 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.566 ' HB ' ' OE1' ' A' ' 51' ' ' GLU . 15.4 p -73.65 97.84 2.75 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -100.84 77.75 1.89 Allowed 'General case' 0 CA--C 1.491 -1.297 0 CA-C-O 122.326 1.06 . . . . 0.0 112.369 -175.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.679 ' CE3' ' HB3' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -54.48 157.36 2.9 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 112.41 -2.177 . . . . 0.0 115.312 176.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -103.94 127.0 51.47 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 113.371 -1.74 . . . . 0.0 107.958 175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 HG12 ' HG2' ' A' ' 49' ' ' GLU . 34.8 m -104.51 156.91 5.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.547 -175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.623 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 25.1 p -141.85 127.65 19.29 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.106 177.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 40.8 t -86.93 135.88 33.15 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 95.1 mt -119.91 135.87 54.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 92.8 t -104.8 104.51 17.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.4 t -96.36 109.15 22.37 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.72 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -88.75 112.99 23.83 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 172.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.537 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -138.85 173.44 11.57 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-O 121.081 0.467 . . . . 0.0 111.802 -172.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.0 mptp? -58.28 116.66 3.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.731 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.443 ' HA ' HG12 ' A' ' 19' ' ' ILE . 2.8 p -63.88 -28.64 69.98 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 123.477 0.711 . . . . 0.0 111.954 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -78.6 -14.69 59.2 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.314 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.8 ttt180 -118.92 15.85 13.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.314 0.578 . . . . 0.0 109.473 -171.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.584 HG23 HD21 ' A' ' 44' ' ' LEU . 28.1 mm -56.89 -46.6 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.972 -176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.9 m -61.94 -31.79 72.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.083 0.468 . . . . 0.0 111.252 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -72.83 -54.78 7.9 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 122.05 0.929 . . . . 0.0 109.275 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.579 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.9 mt -61.96 -47.14 94.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.845 -176.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.6 t -62.23 -37.61 86.04 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.801 0.334 . . . . 0.0 111.369 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.3 m -73.58 -33.86 64.82 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 22' ' ' ILE . 4.5 mt-30 -65.76 -44.84 84.67 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.05 175.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.8 mt -64.43 -43.99 92.56 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-O 120.81 0.338 . . . . 0.0 110.604 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 33' ' ' GLU . 84.9 m-20 -65.65 -12.78 56.41 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.13 -26.17 36.33 Favored 'General case' 0 C--N 1.316 -0.852 0 O-C-N 122.448 -0.158 . . . . 0.0 111.386 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 33.0 m-85 -71.61 149.65 93.34 Favored Pre-proline 0 N--CA 1.425 -1.685 0 C-N-CA 122.204 0.202 . . . . 0.0 110.722 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -60.46 106.75 0.37 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 123.269 2.646 . . . . 0.0 113.869 -174.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 49' ' ' GLU . . . 84.93 0.86 89.03 Favored Glycine 0 C--N 1.321 -0.257 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.808 176.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 44.7 t -92.37 119.75 32.22 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 27' ' ' ASN . 43.6 tt0 -141.4 132.82 26.76 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.252 0.549 . . . . 0.0 110.899 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 46' ' ' VAL . 24.2 t -77.77 131.65 34.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.741 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.09 -74.1 0.63 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.9 t -96.85 133.28 38.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 m -124.68 114.74 19.71 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -106.78 91.64 3.76 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.33 -39.5 75.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 19.2 Cg_endo -53.86 -39.86 82.75 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.915 2.41 . . . . 0.0 112.671 177.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.7 m -93.79 -30.78 14.67 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.689 -176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.28 25.32 37.06 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -100.7 133.99 44.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.297 -0.451 . . . . 0.0 109.814 -174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.584 HD21 HG23 ' A' ' 19' ' ' ILE . 88.0 mt -125.79 119.99 29.37 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 176.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.87 117.72 33.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 34' ' ' VAL . 93.7 t -115.12 139.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.1 t -119.11 116.76 51.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 174.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.623 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 59.9 t -99.51 124.29 52.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.679 ' HB3' ' CE3' ' A' ' 5' ' ' TRP . 36.3 mt-10 -108.59 121.6 45.34 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.393 -1.276 . . . . 0.0 109.479 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.13 151.0 31.33 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.566 ' OE1' ' HB ' ' A' ' 3' ' ' THR . 15.5 tp10 -80.42 -40.08 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 O-C-N 123.361 0.413 . . . . 0.0 110.993 -174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -103.82 151.43 23.09 Favored 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.019 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 57' ' ' ILE . 4.4 m -60.38 -41.87 94.66 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.173 0.989 . . . . 0.0 110.65 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.92 -39.86 83.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.43 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.5 m -66.8 -34.13 77.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.62 0.724 . . . . 0.0 109.084 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 60' ' ' ILE . 19.2 tp -67.45 -50.0 61.16 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.061 177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 53' ' ' SER . 67.5 mt -56.82 -46.47 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.09 0.556 . . . . 0.0 110.629 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.4 tp60 -57.47 -42.88 83.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 123.645 0.778 . . . . 0.0 110.972 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 62' ' ' SER . 23.8 m -73.53 -33.94 64.97 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.004 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 56' ' ' LEU . 81.1 mt -63.88 -45.91 95.68 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 175.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -64.48 -33.66 76.4 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 120.644 -0.422 . . . . 0.0 111.367 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' THR . 58.2 m -57.73 -41.69 82.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.161 0.505 . . . . 0.0 111.034 176.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 43.9 t -63.68 -37.14 78.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.674 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.444 ' HG2' HG11 ' A' ' 72' ' ' VAL . 21.8 mtm180 -74.85 -11.47 60.15 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.739 0.78 . . . . 0.0 110.359 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -85.96 2.51 45.95 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.673 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 69' ' ' VAL . 58.0 t -87.85 135.19 26.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.463 0.649 . . . . 0.0 110.102 177.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -67.44 -36.21 80.76 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 125.559 1.544 . . . . 0.0 112.954 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -77.38 -2.63 80.24 Favored Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.903 -178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.447 HG23 ' HB ' ' A' ' 66' ' ' VAL . 58.6 t -83.18 125.5 40.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.632 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 86.2 mt -91.82 -56.58 3.04 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.3 118.58 10.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.437 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.5 p -114.15 110.14 31.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.891 0.853 . . . . 0.0 110.956 177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.9 m -92.75 139.97 30.0 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.876 -177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -98.87 109.36 22.13 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -88.42 -39.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.994 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 65.04 -88.61 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.504 -1.226 . . . . 0.0 109.152 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -161.32 98.53 1.15 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -87.56 91.87 8.89 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.836 0.826 . . . . 0.0 110.556 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' H ' ' CD ' ' A' ' 79' ' ' GLN . 0.1 OUTLIER -76.88 147.3 37.15 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.117 -1.402 . . . . 0.0 109.241 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 67.28 96.88 0.06 Allowed 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 124.473 1.109 . . . . 0.0 110.566 -175.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -73.42 -47.53 41.05 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -161.42 147.88 14.37 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.685 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 139.28 18.29 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 173.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -135.88 136.11 40.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.576 0.688 . . . . 0.0 110.112 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -137.76 149.11 46.17 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 88.3 m -129.9 123.17 20.81 Favored Pre-proline 0 N--CA 1.402 -2.832 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.27 147.28 41.82 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 C-N-CA 120.706 0.938 . . . . 0.0 110.785 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -79.44 96.76 6.15 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.171 -170.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 12.0 m -101.1 121.45 41.84 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.61 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -94.88 -32.05 13.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.057 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -80.13 -29.1 38.86 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 89' ' ' SER . 54.5 m-70 -111.56 96.82 6.32 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.183 -0.917 . . . . 0.0 108.796 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -94.84 164.57 12.87 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.365 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -74.92 157.16 35.49 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 60.2 m80 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -177.045 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -130.02 118.25 21.29 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 30.2 m -70.72 114.89 9.25 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.059 0.457 . . . . 0.0 110.017 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -97.65 77.19 2.55 Favored 'General case' 0 CA--C 1.494 -1.206 0 CA-C-O 122.427 1.108 . . . . 0.0 112.048 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -105.8 175.26 5.56 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.114 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.64 121.42 45.27 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.743 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.443 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -95.96 125.17 48.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.621 -176.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 52.7 t -122.12 139.73 53.38 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.125 0.488 . . . . 0.0 109.943 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.5 t -104.2 149.73 25.02 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 87.5 mt -128.93 129.27 45.25 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 57.8 t -97.48 102.22 13.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 63.9 t -99.13 114.46 37.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.276 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.98 123.08 32.33 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 173.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -145.44 168.68 19.96 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.31 115.43 3.22 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.37 0.605 . . . . 0.0 110.154 176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 39' ' ' ALA . 5.8 m -64.74 -26.79 68.51 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 125.203 1.401 . . . . 0.0 113.253 -170.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -86.06 -10.68 54.53 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -113.13 15.28 19.52 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.233 1.016 . . . . 0.0 108.63 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 44' ' ' LEU . 2.7 mt -61.98 -35.49 68.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 113.591 0.96 . . . . 0.0 113.591 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.2 m -68.22 -38.99 82.48 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.325 0.583 . . . . 0.0 109.805 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -61.59 -52.53 64.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.15 177.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 75.9 mt -68.28 -38.56 79.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.0 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.0 t -63.58 -32.59 74.1 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.657 0.265 . . . . 0.0 110.53 -179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.0 m -71.47 -39.54 70.86 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -59.37 -53.27 60.14 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.832 173.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 52.9 mt -64.06 -34.35 77.83 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -70.14 -18.48 63.22 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 123.104 0.562 . . . . 0.0 111.047 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.41 -1.88 56.7 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 26.0 m-85 -89.17 147.08 37.63 Favored Pre-proline 0 N--CA 1.414 -2.235 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.396 -177.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.58 108.96 0.68 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.531 2.821 . . . . 0.0 113.479 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 82.95 5.04 89.71 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.608 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.574 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 12.9 t -111.97 126.29 54.98 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -145.84 144.78 30.46 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 35.1 t -81.94 126.8 39.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.16 -59.33 2.19 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.5 t -122.96 125.66 72.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 p -115.91 102.96 10.14 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-O 121.552 0.691 . . . . 0.0 110.568 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.661 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.7 t70 -98.55 94.74 6.85 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.03 -47.25 99.41 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 114.844 -1.071 . . . . 0.0 113.43 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.661 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 17.7 Cg_endo -53.05 -44.76 46.19 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.788 2.992 . . . . 0.0 114.859 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 m -90.68 -24.12 20.55 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.581 -0.699 . . . . 0.0 110.56 -177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 90.71 25.05 26.29 Favored Glycine 0 N--CA 1.432 -1.611 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -102.87 125.24 49.54 Favored 'General case' 0 CA--C 1.488 -1.435 0 CA-C-O 121.663 0.744 . . . . 0.0 110.771 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 19' ' ' ILE . 92.6 mt -114.62 111.79 21.87 Favored 'General case' 0 C--N 1.265 -3.07 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.384 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.5 mm -89.34 117.64 33.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 85.5 t -116.44 136.53 53.17 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.3 t -113.79 126.81 71.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 43.2 t -125.68 111.32 26.73 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -110.52 122.39 47.63 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.833 0.825 . . . . 0.0 110.583 174.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.71 153.24 51.65 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -81.17 -51.55 8.32 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.012 -176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.73 149.75 22.61 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.821 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.432 ' O ' HG13 ' A' ' 57' ' ' ILE . 40.2 t -55.84 -47.68 76.8 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 124.364 1.066 . . . . 0.0 110.177 177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -65.36 -40.6 93.8 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.993 -175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 m -62.06 -37.91 86.78 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.945 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 tp -66.88 -50.29 62.95 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.417 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 53' ' ' SER . 80.2 mt -54.4 -54.5 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.468 0.707 . . . . 0.0 112.273 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.56 -38.0 85.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.45 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.8 m -72.06 -38.99 69.37 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.459 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 68.1 mt -64.03 -37.57 80.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -65.59 -34.51 78.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.13 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.6 m -57.34 -42.62 82.28 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.461 0.648 . . . . 0.0 109.933 176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 48.1 t -62.7 -40.23 87.74 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.467 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 43.0 mtm180 -71.45 -20.46 62.09 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.247 0.546 . . . . 0.0 110.009 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -90.07 13.91 13.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.564 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.486 HG11 HG23 ' A' ' 22' ' ' ILE . 54.6 t -88.39 138.21 19.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' H ' ' HG2' ' A' ' 67' ' ' GLU . 7.4 mm-40 -58.63 -55.61 32.87 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 125.646 1.578 . . . . 0.0 113.44 -169.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.48 6.83 56.59 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.677 -176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' CG2' ' HB ' ' A' ' 66' ' ' VAL . 85.3 t -79.53 135.91 24.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.085 178.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.89 -57.71 2.11 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.38 -178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -146.84 130.82 17.21 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.659 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 67.3 t -108.21 116.11 50.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -101.14 128.17 47.36 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 tt -86.44 119.96 27.26 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -111.91 88.04 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 CA-C-O 122.29 1.043 . . . . 0.0 110.628 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -150.88 -72.28 0.17 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 172.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -157.17 151.89 25.58 Favored 'General case' 0 CA--C 1.487 -1.442 0 N-CA-C 103.147 -2.909 . . . . 0.0 103.147 171.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.704 HE21 ' HA ' ' A' ' 78' ' ' GLN . 0.0 OUTLIER -77.31 -42.22 37.68 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.044 -177.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -125.9 -16.06 5.73 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.013 0.435 . . . . 0.0 112.099 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -88.94 76.29 7.9 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.714 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -80.59 -39.74 27.01 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -83.84 -41.92 16.98 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 142.92 -161.54 27.52 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -111.52 -12.26 13.98 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -61.2 133.8 56.33 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.924 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.1 t -138.17 105.96 7.96 Favored Pre-proline 0 N--CA 1.421 -1.901 0 CA-C-O 121.862 0.839 . . . . 0.0 111.148 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -86.04 176.51 5.14 Favored 'Trans proline' 0 N--CA 1.443 -1.489 0 C-N-CA 122.341 2.027 . . . . 0.0 111.049 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -80.71 -82.4 0.12 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.55 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.6 m -128.78 24.62 5.7 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.685 0.755 . . . . 0.0 109.366 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -129.27 98.7 4.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.276 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -77.11 131.92 38.58 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.533 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.5 m80 -89.85 106.64 18.6 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.68 171.22 7.45 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.619 -0.432 . . . . 0.0 110.792 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.8 p-80 -102.48 175.48 5.49 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.798 177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--N 1.3 -1.545 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.543 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 C--O 1.244 0.793 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -81.34 93.97 6.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.434 0.635 . . . . 0.0 111.193 -176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 p -86.32 146.44 26.49 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.362 178.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -91.94 121.95 34.0 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.411 ' CZ3' ' HG2' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -130.0 146.08 51.67 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.204 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -91.27 142.96 27.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -171.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 49' ' ' GLU . 4.7 m -110.07 146.67 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' HD11 ' A' ' 56' ' ' LEU . 26.3 p -141.77 139.3 32.77 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-O 121.004 0.431 . . . . 0.0 110.543 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.534 ' O ' ' HB ' ' A' ' 75' ' ' VAL . 42.9 t -90.1 124.93 35.22 Favored 'General case' 0 N--CA 1.417 -2.102 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 175.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.3 mt -104.06 129.66 51.71 Favored 'General case' 0 C--N 1.273 -2.733 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.04 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 74.0 t -98.48 101.78 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 174.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.69 111.84 29.32 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.625 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -89.03 117.41 28.03 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.21 173.48 11.68 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.527 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -59.27 117.17 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.627 175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.508 ' HA ' HG12 ' A' ' 19' ' ' ILE . 30.3 t -55.89 -37.09 68.38 Favored 'General case' 0 C--N 1.312 -1.064 0 O-C-N 123.883 0.739 . . . . 0.0 111.425 177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.35 -20.47 62.16 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -114.45 10.65 17.0 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.381 0.61 . . . . 0.0 111.081 -171.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.559 HG23 HD21 ' A' ' 44' ' ' LEU . 17.0 mm -47.81 -49.57 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.489 1.116 . . . . 0.0 113.886 -178.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -62.36 -35.86 80.45 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.203 0.525 . . . . 0.0 112.349 -175.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.81 -40.08 61.3 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 121.053 0.454 . . . . 0.0 110.401 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.42 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -70.65 -42.44 77.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.391 -177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.9 p -62.71 -48.66 78.28 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.823 0.344 . . . . 0.0 111.144 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.4 m -61.46 -36.1 79.45 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.548 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -65.8 -48.69 70.9 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.17 177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 29' ' ' PHE . 85.2 mt -63.47 -33.13 74.89 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 122.973 0.509 . . . . 0.0 112.216 -178.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -68.17 -15.28 63.52 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.437 0.637 . . . . 0.0 111.708 176.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.48 -1.08 54.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 17.8 m-85 -81.64 153.55 70.64 Favored Pre-proline 0 N--CA 1.433 -1.305 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.4 97.88 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 122.855 2.37 . . . . 0.0 112.055 -178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 86.47 30.51 21.61 Favored Glycine 0 N--CA 1.428 -1.877 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.532 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.496 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 80.7 m -122.56 124.18 42.93 Favored 'General case' 0 N--CA 1.426 -1.627 0 CA-C-N 117.374 0.587 . . . . 0.0 110.427 175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -128.31 122.3 31.27 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.311 -0.404 . . . . 0.0 109.991 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 46' ' ' VAL . 43.0 t -78.73 102.75 5.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.03 -46.4 21.06 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.919 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.51 124.82 35.36 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.58 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -103.21 132.03 49.79 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.1 t70 -125.95 91.04 3.31 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.551 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.97 -41.61 89.41 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.633 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.1 Cg_endo -46.13 -44.65 19.21 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.625 2.883 . . . . 0.0 113.561 176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.0 p -94.88 -28.57 15.14 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.657 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.36 22.3 32.38 Favored Glycine 0 N--CA 1.434 -1.479 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -102.19 137.37 40.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.484 0.659 . . . . 0.0 111.914 -178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 19' ' ' ILE . 88.4 mt -114.97 124.81 52.61 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.915 -1.039 . . . . 0.0 108.314 175.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.77 117.04 32.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 175.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG21 HD13 ' A' ' 26' ' ' LEU . 60.9 t -119.84 125.24 74.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.4 t -93.28 114.69 30.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 98.3 t -115.26 124.52 71.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.992 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -117.11 140.1 49.92 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.29 176.45 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -145.09 154.81 42.87 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.644 -177.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -68.99 -73.08 0.16 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.414 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -101.96 176.92 5.04 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.402 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 57' ' ' ILE . 21.3 m -70.97 -39.92 72.26 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 121.308 -0.157 . . . . 0.0 110.842 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.93 -40.48 97.75 Favored 'General case' 0 C--N 1.335 -0.064 0 CA-C-O 120.766 0.317 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 p -67.09 -29.59 69.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.039 0.447 . . . . 0.0 110.635 177.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD11 ' SG ' ' A' ' 8' ' ' CYS . 61.2 tp -68.93 -46.51 68.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.64 178.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.515 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 63.7 mt -54.09 -51.32 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 123.945 0.778 . . . . 0.0 110.55 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -58.66 -42.75 89.15 Favored 'General case' 0 C--O 1.241 0.624 0 O-C-N 123.819 0.7 . . . . 0.0 112.554 -176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.0 m -63.04 -43.73 97.86 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.42 -40.96 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.399 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 57' ' ' ILE . 53.7 mt-10 -60.72 -42.3 96.99 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 13.7 t -64.94 -40.04 94.42 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' THR . 94.7 t -62.98 -39.33 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.69 0.757 . . . . 0.0 110.173 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -70.58 -9.19 56.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.84 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.62 8.1 35.94 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.928 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.8 t -87.39 134.98 26.35 Favored 'Isoleucine or valine' 0 C--O 1.251 1.182 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.631 175.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -49.2 -57.86 6.0 Favored 'General case' 0 N--CA 1.419 -1.988 0 C-N-CA 126.362 1.865 . . . . 0.0 113.503 176.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -77.16 4.23 55.33 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 115.608 1.003 . . . . 0.0 115.608 -173.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.6 138.75 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 118.127 0.963 . . . . 0.0 110.318 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 64.4 mt -108.06 -56.47 2.24 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.47 130.84 35.34 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.643 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.0 t -108.26 109.42 28.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.578 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 40.2 m -101.64 120.08 39.78 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.555 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.28 142.57 29.27 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' HB ' ' O ' ' A' ' 9' ' ' SER . 9.9 p -67.25 -20.09 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.655 0.74 . . . . 0.0 110.976 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -151.04 131.76 14.02 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -82.02 123.41 28.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -70.85 -175.2 1.05 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.652 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -128.11 171.91 11.46 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.949 0.404 . . . . 0.0 111.444 -173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -80.76 69.84 7.39 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 172.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.94 -41.05 91.8 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -113.09 89.02 2.97 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.32 160.0 27.79 Favored Glycine 0 N--CA 1.424 -2.126 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.081 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.89 23.26 9.99 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.592 1.157 . . . . 0.0 111.904 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -72.77 -28.96 62.93 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 172.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 t -118.59 91.67 42.33 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 171.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.48 169.19 18.93 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.502 2.135 . . . . 0.0 112.642 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.78 -29.66 56.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.954 0.407 . . . . 0.0 109.967 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.6 t -86.88 111.0 20.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -77.59 -20.62 53.71 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.022 0.439 . . . . 0.0 110.95 -175.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -88.32 143.67 26.87 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -79.15 156.68 28.14 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -71.83 -32.09 67.19 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.048 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -86.0 134.62 33.85 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.263 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--N 1.296 -1.733 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.466 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.496 -1.109 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -90.23 -63.2 1.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.1 p 59.16 151.12 0.02 OUTLIER 'General case' 0 C--O 1.246 0.903 0 C-N-CA 125.355 1.462 . . . . 0.0 114.772 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.6 m120 74.34 132.49 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.049 0.94 . . . . 0.0 111.237 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.5 p-90 -69.29 143.23 53.91 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.871 177.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -117.85 147.44 43.07 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 35.4 m -114.59 160.89 13.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.337 -176.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' HD21 ' A' ' 56' ' ' LEU . 87.9 m -144.89 126.94 15.56 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 114.335 -1.302 . . . . 0.0 107.594 172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.6 t -83.99 136.97 33.85 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 72.5 mt -123.85 121.75 36.21 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 73' ' ' SER . 47.4 t -90.92 102.4 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 69' ' ' VAL . 57.8 t -94.07 114.34 30.52 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.783 -1.098 . . . . 0.0 109.947 -176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.27 117.99 26.39 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -136.26 171.95 13.72 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 120.623 0.249 . . . . 0.0 110.589 -175.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -63.11 121.4 13.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.986 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.9 m -61.38 -32.48 72.4 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 124.07 0.948 . . . . 0.0 111.146 -177.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -86.55 0.07 55.08 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.765 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -124.07 14.89 9.17 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.8 0.81 . . . . 0.0 109.779 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.596 HG23 HD21 ' A' ' 44' ' ' LEU . 31.4 mm -59.4 -44.51 92.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -175.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -62.32 -32.11 72.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 121.604 0.716 . . . . 0.0 110.882 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -75.16 -52.44 10.97 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.993 . . . . 0.0 110.093 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.445 HD13 ' HB1' ' A' ' 14' ' ' ALA . 81.1 mt -66.33 -42.57 90.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.285 -176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -61.99 -36.75 82.42 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.58 0.229 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -73.98 -32.49 63.45 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.133 0.968 . . . . 0.0 109.013 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -72.88 -38.8 66.86 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.945 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 90.2 mt -67.77 -37.77 82.53 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.183 0.516 . . . . 0.0 109.973 176.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -72.77 -4.22 30.15 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.458 -0.792 . . . . 0.0 112.574 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.4 -22.5 26.56 Favored 'General case' 0 C--N 1.318 -0.761 0 O-C-N 122.073 -0.392 . . . . 0.0 111.059 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m-85 -74.95 146.46 82.66 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -177.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -62.38 113.28 1.86 Allowed 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.186 2.591 . . . . 0.0 113.271 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.13 -1.06 89.34 Favored Glycine 0 CA--C 1.512 -0.126 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.172 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 42.7 t -96.67 121.17 38.21 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 120.975 0.417 . . . . 0.0 110.31 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -135.01 138.55 44.07 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.892 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.3 107.77 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 172.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.94 -42.02 21.97 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.55 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 44.0 t -129.08 114.01 30.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.6 p -109.84 110.92 22.06 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.631 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 18.6 t70 -114.89 89.43 3.09 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.558 0.694 . . . . 0.0 109.463 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.549 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.79 -43.49 98.72 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-N 114.793 -1.094 . . . . 0.0 113.327 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.631 ' HG2' ' OD2' ' A' ' 38' ' ' ASP . 8.2 Cg_endo -45.58 -44.52 17.19 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 123.774 2.983 . . . . 0.0 113.797 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 56.1 p -90.22 -31.4 17.03 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 120.175 -0.61 . . . . 0.0 111.169 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.34 24.38 24.33 Favored Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -116.04 132.23 56.71 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-O 121.214 0.531 . . . . 0.0 110.572 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD21 HG23 ' A' ' 19' ' ' ILE . 76.6 mt -118.62 138.14 52.79 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.402 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.423 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 42.6 mm -102.01 117.58 47.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 26' ' ' LEU . 56.1 t -109.21 130.86 61.46 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.4 t -111.74 114.36 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 98.5 t -99.82 124.18 53.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG2' HG12 ' A' ' 7' ' ' VAL . 54.6 mt-10 -105.54 122.49 46.13 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -149.36 138.0 20.99 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 36.2 tt0 -79.81 -35.21 38.78 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.126 0.488 . . . . 0.0 110.714 -178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 14.6 t70 -102.72 148.02 26.11 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.063 -176.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.458 ' O ' HG13 ' A' ' 57' ' ' ILE . 28.8 t -63.11 -43.15 99.25 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.794 0.838 . . . . 0.0 111.277 -177.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -71.86 -35.39 69.79 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 121.32 0.581 . . . . 0.0 110.725 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 33.0 m -64.15 -32.4 73.95 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.616 177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.569 HD21 ' SG ' ' A' ' 8' ' ' CYS . 49.3 tp -69.01 -50.61 47.29 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.267 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 53' ' ' SER . 76.2 mt -55.72 -46.91 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.408 0.683 . . . . 0.0 110.839 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 52.7 tp60 -56.61 -46.87 80.67 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 123.88 0.872 . . . . 0.0 111.119 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 62' ' ' SER . 19.1 m -72.01 -35.92 69.57 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.998 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 56' ' ' LEU . 74.8 mt -64.0 -47.1 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.52 0.2 . . . . 0.0 110.835 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -63.18 -33.35 75.28 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 120.603 0.24 . . . . 0.0 111.167 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' THR . 72.3 m -60.18 -44.84 94.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.112 0.482 . . . . 0.0 111.117 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 39.0 t -59.4 -37.64 70.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.179 177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -75.7 -13.84 60.33 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.797 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.71 -2.91 58.84 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.984 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.1 t -74.34 129.98 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.655 0.741 . . . . 0.0 111.039 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.3 mm-40 -35.62 -64.93 0.27 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 128.643 2.777 . . . . 0.0 114.201 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -84.43 8.68 67.2 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 120.553 -0.832 . . . . 0.0 113.297 -174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.431 HG13 HG13 ' A' ' 12' ' ' VAL . 70.5 t -85.17 129.91 37.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.896 177.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -102.74 -60.62 1.52 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.854 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.17 125.25 24.42 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 -176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.0 t -108.77 114.03 45.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.529 ' HB3' ' HB ' ' A' ' 11' ' ' VAL . 9.7 t -91.23 115.09 27.74 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -87.54 119.75 28.15 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.6 p -55.89 -29.59 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -133.1 94.45 3.36 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 -174.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -157.42 138.3 13.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.521 ' HG3' ' HG3' ' A' ' 80' ' ' GLU . 23.8 pt20 -131.81 151.08 51.92 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.55 79.46 1.97 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.4 0.619 . . . . 0.0 112.237 -175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.521 ' HG3' ' HG3' ' A' ' 78' ' ' GLN . 35.8 mt-10 -102.81 -55.96 2.33 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.553 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -78.69 -12.58 60.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.226 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -150.8 94.79 2.12 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.392 0.615 . . . . 0.0 109.798 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.72 -60.8 0.01 OUTLIER Glycine 0 C--N 1.303 -1.302 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -91.66 19.0 6.76 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.019 0.438 . . . . 0.0 110.463 -178.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 26.2 mm-40 -52.79 117.58 3.04 Favored 'General case' 0 CA--C 1.505 -0.76 0 C-N-CA 124.622 1.169 . . . . 0.0 111.486 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.3 m -105.44 99.04 18.75 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 177.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 60.0 Cg_endo -87.68 -25.69 0.88 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.901 1.734 . . . . 0.0 112.329 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 89.0 mtt180 -97.71 102.42 14.18 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.211 -175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.2 m -101.77 100.87 11.27 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.434 0.635 . . . . 0.0 110.67 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -85.45 156.68 20.72 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.526 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -97.53 83.88 3.32 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -137.61 32.17 2.52 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.295 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -159.2 148.01 18.22 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.464 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -94.26 -38.36 11.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 176.297 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 9.5 m-70 -86.63 100.84 12.73 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.4 p -74.08 -29.8 62.05 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 170.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -99.35 83.7 2.87 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.67 140.12 57.59 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.083 -0.962 . . . . 0.0 112.71 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 53' ' ' SER . 7.6 pt20 -89.9 134.06 34.42 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.113 -175.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.44 HG12 ' HB3' ' A' ' 49' ' ' GLU . 17.5 m -110.58 148.75 13.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.788 -1.096 . . . . 0.0 108.73 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.546 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 21.2 p -140.89 139.44 34.38 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 39.7 t -100.71 135.5 42.05 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.73 123.4 45.93 Favored 'General case' 0 C--N 1.266 -3.039 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 28.8 t -93.81 101.94 13.1 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 59.3 t -90.0 111.87 23.84 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.192 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.677 -177.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -96.65 110.0 22.52 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.21 172.87 12.35 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.461 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.5 mptp? -57.55 119.86 7.28 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.914 0.759 . . . . 0.0 110.547 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.452 ' HA ' HG12 ' A' ' 19' ' ' ILE . 36.8 t -58.4 -36.86 74.2 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.892 0.877 . . . . 0.0 110.889 -178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.32 -21.0 61.4 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.047 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -111.58 6.55 20.12 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 121.96 -0.462 . . . . 0.0 110.393 -172.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 16' ' ' SER . 22.9 mm -49.38 -48.95 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -176.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 m -61.63 -33.03 73.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -79.2 -37.74 37.47 Favored 'General case' 0 C--O 1.245 0.857 0 CA-C-O 121.762 0.791 . . . . 0.0 110.065 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.594 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 82.5 mt -67.73 -48.08 77.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.285 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 p -58.48 -43.07 88.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.902 0.382 . . . . 0.0 111.451 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -64.31 -41.18 96.96 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.922 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -63.69 -43.21 97.28 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.391 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 80.4 mt -62.65 -43.67 98.21 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-O 121.077 0.465 . . . . 0.0 110.016 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -60.95 -22.13 64.13 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.785 1.234 . . . . 0.0 111.779 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.96 -12.25 55.6 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 41.6 m-85 -81.78 146.42 56.23 Favored Pre-proline 0 N--CA 1.426 -1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 111.044 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.98 101.58 0.49 Allowed 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.294 2.663 . . . . 0.0 114.202 -175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . 98.69 4.54 56.97 Favored Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.465 178.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 36.9 t -111.69 113.49 25.9 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -136.38 149.91 48.56 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -88.34 142.2 13.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -176.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.71 -66.73 1.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.861 0.363 . . . . 0.0 110.623 179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.6 t -113.05 122.43 67.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -176.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.7 m -111.45 129.28 56.08 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 120.601 0.238 . . . . 0.0 110.582 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 21.5 t70 -132.38 90.67 2.82 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.568 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.65 -43.56 98.9 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.878 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 17.6 Cg_endo -50.88 -44.09 43.53 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 123.495 2.797 . . . . 0.0 113.595 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 m -90.82 -22.33 21.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.309 0.576 . . . . 0.0 109.871 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.44 44.12 Favored Glycine 0 N--CA 1.44 -1.038 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 27.2 mt-30 -107.62 128.1 54.24 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.323 0.582 . . . . 0.0 110.92 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 66.4 mt -122.5 126.86 48.7 Favored 'General case' 0 C--N 1.286 -2.16 0 CA-C-N 115.467 -0.788 . . . . 0.0 108.896 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.74 118.09 34.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.477 HG21 HD13 ' A' ' 26' ' ' LEU . 89.8 t -117.57 131.83 69.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.553 -0.749 . . . . 0.0 108.994 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -103.54 118.43 50.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.546 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.9 t -113.21 115.97 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.912 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.44 ' HB3' HG12 ' A' ' 7' ' ' VAL . 9.6 pt-20 -127.89 122.43 32.51 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.328 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -139.75 150.4 44.75 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.963 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 2' ' ' HIS . 39.7 tt0 -75.69 -36.1 60.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 124.085 0.866 . . . . 0.0 110.697 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -102.13 138.71 38.72 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.879 -177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 12.0 m -54.09 -53.1 57.85 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.208 1.003 . . . . 0.0 112.31 -178.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 44.9 mt-10 -72.37 -34.73 68.18 Favored 'General case' 0 N--CA 1.434 -1.268 0 C-N-CA 122.675 0.39 . . . . 0.0 110.408 -176.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 57.7 m -60.41 -34.0 73.31 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.985 176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 ' O ' HG13 ' A' ' 60' ' ' ILE . 21.7 tp -67.0 -50.34 62.54 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 175.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 53' ' ' SER . 47.9 mm -56.01 -48.31 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.172 -178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 30.3 mm-40 -55.3 -42.77 74.12 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 121.266 0.555 . . . . 0.0 110.583 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 62' ' ' SER . 38.7 m -70.11 -36.27 74.72 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.233 -178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.1 mt -65.8 -40.35 87.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.86 -38.45 91.14 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.358 177.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 59' ' ' THR . 66.9 m -57.43 -45.99 84.05 Favored 'General case' 0 C--O 1.225 -0.218 0 C-N-CA 123.448 0.699 . . . . 0.0 110.752 177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.4 t -59.54 -37.53 70.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.92 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 53.7 mtm180 -75.94 -17.19 59.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 0.0 110.366 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.84 -5.35 59.13 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 122.583 0.353 . . . . 0.0 111.049 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.67 114.75 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 121.731 0.777 . . . . 0.0 109.963 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -72.54 108.9 5.84 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.096 -178.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 138.32 -10.65 3.53 Favored Glycine 0 C--N 1.277 -2.734 0 CA-C-N 112.876 -1.965 . . . . 0.0 109.109 -176.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.9 t -89.22 138.09 19.96 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-O 120.891 0.377 . . . . 0.0 110.283 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 57.4 mt -97.81 -58.83 1.9 Allowed 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.46 134.9 31.4 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 115.206 -0.907 . . . . 0.0 109.859 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.5 t -108.41 108.85 26.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 16.4 m -89.83 113.17 24.7 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.4 tt -86.67 107.36 18.17 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.934 -172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 59.0 t -91.78 87.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-O 121.917 0.865 . . . . 0.0 109.572 178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -145.68 124.49 12.65 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -100.06 141.97 32.17 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.636 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -141.94 156.73 45.48 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.469 ' NE2' ' H ' ' A' ' 79' ' ' GLN . 1.8 mp0 -69.86 93.22 0.74 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 123.069 0.547 . . . . 0.0 110.842 -178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -97.69 129.12 44.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -89.68 -36.82 15.01 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.06 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 67.33 -77.94 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.532 1.133 . . . . 0.0 112.312 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.83 -170.64 54.03 Favored Glycine 0 C--O 1.243 0.659 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.509 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 66.37 107.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.694 0 C-N-CA 125.472 1.509 . . . . 0.0 111.933 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -122.81 135.07 54.42 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.421 0.629 . . . . 0.0 111.394 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 43.6 m -128.23 91.51 44.09 Favored Pre-proline 0 C--N 1.295 -1.781 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.15 -75.32 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.077 1.851 . . . . 0.0 113.01 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -123.8 19.41 9.39 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t 75.25 144.76 0.08 Allowed 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.718 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -81.85 -35.8 28.97 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -109.72 140.64 43.36 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.616 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -69.56 108.46 3.83 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.473 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -79.44 96.28 6.01 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.081 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.1 t60 -130.67 116.84 18.61 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.2 m170 . . . . . 0 C--N 1.3 -1.586 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 120.268 0.08 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 74.01 145.31 0.08 Allowed 'General case' 0 C--O 1.24 0.589 0 C-N-CA 125.526 1.53 . . . . 0.0 110.951 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.9 m -78.08 -46.14 21.59 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -145.68 115.62 7.37 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -109.03 160.44 16.04 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -125.35 138.66 54.05 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 124.867 1.267 . . . . 0.0 107.883 174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 16.2 m -109.3 137.93 39.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 121.22 0.533 . . . . 0.0 110.869 176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.452 ' SG ' HD21 ' A' ' 56' ' ' LEU . 27.5 p -125.95 146.72 49.74 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.1 t -98.48 134.55 41.3 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 75.3 mt -113.78 116.73 29.83 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 99.6 t -90.06 101.44 12.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -95.7 110.35 24.15 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.105 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.216 -178.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -84.03 132.23 34.75 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.86 172.02 14.81 Favored 'General case' 0 C--N 1.276 -2.628 0 O-C-N 123.272 0.358 . . . . 0.0 110.923 -176.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -63.73 123.82 19.88 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 123.501 0.501 . . . . 0.0 110.037 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.512 ' HA ' HG12 ' A' ' 19' ' ' ILE . 16.5 m -62.29 -29.84 70.71 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 123.982 0.913 . . . . 0.0 112.718 -174.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.4 -4.89 59.3 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.027 0.442 . . . . 0.0 111.045 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -123.06 9.71 9.34 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 121.613 0.72 . . . . 0.0 109.346 -173.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.512 HG12 ' HA ' ' A' ' 16' ' ' SER . 33.6 mm -59.94 -42.86 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.37 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 t -63.84 -38.28 90.51 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.096 0.474 . . . . 0.0 110.378 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.05 -45.36 42.05 Favored 'General case' 0 C--N 1.312 -1.037 0 O-C-N 122.089 -0.382 . . . . 0.0 111.492 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.61 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 86.8 mt -64.61 -40.27 88.5 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.247 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.336 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 25.7 p -63.52 -28.77 70.17 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.157 0.503 . . . . 0.0 111.682 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.4 m -76.45 -36.25 58.04 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -69.54 -41.33 76.07 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 113.941 -1.482 . . . . 0.0 111.18 177.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 72.0 mt -65.57 -32.43 74.01 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 121.23 0.538 . . . . 0.0 110.689 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -80.35 -5.82 57.0 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.943 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.16 2.81 56.37 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-O 120.779 0.324 . . . . 0.0 111.738 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.556 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 42.4 m-85 -97.26 145.83 30.31 Favored Pre-proline 0 N--CA 1.407 -2.596 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 176.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -66.79 121.62 8.87 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.72 2.28 . . . . 0.0 112.451 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.88 -7.4 74.64 Favored Glycine 0 CA--C 1.51 -0.263 0 CA-C-O 121.326 0.403 . . . . 0.0 112.74 177.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 50.5 t -98.27 124.31 42.82 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -141.0 130.2 23.5 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.605 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.9 t -73.19 131.61 34.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.196 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -101.45 -51.09 3.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.259 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.1 t -127.06 137.33 58.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.6 m -123.78 118.57 27.48 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.72 93.31 4.32 Favored 'General case' 0 CA--C 1.474 -1.947 0 C-N-CA 121.051 -0.26 . . . . 0.0 110.655 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.9 -43.91 99.57 Favored Pre-proline 0 C--N 1.299 -1.613 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.259 171.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 29.5 Cg_endo -56.74 -43.89 50.44 Favored 'Trans proline' 0 C--N 1.395 2.989 0 C-N-CA 123.405 2.737 . . . . 0.0 112.911 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -83.12 -26.42 31.02 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.306 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 80.77 25.85 55.2 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -113.07 132.28 55.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 123.577 0.751 . . . . 0.0 110.245 -172.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.428 HD21 HG23 ' A' ' 19' ' ' ILE . 64.8 mt -122.7 116.35 23.62 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 174.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.5 mm -93.07 118.51 38.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.474 HG11 ' SG ' ' A' ' 32' ' ' CYS . 98.8 t -115.71 133.65 61.42 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -119.02 123.68 71.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG22 ' HA ' ' A' ' 32' ' ' CYS . 28.3 t -120.13 142.17 37.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -104.93 122.46 45.86 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -135.04 161.87 34.09 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -104.63 -44.42 4.88 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -101.36 148.28 25.34 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.922 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 23.1 t -72.59 -40.86 66.25 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.399 0.437 . . . . 0.0 110.602 -177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.65 -34.98 65.21 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.388 -176.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 m -59.82 -38.45 82.03 Favored 'General case' 0 C--O 1.248 1.011 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 174.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.452 HD21 ' SG ' ' A' ' 8' ' ' CYS . 67.3 tp -63.24 -50.35 70.57 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.054 -0.975 . . . . 0.0 109.592 177.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 53' ' ' SER . 76.4 mt -54.95 -45.04 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 123.334 0.653 . . . . 0.0 111.45 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -61.61 -37.65 84.73 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.047 0.451 . . . . 0.0 111.927 179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 35.9 m -70.9 -41.79 70.82 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.236 0.541 . . . . 0.0 109.778 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 82.4 mt -61.91 -32.82 55.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.373 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.62 -49.24 68.27 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.732 0.413 . . . . 0.0 110.654 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 t -64.18 -35.68 81.59 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.864 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.511 HG13 HD22 ' A' ' 26' ' ' LEU . 96.7 t -61.92 -37.73 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.652 0.739 . . . . 0.0 109.759 176.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 22.9 mtm180 -77.88 -15.1 59.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.191 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.35 -16.59 60.9 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.13 120.06 17.28 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 CA-C-O 121.739 0.78 . . . . 0.0 111.577 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.69 113.25 11.74 Favored 'General case' 0 N--CA 1.379 -3.98 0 CA-C-O 122.489 1.138 . . . . 0.0 110.36 175.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.65 -17.32 2.42 Favored Glycine 0 C--N 1.263 -3.515 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.863 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 69.0 t -82.04 134.49 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.161 -0.52 . . . . 0.0 109.654 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.9 mt -96.08 -44.47 7.31 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -163.92 136.3 5.01 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.059 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.2 t -108.91 109.32 27.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 49.0 m -92.38 113.24 25.46 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.34 108.83 10.75 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.9 t -96.48 87.11 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 CA-C-O 122.755 1.264 . . . . 0.0 109.984 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -130.84 -47.16 1.03 Allowed 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.9 m170 65.48 -168.37 0.21 Allowed 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.215 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -98.56 164.34 12.3 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.08 177.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.53 0.08 3.38 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -174.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -102.66 127.14 49.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.38 -60.83 2.95 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.629 0.771 . . . . 0.0 110.258 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -87.83 48.24 1.61 Allowed 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.18 61.73 3.78 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.9 -177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -158.15 143.72 16.88 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -62.35 110.78 1.76 Allowed 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.7 m -119.97 114.65 33.69 Favored Pre-proline 0 N--CA 1.413 -2.308 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.251 -176.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.77 -160.08 0.11 Allowed 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 122.684 2.256 . . . . 0.0 111.655 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.2 ptp180 -64.31 -11.37 31.38 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.149 0.58 . . . . 0.0 112.246 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.2 t -81.33 19.09 1.0 Allowed 'General case' 0 CA--C 1.557 1.223 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -79.21 -14.13 59.26 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 174.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 58.4 m80 66.18 79.57 0.24 Allowed 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.321 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -81.47 82.42 7.27 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.98 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.5 t60 167.37 -39.76 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 127.234 2.214 . . . . 0.0 105.572 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -72.08 -45.68 59.74 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.329 -1.305 . . . . 0.0 107.832 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 27.1 t60 . . . . . 0 N--CA 1.43 -1.435 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 174.617 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mtm . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -85.61 101.69 12.93 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.18 -0.325 . . . . 0.0 110.263 -178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.5 p -89.78 -15.49 32.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.434 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.8 OUTLIER -79.16 103.48 9.12 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.674 0.75 . . . . 0.0 110.432 -179.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.43 ' HB2' ' O ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -91.98 177.28 6.22 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.215 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -133.57 159.21 41.12 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.051 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 49' ' ' GLU . 13.2 m -122.26 148.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.57 ' SG ' HD11 ' A' ' 56' ' ' LEU . 29.7 p -144.44 156.14 44.06 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.5 t -116.54 139.81 50.08 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 84.1 mt -116.07 122.02 43.92 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 44.9 t -99.86 102.23 13.15 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.9 t -99.6 116.68 43.38 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.791 -175.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -86.4 116.49 24.59 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 169.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.69 172.93 11.41 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 110.572 -0.158 . . . . 0.0 110.572 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.31 113.21 2.05 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.7 m -58.68 -32.98 69.63 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 124.457 1.103 . . . . 0.0 112.85 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -86.82 -0.89 57.23 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.823 0.344 . . . . 0.0 111.325 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -123.56 14.33 9.48 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.754 0.788 . . . . 0.0 109.732 -175.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.419 HG23 HD21 ' A' ' 44' ' ' LEU . 31.3 mm -54.24 -45.73 67.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.5 m -70.39 -31.89 69.3 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.957 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -66.02 -45.27 82.07 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.831 0.824 . . . . 0.0 109.658 176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.513 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 64.3 mt -70.61 -37.74 70.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.519 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 47.8 t -60.19 -36.05 76.77 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 122.704 0.402 . . . . 0.0 111.202 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -71.88 -35.71 69.86 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -68.58 -47.67 66.18 Favored 'General case' 0 N--CA 1.407 -2.587 0 CA-C-N 113.7 -1.591 . . . . 0.0 112.125 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 86.5 mt -66.64 -34.24 77.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 122.879 0.472 . . . . 0.0 111.64 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -77.85 -5.03 49.53 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.326 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -100.54 2.47 41.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 -177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.617 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 63.5 m-85 -89.48 149.19 42.05 Favored Pre-proline 0 N--CA 1.412 -2.372 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.77 98.81 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.301 2.001 . . . . 0.0 113.744 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.27 44.41 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 25.0 t -116.21 126.07 53.12 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -155.59 137.34 14.33 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.418 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 46' ' ' VAL . 21.9 t -71.59 145.61 12.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 123.967 0.907 . . . . 0.0 109.637 -178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -120.26 -68.02 0.94 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 177.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 38.3 t -98.31 143.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.8 m -139.49 140.68 37.3 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -139.3 91.43 2.5 Favored 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 175.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.78 -42.18 91.34 Favored Pre-proline 0 CA--C 1.563 1.457 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 175.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 16.2 Cg_endo -52.9 -44.41 48.66 Favored 'Trans proline' 0 C--N 1.384 2.434 0 C-N-CA 123.221 2.614 . . . . 0.0 113.254 177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.1 t -89.23 -23.81 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.157 0.503 . . . . 0.0 110.074 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.54 25.99 37.21 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -99.82 135.14 41.7 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 114.926 -0.637 . . . . 0.0 111.118 -173.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.419 HD21 HG23 ' A' ' 19' ' ' ILE . 69.7 mt -130.9 121.43 25.2 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.392 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 41.2 mm -99.24 118.39 45.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.438 HG11 ' SG ' ' A' ' 32' ' ' CYS . 91.3 t -117.02 130.98 71.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.9 t -106.48 122.22 60.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.413 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 26.7 t -125.18 111.59 28.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -108.56 130.6 55.29 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 5' ' ' TRP . . . -131.2 145.05 51.78 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.422 -174.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -56.47 -50.05 72.87 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 124.881 1.363 . . . . 0.0 109.095 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -120.17 143.46 48.21 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.613 -1.176 . . . . 0.0 110.232 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 56' ' ' LEU . 16.4 m -72.67 -32.16 65.6 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -175.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -73.45 -32.22 64.24 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.74 0.781 . . . . 0.0 108.915 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 m -63.84 -38.71 92.1 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 173.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.57 HD11 ' SG ' ' A' ' 8' ' ' CYS . 29.9 tp -58.57 -50.09 75.05 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.047 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG13 ' O ' ' A' ' 53' ' ' SER . 68.0 mt -56.79 -50.72 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 123.619 0.574 . . . . 0.0 110.809 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -59.7 -36.84 77.32 Favored 'General case' 0 C--O 1.248 0.993 0 CA-C-O 121.263 0.554 . . . . 0.0 111.428 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.5 m -70.69 -45.49 64.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.972 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 77.3 mt -66.04 -35.22 74.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.262 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.0 -39.63 94.55 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 75.4 m -59.92 -40.86 90.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.774 0.797 . . . . 0.0 110.525 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 34.5 t -62.85 -41.51 92.85 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.574 176.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 55.3 mtm180 -73.65 -11.36 60.39 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.261 0.553 . . . . 0.0 110.979 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -93.1 -1.76 56.13 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.571 -0.741 . . . . 0.0 111.816 178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.6 t -72.38 121.36 22.63 Favored 'Isoleucine or valine' 0 C--O 1.249 1.041 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 62.6 mt-10 -86.31 66.8 9.7 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -174.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -158.09 14.4 0.27 Allowed Glycine 0 C--N 1.291 -1.934 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 173.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 72' ' ' VAL . 54.1 t -103.14 146.29 11.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.341 -0.43 . . . . 0.0 111.203 -174.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 52.1 mt -101.19 -58.83 1.81 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -147.52 133.36 19.04 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.221 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 69' ' ' VAL . 58.0 t -108.16 109.18 27.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 20.4 m -92.68 111.81 23.54 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -87.17 121.64 29.9 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.9 87.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.169 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -178.69 -57.27 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.381 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -166.58 147.62 6.21 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.37 138.04 54.41 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -125.08 -77.18 0.59 Allowed 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.323 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 57.82 -176.53 0.07 Allowed 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.945 0.898 . . . . 0.0 111.298 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -89.66 -61.33 1.72 Allowed 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 172.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -151.79 155.35 38.04 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.752 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -139.83 156.39 24.82 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -83.51 77.3 9.85 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.863 0.84 . . . . 0.0 108.988 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.01 -45.33 90.96 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 113.777 -1.556 . . . . 0.0 111.403 -175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.7 t -139.91 91.07 10.51 Favored Pre-proline 0 N--CA 1.42 -1.929 0 CA-C-O 121.726 0.774 . . . . 0.0 110.617 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -71.11 -175.12 1.36 Allowed 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 122.224 1.949 . . . . 0.0 111.832 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 61.68 85.23 0.12 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.774 1.23 . . . . 0.0 110.742 -174.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.9 p -66.73 -50.56 62.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 174.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 38.9 p-80 -91.77 132.14 36.62 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.2 m170 -73.49 -66.58 0.68 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -171.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -172.68 148.21 1.88 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -150.72 105.6 3.31 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -80.29 64.6 5.16 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.868 0.842 . . . . 0.0 112.642 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 N--CA 1.436 -1.164 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 177.676 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.9 mmm . . . . . 0 C--O 1.224 -0.252 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -96.35 -17.88 20.35 Favored 'General case' 0 C--O 1.211 -0.951 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.8 m -113.04 -33.9 5.89 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -99.6 105.66 17.55 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.435 ' CZ2' ' HG2' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -162.14 178.44 8.78 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 122.944 0.498 . . . . 0.0 111.022 -174.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -105.16 120.59 41.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG12 ' HG3' ' A' ' 49' ' ' GLU . 12.0 m -121.46 156.64 25.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.501 -177.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB ' ' A' ' 48' ' ' VAL . 19.6 p -152.04 160.24 43.5 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.0 t -115.11 143.53 45.06 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 85.6 mt -120.84 125.97 48.87 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.0 t -97.21 102.38 13.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 173.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' GLN . 50.2 t -93.66 119.07 40.9 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.031 -175.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -91.46 120.22 32.1 Favored 'General case' 0 C--O 1.252 1.229 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -137.7 173.33 11.77 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.437 -174.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -59.17 113.09 1.96 Allowed 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 173.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.6 m -58.7 -28.25 65.61 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 124.151 0.98 . . . . 0.0 112.197 -176.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.16 -18.83 41.42 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.145 0.497 . . . . 0.0 111.357 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.71 15.28 21.05 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.602 0.715 . . . . 0.0 111.117 -170.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.417 HG13 ' HA ' ' A' ' 39' ' ' ALA . 42.5 mm -52.09 -42.38 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -176.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -61.31 -45.71 93.31 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.104 0.478 . . . . 0.0 111.53 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -62.81 -46.81 86.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.756 0.789 . . . . 0.0 110.448 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 66.9 mt -67.4 -39.21 82.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.264 -177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.9 t -61.94 -35.18 77.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 43.4 m -72.8 -32.88 65.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 122.482 1.134 . . . . 0.0 108.891 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.47 -43.29 60.55 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.793 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 74.4 mt -72.1 -39.27 69.03 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.046 0.45 . . . . 0.0 111.516 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB2' HG23 ' A' ' 34' ' ' VAL . 62.1 t30 -80.07 7.55 8.9 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-O 121.677 0.751 . . . . 0.0 110.931 -177.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -109.34 -0.47 19.06 Favored 'General case' 0 C--N 1.312 -1.041 0 O-C-N 121.912 -0.492 . . . . 0.0 110.962 178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 24.4 m-85 -81.27 148.52 63.5 Favored Pre-proline 0 N--CA 1.424 -1.77 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -46.49 -33.41 12.85 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 124.826 3.684 . . . . 0.0 117.381 -169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 48' ' ' VAL . . . -138.31 22.74 3.04 Favored Glycine 0 C--N 1.269 -3.189 0 C-N-CA 120.331 -0.938 . . . . 0.0 112.279 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 60.6 m -112.16 120.46 41.86 Favored 'General case' 0 N--CA 1.422 -1.853 0 O-C-N 122.652 -0.322 . . . . 0.0 110.347 -176.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -125.63 133.99 52.04 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.5 HG23 ' HB2' ' A' ' 27' ' ' ASN . 41.9 t -82.84 116.56 27.26 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.01 -56.41 3.34 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.802 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.92 120.95 58.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -114.63 109.65 18.57 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 33.4 t70 -112.49 91.03 3.51 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-O 121.503 0.668 . . . . 0.0 109.856 -177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -53.41 -44.82 98.32 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 114.403 -1.271 . . . . 0.0 114.39 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 11.3 Cg_endo -49.66 -38.53 46.01 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.416 2.744 . . . . 0.0 113.086 177.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.9 m -92.75 -18.24 23.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.741 0.305 . . . . 0.0 111.666 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.85 24.76 68.74 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 24.9 mt-30 -117.42 137.03 52.77 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 120.956 0.408 . . . . 0.0 111.745 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 mp -126.3 133.03 51.52 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.8 mm -95.07 118.1 40.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.13 119.13 59.87 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.3 t -94.1 124.53 46.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.548 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 46.3 t -116.63 123.74 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.948 -175.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.529 ' HG3' HG12 ' A' ' 7' ' ' VAL . 5.2 mp0 -106.11 136.25 46.13 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.622 -1.172 . . . . 0.0 107.942 175.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -154.32 162.22 41.3 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.169 0.509 . . . . 0.0 110.402 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -80.16 -73.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.317 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.501 ' HB2' ' OG1' ' A' ' 55' ' ' THR . 15.4 m-20 -86.92 155.24 20.3 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.267 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.443 ' O ' HG13 ' A' ' 57' ' ' ILE . 12.4 m -66.43 -44.09 83.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.405 -176.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.21 -40.56 77.92 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.565 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 25.8 m -58.09 -42.76 86.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.563 176.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.529 HD11 ' SG ' ' A' ' 8' ' ' CYS . 62.0 tp -58.96 -50.98 72.03 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.893 176.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 53' ' ' SER . 82.2 mt -56.54 -48.18 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.095 0.558 . . . . 0.0 110.948 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -62.84 -36.43 83.19 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.527 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 47.8 m -66.58 -41.85 87.9 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.406 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 85.5 mt -67.42 -33.37 62.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.353 179.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -66.26 -35.04 79.39 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.991 -0.283 . . . . 0.0 110.475 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 17.8 t -65.32 -37.64 87.72 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.54 HG13 HD22 ' A' ' 26' ' ' LEU . 81.7 t -61.57 -42.12 92.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.458 175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -71.58 -11.54 60.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.38 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -88.47 0.86 55.82 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 68' ' ' GLY . 70.2 t -76.13 133.35 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.39 -24.86 63.01 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 124.597 1.159 . . . . 0.0 112.871 -170.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -88.32 -3.25 78.86 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.169 -1.015 . . . . 0.0 111.269 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.0 137.63 21.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.105 0.479 . . . . 0.0 110.617 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 70.8 mt -102.19 -60.99 1.45 Allowed 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.578 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -141.82 131.83 24.58 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.241 -178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.0 t -108.84 108.78 26.15 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.1 m -88.3 112.6 23.01 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 tt -84.63 112.27 20.3 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.007 -172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.9 84.31 2.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -172.46 125.0 0.49 Allowed 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 53.1 m80 -110.71 134.05 52.8 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -177.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -81.24 81.45 7.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -85.18 82.08 8.55 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.842 0.829 . . . . 0.0 109.365 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -116.71 119.78 36.54 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 113.992 -1.458 . . . . 0.0 110.993 -176.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -89.61 -24.21 21.74 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.618 -177.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -124.61 159.92 29.63 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.75 94.92 1.91 Allowed Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -78.91 67.82 4.71 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 122.565 1.174 . . . . 0.0 109.31 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -121.74 -60.17 1.62 Allowed 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.2 m -146.13 91.27 5.55 Favored Pre-proline 0 N--CA 1.417 -2.079 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.48 7.12 3.19 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.945 2.43 . . . . 0.0 113.257 -176.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -118.28 141.92 48.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 CA-C-O 121.062 0.458 . . . . 0.0 111.249 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 26.9 t -140.05 -71.25 0.38 Allowed 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -147.37 128.39 14.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -153.69 -54.41 0.11 Allowed 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -62.31 137.81 58.32 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 172.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -69.75 119.5 14.08 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.406 -173.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -79.13 110.5 14.45 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 173.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 55.6 m80 . . . . . 0 C--N 1.287 -2.135 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -177.651 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 ttm . . . . . 0 C--O 1.212 -0.872 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -93.78 128.07 39.83 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 171.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.9 p -71.53 138.49 48.91 Favored 'General case' 0 N--CA 1.428 -1.528 0 O-C-N 123.536 0.523 . . . . 0.0 111.006 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -60.71 131.85 52.01 Favored 'General case' 0 CA--C 1.494 -1.195 0 CA-C-O 121.652 0.739 . . . . 0.0 112.396 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 33.0 p-90 -120.14 158.81 26.12 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.48 -1.236 . . . . 0.0 111.001 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -108.82 140.89 41.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 p -117.79 125.28 74.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.077 0.465 . . . . 0.0 109.92 178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 65.9 m -137.53 152.57 49.61 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 30.5 t -102.51 149.81 24.02 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' ILE . 84.4 mt -124.12 119.17 28.67 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 98.7 t -91.48 101.82 12.89 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 173.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 69' ' ' VAL . 70.8 t -95.19 110.19 23.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.989 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -93.85 122.96 36.87 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -140.6 172.61 12.46 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.278 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 68' ' ' GLY . 4.6 mptp? -51.61 115.62 1.71 Allowed 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 124.402 1.064 . . . . 0.0 109.489 173.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.6 m -54.83 -35.31 63.82 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 124.302 1.041 . . . . 0.0 111.194 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -75.81 -21.49 57.27 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.005 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.4 ttt85 -112.2 9.19 20.06 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.424 0.63 . . . . 0.0 110.19 -171.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.484 HD11 ' HA2' ' A' ' 42' ' ' GLY . 35.0 mt -55.37 -43.1 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -57.43 -44.28 84.53 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-O 120.905 0.383 . . . . 0.0 111.348 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.73 -55.54 19.3 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.773 0.797 . . . . 0.0 109.24 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 76.3 mt -59.61 -44.24 92.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.992 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.72 -176.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -62.11 -31.17 71.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.942 0.401 . . . . 0.0 111.162 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.5 m -79.6 -35.89 38.9 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.998 0.904 . . . . 0.0 108.693 -177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.479 HE21 ' HA ' ' A' ' 22' ' ' ILE . 20.6 mt-30 -70.05 -42.66 72.57 Favored 'General case' 0 N--CA 1.414 -2.229 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 83.5 mt -66.45 -34.73 78.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -75.48 -10.8 59.77 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.655 0.741 . . . . 0.0 110.208 -177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.99 -11.21 44.93 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.352 -178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 55.0 m-85 -72.46 149.24 91.08 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.98 101.73 0.16 Allowed 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 123.587 2.858 . . . . 0.0 113.586 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.74 15.43 75.57 Favored Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.816 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 49.7 m -113.25 129.7 56.45 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -137.19 137.62 39.34 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.471 -0.491 . . . . 0.0 110.356 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.5 t -83.2 104.77 12.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.13 -41.89 19.86 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.281 0.562 . . . . 0.0 110.141 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 45' ' ' ILE . 58.6 t -119.67 109.91 27.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 44' ' ' LEU . 1.8 m -105.82 105.09 14.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.542 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 24.2 t70 -124.39 97.0 5.12 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.436 0.636 . . . . 0.0 110.895 -177.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.46 -41.79 75.83 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 27.8 Cg_endo -55.66 -44.54 47.04 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.144 2.563 . . . . 0.0 112.852 -178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 t -90.74 -13.87 33.19 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.03 0.443 . . . . 0.0 110.039 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 77.58 25.09 63.73 Favored Glycine 0 CA--C 1.499 -0.931 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.106 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -110.31 125.52 53.24 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.731 0.777 . . . . 0.0 111.302 -176.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD21 HG23 ' A' ' 19' ' ' ILE . 79.5 mt -115.94 110.86 19.55 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 48.7 mt -90.99 118.53 36.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 116.205 -0.452 . . . . 0.0 109.905 -178.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.95 119.94 60.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.59 122.14 47.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.7 t -121.31 130.61 74.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.584 -175.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -106.19 121.5 44.31 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.29 142.79 50.52 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -75.54 -31.93 60.27 Favored 'General case' 0 C--N 1.292 -1.899 0 O-C-N 123.694 0.621 . . . . 0.0 111.573 -174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 55' ' ' THR . 23.1 t70 -129.81 149.71 51.43 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.803 -177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.3 m -55.18 -45.82 75.79 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.28 1.032 . . . . 0.0 112.731 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -78.65 -35.25 45.6 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 0.0 110.182 -176.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 52' ' ' ASP . 18.8 m -61.72 -36.85 82.15 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 60' ' ' ILE . 63.6 tp -59.59 -51.08 71.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.38 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.82 -48.08 90.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.398 -177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -57.23 -43.21 82.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 122.764 0.425 . . . . 0.0 111.472 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 62' ' ' SER . 25.1 m -65.2 -39.23 92.55 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.274 0.559 . . . . 0.0 109.935 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 56' ' ' LEU . 98.1 mt -65.71 -39.6 85.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.113 177.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.05 -32.38 73.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.382 176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 59' ' ' THR . 67.1 m -63.99 -42.31 97.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.583 0.706 . . . . 0.0 109.635 174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG13 HD22 ' A' ' 26' ' ' LEU . 9.6 t -61.3 -39.4 82.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.063 174.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.5 mtp180 -67.77 -14.95 63.37 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.68 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.33 -10.57 58.41 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.467 178.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 92.9 t -71.64 121.16 21.18 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.378 0 CA-C-O 121.693 0.759 . . . . 0.0 109.086 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -73.73 116.53 14.43 Favored 'General case' 1 N--CA 1.373 -4.313 0 CA-C-N 114.548 -1.206 . . . . 0.0 112.491 -175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' O ' ' HD3' ' A' ' 15' ' ' LYS . . . 128.7 -10.26 6.38 Favored Glycine 0 N--CA 1.408 -3.215 0 CA-C-N 112.906 -1.952 . . . . 0.0 109.658 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.442 HG13 HG13 ' A' ' 12' ' ' VAL . 89.5 t -80.93 132.63 31.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.18 -60.4 1.54 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -135.06 127.49 30.47 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.637 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.3 t -108.84 109.94 30.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 32.8 m -94.04 115.87 28.24 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tt -81.88 108.26 15.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 121.634 0.73 . . . . 0.0 109.314 -176.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 48.4 t -92.75 89.75 2.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 179.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -66.57 -33.32 75.41 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -63.33 143.63 57.64 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.775 -1.557 . . . . 0.0 109.928 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -125.97 -176.53 3.66 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -54.9 -48.79 72.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 123.896 0.878 . . . . 0.0 111.053 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -130.66 123.65 29.86 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -66.33 -62.22 1.59 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.892 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -149.68 148.48 29.32 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.663 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -87.92 53.8 4.27 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 111.299 -0.721 . . . . 0.0 111.299 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -96.73 102.51 14.31 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-O 120.852 0.358 . . . . 0.0 110.426 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.55 ' O ' ' HD3' ' A' ' 87' ' ' PRO . 8.0 pt-20 -105.04 1.78 28.88 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 176.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -95.86 104.34 16.21 Favored Pre-proline 0 C--N 1.308 -1.223 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.63 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 72.2 Cg_endo -99.05 154.72 0.63 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 0 C-N-CA 122.863 2.375 . . . . 0.0 112.495 177.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? 70.46 151.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.529 1.532 . . . . 0.0 111.605 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 44.6 t -78.39 90.78 4.43 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.16 115.03 24.55 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -130.43 154.67 47.49 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -84.96 -17.22 38.38 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 120.923 0.392 . . . . 0.0 110.81 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 60.6 m80 65.22 -170.95 0.19 Allowed 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.218 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -142.13 144.66 33.6 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 . . . . . 0 C--N 1.302 -1.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.307 177.137 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtm . . . . . 0 N--CA 1.464 0.259 0 CA-C-O 120.622 0.248 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.5 t60 -138.97 92.75 2.63 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -92.5 -66.0 0.96 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -161.35 133.74 5.96 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.444 ' H ' ' HD1' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -117.13 160.17 21.44 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -174.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -114.53 137.65 51.6 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.198 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 49' ' ' GLU . 24.3 m -108.35 146.29 14.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.549 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 45.1 t -137.54 138.37 39.56 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 38.5 t -100.74 137.59 38.92 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 177.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.448 ' HB2' ' HB ' ' A' ' 46' ' ' VAL . 93.9 mt -119.82 127.43 52.76 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.3 t -95.57 102.24 13.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 69' ' ' VAL . 54.6 t -94.63 111.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.726 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -86.89 117.45 25.63 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 173.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.15 172.49 12.68 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.504 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -70.62 121.2 17.46 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.88 175.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 t -59.13 -43.42 91.99 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 123.104 0.562 . . . . 0.0 111.493 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.67 -16.6 63.88 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.164 0.507 . . . . 0.0 112.074 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' HG13 ' A' ' 22' ' ' ILE . 18.2 ttm180 -108.84 2.66 21.74 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-O 121.181 0.515 . . . . 0.0 110.146 -177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.553 HD11 ' HA2' ' A' ' 42' ' ' GLY . 6.8 mt -53.82 -39.47 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -66.32 -36.59 83.33 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.516 0.674 . . . . 0.0 109.965 -177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -73.74 -40.38 63.57 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.741 0.781 . . . . 0.0 109.292 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 81.0 mt -67.7 -48.47 75.98 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.085 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 p -61.91 -37.07 83.28 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.836 0.351 . . . . 0.0 111.625 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 48.6 m -72.42 -32.41 66.3 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -41.32 67.28 Favored 'General case' 0 N--CA 1.432 -1.348 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.238 177.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 59.6 mt -64.29 -41.0 97.08 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.643 0.377 . . . . 0.0 110.145 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -68.14 -14.85 63.29 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.6 0.76 . . . . 0.0 111.354 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.52 -25.51 54.25 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 62' ' ' SER . 43.5 m-85 -81.03 135.81 51.02 Favored Pre-proline 0 N--CA 1.415 -2.194 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 29' ' ' PHE . 16.9 Cg_exo -63.42 104.03 0.41 Allowed 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 123.176 2.584 . . . . 0.0 113.052 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.19 -2.27 29.79 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.819 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 44.1 t -111.32 116.84 31.67 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 122.858 0.463 . . . . 0.0 109.84 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -134.17 137.41 44.44 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.157 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.51 119.49 30.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.13 -69.15 0.73 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.063 -177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.2 t -109.39 116.75 52.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.5 p -99.77 133.51 44.02 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.556 ' OD1' ' HG2' ' A' ' 40' ' ' PRO . 17.1 t70 -126.08 89.42 3.01 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.573 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -60.65 -44.8 96.41 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.458 177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.6 Cg_endo -49.35 -44.65 33.45 Favored 'Trans proline' 0 C--N 1.385 2.468 0 C-N-CA 123.378 2.719 . . . . 0.0 114.219 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.3 t -93.82 -29.81 15.15 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.202 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.553 ' HA2' HD11 ' A' ' 19' ' ' ILE . . . 99.49 25.12 9.53 Favored Glycine 0 N--CA 1.439 -1.162 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.496 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -114.99 132.66 56.52 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.119 0.485 . . . . 0.0 110.859 -175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.8 mt -120.8 126.29 49.74 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 mm -91.7 118.45 37.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 10' ' ' LEU . 92.4 t -111.77 136.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.9 p -109.69 114.57 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 176.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 43.7 t -109.5 125.21 66.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB3' HG12 ' A' ' 7' ' ' VAL . 14.3 pt-20 -130.98 122.64 27.21 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.379 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -153.8 160.03 42.09 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 5' ' ' TRP . 40.1 tt0 -77.64 -66.98 0.77 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.083 0.468 . . . . 0.0 110.999 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.03 139.27 41.36 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.563 -175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.562 ' O ' HG13 ' A' ' 57' ' ' ILE . 53.6 m -57.74 -39.94 78.52 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.235 0.614 . . . . 0.0 112.489 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -69.34 -36.98 77.46 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.8 m -64.49 -42.22 95.99 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.131 176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.6 tp -63.19 -50.68 69.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.642 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 HG13 ' O ' ' A' ' 53' ' ' SER . 84.2 mt -55.21 -49.16 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.739 0.816 . . . . 0.0 111.739 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.4 -33.09 74.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 62' ' ' SER . 28.2 m -70.73 -37.1 73.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 176.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.484 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 74.1 mt -67.72 -38.08 79.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.617 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -66.82 -35.77 80.82 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 59' ' ' THR . 75.1 m -58.81 -42.86 90.16 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.367 0.603 . . . . 0.0 109.993 175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 60' ' ' ILE . 17.1 t -58.94 -37.73 69.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.697 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.449 ' HG2' HG11 ' A' ' 72' ' ' VAL . 38.7 mtm180 -75.63 -11.93 60.11 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.257 0.551 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -91.15 -0.39 57.7 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.795 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.59 120.43 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-O 121.944 0.878 . . . . 0.0 108.75 175.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -38.71 -35.18 0.18 Allowed 'General case' 0 C--N 1.292 -1.891 0 C-N-CA 128.142 2.577 . . . . 0.0 116.518 -176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 22' ' ' ILE . . . -102.29 12.18 57.04 Favored Glycine 0 N--CA 1.423 -2.195 0 C-N-CA 118.881 -1.628 . . . . 0.0 113.938 -171.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 12' ' ' VAL . 60.1 t -84.93 122.47 38.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.251 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.504 HD21 ' HE2' ' A' ' 15' ' ' LYS . 88.4 mt -90.69 -57.74 2.72 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -142.34 129.52 20.95 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.449 HG11 ' HG2' ' A' ' 64' ' ' ARG . 2.8 p -122.08 112.01 33.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 CA-C-O 121.57 0.7 . . . . 0.0 110.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.8 t -88.09 132.5 34.28 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.181 -177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 tt -91.58 114.81 27.45 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.547 0.689 . . . . 0.0 110.3 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 58.8 t -99.15 89.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-O 121.869 0.842 . . . . 0.0 110.018 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -151.98 137.53 17.77 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 172.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -89.31 133.98 34.26 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.434 -174.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -79.47 158.97 27.16 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.641 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.65 -31.48 41.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 120.492 0.187 . . . . 0.0 110.626 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -76.73 85.78 3.36 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -62.64 -41.82 99.24 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -88.25 -38.18 15.44 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 102.0 156.86 26.24 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -88.58 114.99 25.77 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -124.95 -67.92 0.88 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.568 -177.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 m -127.38 94.94 37.13 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 121.908 -0.495 . . . . 0.0 111.41 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -96.91 26.22 0.24 Allowed 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 123.141 2.561 . . . . 0.0 110.585 176.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -100.81 163.51 12.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.991 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.8 m -91.32 108.74 20.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -134.64 -17.88 1.94 Allowed 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -77.53 -16.16 58.84 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.046 0.927 . . . . 0.0 109.044 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -147.16 138.87 24.2 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.395 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.0 t60 -114.2 -25.02 8.66 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 71.86 106.79 0.07 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.356 1.462 . . . . 0.0 113.758 175.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 . . . . . 0 C--O 1.251 1.142 0 C-N-CA 124.426 1.09 . . . . 0.0 112.471 175.392 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' HA ' ' HB3' ' A' ' 5' ' ' TRP . 26.8 ptt? . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -125.33 -70.43 0.75 Allowed 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.048 -0.661 . . . . 0.0 111.206 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 m -68.42 -33.59 74.5 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.604 0.716 . . . . 0.0 110.159 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -148.12 147.17 29.2 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.49 ' HB3' ' HA ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 177.27 169.89 0.58 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.403 1.481 . . . . 0.0 108.495 176.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' A' ' 53' ' ' SER . 17.5 mt-30 -85.43 119.74 26.12 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -176.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.0 m -129.07 102.57 7.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.6 m -111.79 132.84 54.4 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.206 -176.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.6 t -83.6 141.68 31.38 Favored 'General case' 0 N--CA 1.423 -1.793 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -124.36 131.63 53.52 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 123.765 0.826 . . . . 0.0 109.04 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 58.0 t -96.61 101.91 12.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.81 106.75 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.75 117.0 27.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.487 ' HB1' HD13 ' A' ' 22' ' ' ILE . . . -140.65 174.05 10.89 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.682 -169.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -58.27 112.79 1.67 Allowed 'General case' 0 C--N 1.346 0.455 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.434 ' HA ' HG12 ' A' ' 19' ' ' ILE . 13.5 m -59.38 -33.38 71.13 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 123.94 0.896 . . . . 0.0 112.423 -175.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -75.39 -11.67 60.1 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.201 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.495 ' O ' HG13 ' A' ' 22' ' ' ILE . 19.0 ttt180 -122.04 9.95 10.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.229 0.538 . . . . 0.0 110.584 -171.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.434 HG12 ' HA ' ' A' ' 16' ' ' SER . 29.1 mm -52.75 -41.37 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.1 m -63.43 -39.9 95.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.721 -176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -72.34 -41.99 65.84 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.561 0.696 . . . . 0.0 110.008 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.534 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 70.0 mt -62.76 -42.48 96.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.878 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.7 t -58.58 -38.82 78.73 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 123.45 0.469 . . . . 0.0 110.984 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 m -75.02 -35.55 61.94 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.887 0.851 . . . . 0.0 109.177 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 22' ' ' ILE . 15.5 mt-30 -66.1 -44.99 82.75 Favored 'General case' 0 N--CA 1.416 -2.127 0 CA-C-N 114.198 -1.365 . . . . 0.0 111.473 177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 22' ' ' ILE . 84.6 mt -69.0 -35.1 76.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.136 0.574 . . . . 0.0 110.828 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -69.24 -13.73 62.57 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 123.708 0.803 . . . . 0.0 109.711 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -94.01 4.84 53.33 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.971 -0.456 . . . . 0.0 112.079 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 32' ' ' CYS . 39.6 m-85 -87.13 149.26 46.98 Favored Pre-proline 0 N--CA 1.432 -1.342 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 175.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -61.08 99.89 0.16 Allowed 'Trans proline' 0 C--O 1.245 0.831 0 C-N-CA 122.972 2.448 . . . . 0.0 113.268 -175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' A' ' 49' ' ' GLU . . . 85.21 15.73 66.21 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.598 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 29' ' ' PHE . 48.4 m -108.48 111.32 23.13 Favored 'General case' 0 N--CA 1.411 -2.411 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -121.96 139.7 53.35 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.7 t -80.17 121.25 33.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.05 -43.56 8.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.974 0.416 . . . . 0.0 110.602 -177.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.6 t -133.7 130.17 55.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' HD23 ' A' ' 44' ' ' LEU . 7.2 m -115.36 130.31 56.86 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' OD2' ' HG2' ' A' ' 40' ' ' PRO . 20.2 t70 -133.94 89.31 2.56 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.624 0.726 . . . . 0.0 109.467 175.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -58.9 -41.11 86.8 Favored Pre-proline 0 CA--C 1.55 0.948 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.358 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 12.0 Cg_endo -51.61 -45.04 40.34 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.995 2.463 . . . . 0.0 113.253 176.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.1 m -94.19 -4.26 49.37 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.944 -0.702 . . . . 0.0 111.702 -177.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.76 26.16 72.11 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.388 -0.91 . . . . 0.0 111.957 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -116.2 129.38 56.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.4 0.619 . . . . 0.0 111.085 -174.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 37' ' ' SER . 78.7 mt -120.45 125.09 47.04 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.542 176.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.9 mm -92.86 118.11 37.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 80.0 t -119.49 130.06 74.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.6 t -103.98 114.93 44.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.6 t -100.77 122.1 52.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 31' ' ' GLY . 16.4 pt-20 -107.29 134.87 49.73 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.292 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.59 163.17 35.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -94.45 -58.1 2.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.413 ' HB3' ' OE2' ' A' ' 54' ' ' GLU . 15.1 m-20 -83.21 147.33 28.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.414 ' HA ' HE22 ' A' ' 6' ' ' GLN . 12.9 p -67.14 -46.11 75.05 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -175.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -72.56 -35.12 67.91 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.701 -0.227 . . . . 0.0 110.818 -178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.0 m -62.4 -35.66 79.91 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.244 0.545 . . . . 0.0 109.532 176.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 60' ' ' ILE . 52.2 tp -63.31 -50.85 68.44 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.6 mt -58.07 -48.54 84.11 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.973 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 99.1 mt-30 -52.21 -47.77 65.44 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.37 0.668 . . . . 0.0 111.167 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 63' ' ' VAL . 19.3 m -64.96 -43.59 92.18 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.331 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.518 ' O ' ' HG3' ' A' ' 64' ' ' ARG . 77.7 mt -63.11 -38.8 83.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.896 0.379 . . . . 0.0 110.419 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -62.33 -39.37 92.85 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.568 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 8.6 t -65.14 -38.13 89.63 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 59' ' ' THR . 94.8 t -57.98 -41.04 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.617 0.723 . . . . 0.0 109.824 177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.518 ' HG3' ' O ' ' A' ' 60' ' ' ILE . 89.2 mtt-85 -65.84 -22.76 66.56 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.014 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.0 m-80 -83.64 1.95 39.87 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -175.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG12 ' H ' ' A' ' 68' ' ' GLY . 58.5 t -78.15 137.15 22.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 C-N-CA 119.411 -0.915 . . . . 0.0 111.897 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -43.04 -55.9 3.6 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 127.982 2.513 . . . . 0.0 113.588 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' H ' HG12 ' A' ' 66' ' ' VAL . . . -74.41 -7.41 78.37 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.29 -0.957 . . . . 0.0 114.166 -176.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.409 HG23 ' HB ' ' A' ' 66' ' ' VAL . 99.4 t -88.97 144.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 117.644 0.722 . . . . 0.0 110.762 -176.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.11 -58.49 1.94 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -140.97 133.43 28.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.106 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -108.9 109.04 26.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 175.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 46.2 m -92.07 127.99 37.75 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 177.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -91.3 111.12 22.47 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.5 t -71.57 -53.63 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 CA-C-O 121.604 0.716 . . . . 0.0 111.982 -176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -99.73 84.04 2.86 Favored 'General case' 0 C--N 1.269 -2.912 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.286 -177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -131.91 106.34 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.171 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -123.16 110.16 14.92 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -90.55 -67.33 0.86 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.448 178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 82' ' ' GLN . 9.2 tp10 -165.41 138.64 4.49 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 177.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -83.46 -38.37 21.93 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.3 -171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 3.8 pt20 -124.88 177.78 5.84 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 106.32 -69.0 0.23 Allowed Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.85 -59.7 2.34 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -93.07 151.82 19.65 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 61.6 m -148.7 83.81 6.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -73.73 -43.56 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.19 1.926 . . . . 0.0 111.426 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.482 ' HD2' ' CE1' ' A' ' 90' ' ' HIS . 33.6 ptt180 -153.23 143.44 22.34 Favored 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.507 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.8 m -113.05 88.1 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' CE1' ' HD2' ' A' ' 88' ' ' ARG . 52.0 m170 -98.37 84.93 3.3 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.45 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -105.11 76.42 1.24 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.254 1.026 . . . . 0.0 111.458 -177.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -72.71 125.12 26.75 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 173.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -78.09 95.64 4.94 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.703 0.287 . . . . 0.0 111.718 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 35.3 m80 69.47 -71.87 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.24 1.816 . . . . 0.0 110.582 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 . . . . . 0 C--N 1.314 -0.968 0 N-CA-C 105.068 -2.197 . . . . 0.0 105.068 177.527 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 tpp . . . . . 0 C--O 1.219 -0.535 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -97.65 -37.59 9.85 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.104 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 79.4 m -64.4 -53.19 52.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -98.39 92.77 5.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.518 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -108.89 162.11 14.5 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.283 -178.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.436 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 11.6 mt-30 -72.68 120.24 18.02 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.469 -173.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.3 m -119.17 130.5 73.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 56' ' ' LEU . 15.6 p -142.99 148.18 36.36 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 37.0 t -104.5 150.55 24.49 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 94.3 mt -124.28 122.65 38.33 Favored 'General case' 0 C--N 1.27 -2.874 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.2 t -90.1 101.63 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 172.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 44' ' ' LEU . 85.6 t -97.0 115.38 36.41 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.422 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.538 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -92.01 121.77 33.9 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -139.03 173.12 11.89 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.477 ' HE2' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -59.94 125.53 24.0 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 176.607 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.502 ' HA ' HG12 ' A' ' 19' ' ' ILE . 10.9 p -64.85 -27.45 68.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.643 0.735 . . . . 0.0 111.339 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -78.96 -10.75 59.92 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.7 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.44 ' HG2' HG13 ' A' ' 22' ' ' ILE . 65.6 ttt180 -121.8 18.71 11.06 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-O 121.931 0.872 . . . . 0.0 110.516 -173.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.58 HG23 HD21 ' A' ' 44' ' ' LEU . 25.6 mm -62.34 -47.51 92.73 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.69 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.9 m -61.22 -40.89 95.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.32 -57.38 9.56 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.967 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 91.9 mt -64.87 -34.87 73.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.662 -176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -63.92 -30.66 71.72 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 65.8 m -81.82 -28.45 33.09 Favored 'General case' 0 C--O 1.241 0.658 0 CA-C-O 121.959 0.885 . . . . 0.0 108.694 -177.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -73.45 -47.5 40.99 Favored 'General case' 0 N--CA 1.408 -2.569 0 CA-C-N 114.573 -1.194 . . . . 0.0 111.364 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.548 HD22 HG13 ' A' ' 63' ' ' VAL . 45.9 mt -70.18 -32.94 71.11 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -177.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' OD1' ' HG3' ' A' ' 33' ' ' GLU . 59.6 t30 -81.84 6.48 15.55 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.726 0.774 . . . . 0.0 110.905 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -102.55 9.29 39.55 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.619 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.554 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 67.8 m-85 -103.28 150.13 37.64 Favored Pre-proline 0 N--CA 1.418 -2.071 0 O-C-N 122.331 -0.23 . . . . 0.0 110.454 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -69.8 114.44 3.71 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.801 2.334 . . . . 0.0 112.101 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.43 -0.33 80.64 Favored Glycine 0 C--N 1.318 -0.469 0 C-N-CA 120.81 -0.71 . . . . 0.0 111.811 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 34.7 t -115.1 112.65 22.91 Favored 'General case' 0 N--CA 1.418 -2.069 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.486 ' HG3' ' OD1' ' A' ' 27' ' ' ASN . 36.3 tt0 -132.61 143.45 49.69 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.288 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 46' ' ' VAL . 40.8 t -86.24 127.99 39.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.38 -54.27 2.9 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.17 0.509 . . . . 0.0 110.901 -178.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.3 t -121.49 124.02 70.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.7 m -114.47 106.44 14.28 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 43' ' ' GLN . 4.4 m-20 -99.29 96.63 7.87 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.526 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -57.53 -48.74 96.74 Favored Pre-proline 0 CA--C 1.561 1.384 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 36.0 Cg_endo -57.02 -35.39 98.91 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.225 2.617 . . . . 0.0 113.138 -176.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.3 m -96.34 -9.09 30.89 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.163 -175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 72.31 26.0 73.08 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.697 -1.24 . . . . 0.0 110.716 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 26.6 mt-30 -102.23 132.14 48.34 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.299 0.571 . . . . 0.0 112.487 -174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.58 HD21 HG23 ' A' ' 19' ' ' ILE . 83.0 mt -125.66 117.56 23.77 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 173.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 mm -91.74 116.99 34.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 34' ' ' VAL . 62.0 t -117.39 122.23 69.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.636 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.3 108.72 22.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.4 t -105.19 115.78 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 6' ' ' GLN . 8.6 pt-20 -119.44 122.59 42.09 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.709 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.04 144.87 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -178.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.58 -57.75 3.73 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.769 -174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 21.7 m-20 -81.71 147.53 29.44 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.319 -175.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -62.47 -48.21 80.63 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.478 0.711 . . . . 0.0 110.636 -177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' OE1' ' HB3' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -68.65 -39.59 80.62 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.638 -178.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.3 m -62.17 -35.84 80.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.43 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 8' ' ' CYS . 45.8 tp -61.98 -49.95 74.06 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 177.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 61.2 mt -60.89 -43.45 95.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.742 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 54' ' ' GLU . 10.2 mm100 -63.12 -34.55 77.86 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.617 -179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 29.0 m -75.86 -41.96 50.85 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.021 0.438 . . . . 0.0 109.894 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 75.9 mt -62.67 -37.9 80.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.947 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -66.07 -38.5 88.46 Favored 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 119.114 -1.034 . . . . 0.0 111.06 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 68.8 m -57.98 -43.41 86.51 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.562 0.696 . . . . 0.0 110.601 178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG13 HD22 ' A' ' 26' ' ' LEU . 38.2 t -60.22 -41.98 88.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.198 176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -78.77 -10.07 59.65 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.649 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -85.48 -6.78 59.16 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.14 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.7 t -72.17 115.43 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -75.89 108.18 8.59 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.734 -178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 146.84 -11.22 1.44 Allowed Glycine 0 C--N 1.282 -2.467 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.58 143.49 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.848 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.477 HD21 ' HE2' ' A' ' 15' ' ' LYS . 96.0 mt -102.64 -54.79 2.58 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.77 132.42 12.22 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.157 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.88 121.85 63.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.3 t -103.46 118.24 36.3 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 175.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.59 107.69 16.21 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.337 0.589 . . . . 0.0 110.062 -174.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 9' ' ' SER . 42.4 t -84.34 85.27 2.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.748 1.261 . . . . 0.0 108.996 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -160.63 -39.49 0.05 OUTLIER 'General case' 0 C--N 1.283 -2.324 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 28.4 m170 75.76 159.33 0.21 Allowed 'General case' 0 CA--C 1.504 -0.812 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.702 171.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -121.98 -47.42 2.17 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.748 -1.114 . . . . 0.0 108.633 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -85.16 91.08 8.04 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 122.362 1.077 . . . . 0.0 111.271 179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -130.46 -54.63 1.09 Allowed 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 175.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -63.88 -32.89 74.56 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.711 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -92.18 -0.25 57.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.635 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.56 125.62 2.61 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -80.41 -20.69 43.39 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.316 0.579 . . . . 0.0 110.635 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -84.11 136.57 33.95 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.4 p -90.26 117.58 68.15 Favored Pre-proline 0 N--CA 1.408 -2.565 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -84.85 -164.74 0.26 Allowed 'Trans proline' 0 N--CA 1.443 -1.45 0 C-N-CA 122.36 2.04 . . . . 0.0 112.865 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -74.35 98.3 3.22 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.424 0.63 . . . . 0.0 111.432 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.9 m -72.77 128.39 35.37 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.314 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.1 m80 73.46 102.39 0.07 Allowed 'General case' 0 C--O 1.244 0.794 0 C-N-CA 125.176 1.39 . . . . 0.0 111.6 -176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -81.11 80.71 7.51 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 176.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -100.08 -16.24 17.93 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.398 -175.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -126.14 97.28 5.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.434 -177.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -77.23 100.73 5.93 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 175.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.4 p-80 . . . . . 0 C--N 1.285 -2.212 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.364 -174.638 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.392 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -135.6 18.01 3.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.579 0.704 . . . . 0.0 110.134 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.0 m -90.84 157.14 17.53 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -83.76 85.93 7.22 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 167.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -54.69 113.19 1.22 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -67.45 123.61 20.87 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 112.879 -1.964 . . . . 0.0 113.659 -170.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.475 HG12 ' HB3' ' A' ' 49' ' ' GLU . 18.1 m -102.06 148.64 7.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 CA-C-N 113.778 -1.555 . . . . 0.0 108.841 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.561 ' SG ' HD21 ' A' ' 56' ' ' LEU . 73.8 m -145.18 126.48 14.84 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 174.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -88.46 135.12 33.63 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 73.7 mt -115.54 134.14 55.36 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.578 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 73' ' ' SER . 53.8 t -94.8 101.39 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.948 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 170.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.4 t -95.04 105.36 16.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.313 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -85.5 114.33 22.44 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.5 172.17 13.41 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.769 -0.372 . . . . 0.0 111.53 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -55.92 116.38 2.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.467 174.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.6 p -60.01 -28.65 67.89 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.764 0.792 . . . . 0.0 111.779 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.97 -12.44 60.04 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.662 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -123.95 17.52 9.32 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.661 0.743 . . . . 0.0 109.905 -170.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.453 HG23 HD21 ' A' ' 44' ' ' LEU . 31.5 mm -60.32 -50.24 81.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.535 -175.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -60.18 -36.67 78.13 Favored 'General case' 0 C--O 1.253 1.252 0 CA-C-O 121.242 0.544 . . . . 0.0 110.805 -178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -64.7 -53.7 43.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.2 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 72.3 mt -65.72 -34.96 73.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.215 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 41.3 m -61.64 -31.43 71.52 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.797 0.332 . . . . 0.0 111.573 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.0 m -77.84 -34.82 51.69 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.75 -42.93 63.53 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 113.72 -1.582 . . . . 0.0 111.869 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 46' ' ' VAL . 95.0 mt -66.32 -32.49 73.93 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 122.532 0.333 . . . . 0.0 111.835 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -83.05 2.02 37.19 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.684 0.278 . . . . 0.0 111.736 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -92.15 -8.67 44.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -177.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.547 ' HB2' ' HB3' ' A' ' 32' ' ' CYS . 32.0 m-85 -92.4 141.36 24.74 Favored Pre-proline 0 N--CA 1.405 -2.719 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -70.71 110.24 2.7 Favored 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 122.606 2.204 . . . . 0.0 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.86 7.66 55.13 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.031 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 29' ' ' PHE . 33.9 t -122.5 121.2 35.99 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.36 141.6 37.61 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.654 -177.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 46' ' ' VAL . 39.8 t -84.4 130.54 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -66.93 0.87 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 99.9 t -106.91 132.38 54.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.834 -178.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 m -119.8 121.78 39.9 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 175.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -114.67 93.11 4.18 Favored 'General case' 0 CA--C 1.486 -1.499 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 176.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.575 ' N ' ' HD2' ' A' ' 40' ' ' PRO . . . -56.05 -42.55 96.74 Favored Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 39' ' ' ALA . 13.3 Cg_endo -52.29 -44.64 44.99 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 123.268 2.645 . . . . 0.0 113.572 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.3 m -98.27 -12.21 21.81 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.36 63.1 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.051 -1.071 . . . . 0.0 111.206 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -97.91 128.95 44.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -176.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD21 HG23 ' A' ' 19' ' ' ILE . 61.0 mt -120.55 116.89 26.27 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.809 175.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.2 118.01 34.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.462 ' CG2' HD13 ' A' ' 26' ' ' LEU . 88.7 t -116.56 129.79 72.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -178.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.4 t -107.18 113.12 42.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.3 t -106.36 126.32 62.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.475 ' HB3' HG12 ' A' ' 7' ' ' VAL . 12.8 pt-20 -131.89 122.11 25.13 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.15 145.11 33.85 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 112.677 0.621 . . . . 0.0 112.677 -174.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -53.4 -62.16 1.83 Allowed 'General case' 0 C--O 1.238 0.494 0 C-N-CA 126.132 1.773 . . . . 0.0 111.764 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.15 144.92 25.95 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.214 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.2 m -54.41 -38.97 66.84 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.707 0.803 . . . . 0.0 112.115 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -76.5 -31.32 57.64 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.952 0.406 . . . . 0.0 110.76 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 m -62.29 -36.86 83.42 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD21 ' SG ' ' A' ' 8' ' ' CYS . 41.9 tp -62.9 -50.73 69.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.233 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 74.4 mt -55.64 -47.48 78.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.907 0.883 . . . . 0.0 111.079 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -63.79 -39.66 94.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.984 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.4 m -70.14 -36.88 75.07 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 120.973 0.416 . . . . 0.0 110.493 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 74.9 mt -65.88 -34.89 73.32 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.171 0.51 . . . . 0.0 109.749 176.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -59.36 -44.06 92.75 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.901 177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 53.6 m -57.85 -43.43 85.91 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.149 0.58 . . . . 0.0 112.049 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.2 -40.75 81.9 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.573 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.84 -27.12 66.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.967 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -77.69 -8.19 57.56 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.83 125.11 35.12 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.648 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -72.81 116.81 13.75 Favored 'General case' 0 N--CA 1.394 -3.27 0 CA-C-O 122.115 0.96 . . . . 0.0 111.411 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.27 -7.62 5.66 Favored Glycine 0 C--N 1.268 -3.211 0 CA-C-N 113.246 -1.797 . . . . 0.0 109.773 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.97 136.74 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.3 mt -101.89 -41.99 6.29 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.776 -177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -157.38 129.83 7.37 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.456 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 79.3 t -107.19 109.17 27.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 174.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.512 ' HB2' ' HB ' ' A' ' 11' ' ' VAL . 59.4 m -104.88 146.11 29.47 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.596 -177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 26.0 mt -95.36 116.71 29.15 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 122.769 0.427 . . . . 0.0 111.351 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.27 -44.76 87.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -131.77 123.64 28.05 Favored 'General case' 0 N--CA 1.405 -2.697 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -100.68 165.06 11.58 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.38 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -62.09 152.41 32.84 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.277 174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -75.63 101.89 5.13 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.526 0.679 . . . . 0.0 109.366 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -95.77 169.27 10.12 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.258 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -76.88 -51.03 11.98 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -178.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 61.65 -174.04 0.14 Allowed 'General case' 0 C--O 1.241 0.612 0 O-C-N 124.106 0.879 . . . . 0.0 112.012 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -165.68 35.42 Favored Glycine 0 N--CA 1.434 -1.487 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -77.71 -36.92 50.52 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.053 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -82.54 142.32 31.92 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.275 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.4 p -132.67 103.71 13.31 Favored Pre-proline 0 C--N 1.299 -1.599 0 CA-C-O 121.128 0.489 . . . . 0.0 110.201 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.23 168.49 20.23 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.423 2.082 . . . . 0.0 113.436 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -87.24 -67.5 0.82 Allowed 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 174.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.7 m -113.47 -41.89 3.57 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 166.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' CG ' ' H ' ' A' ' 91' ' ' HIS . 12.6 t-80 177.3 -152.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 101.979 -3.341 . . . . 0.0 101.979 175.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.425 ' H ' ' CG ' ' A' ' 90' ' ' HIS . 58.7 t60 -67.7 100.68 0.94 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 173.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 74.99 174.46 0.25 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 125.109 1.364 . . . . 0.0 109.793 -173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -96.08 -66.81 0.88 Allowed 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -162.91 13.88 0.07 Allowed 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 . . . . . 0 N--CA 1.417 -2.099 0 N-CA-C 100.905 -3.739 . . . . 0.0 100.905 -174.162 . . . . . . . . 0 0 . 1 stop_ save_